Россия, г. Королев.

eburdiyg@gmail.com

8 (903) 781-84-63

  • Главная
  • Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

Номер патента: US11124580B2
Опубликовано: 21-09-2021
Автор(ы): Richard A. Morgan, Steven A. Rosenberg
Принадлежит: US Department of Health and Human Services
Получить PDF файл: Открыть в новом окне

Вам могут быть интересны следующие патенты

Рисунок 1. Взаимосвязь патентов (ближайшие 20).

Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

Номер патента: US9266960B2. Автор: Steven A. Rosenberg,Richard A. Morgan. Владелец: US Department of Health and Human Services. Дата публикации: 2016-02-23.

Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer

Номер патента: EP3459560A1. Автор: Steven A. Rosenberg,Richard Arthur Morgan. Владелец: US Department of Health and Human Services. Дата публикации: 2019-03-27.

Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer

Номер патента: IL228686A. Автор: . Владелец: Us Health. Дата публикации: 2017-09-28.

Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer

Номер патента: CA2832540C. Автор: Steven A. Rosenberg,Richard A. Morgan. Владелец: US Department of Health and Human Services. Дата публикации: 2020-09-15.

Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer

Номер патента: WO2012138475A1. Автор: Steven A. Rosenberg,Richard A. Morgan. Владелец: The United States of America, as represented by the Secretary, Department of Health and Human Services. Дата публикации: 2012-10-11.

Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

Номер патента: US9624306B2. Автор: Steven A. Rosenberg,Richard A. Morgan. Владелец: US Department of Health and Human Services. Дата публикации: 2017-04-18.

Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

Номер патента: US11879017B2. Автор: Steven A. Rosenberg,Richard A Morgan. Владелец: US Department of Health and Human Services. Дата публикации: 2024-01-23.

ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III CHIMERIC ANTIGEN RECEPTORS AND USE OF SAME FOR THE TREATMENT OF CANCER

Номер патента: US20200157241A1. Автор: Rosenberg Steven A.,Morgan Richard A.. Владелец: The United States of America,as represented by the Secretary,Department of Health and Human Services. Дата публикации: 2020-05-21.

Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

Номер патента: US10570214B2. Автор: Steven A. Rosenberg,Richard A. Morgan. Владелец: US Department of Health and Human Services. Дата публикации: 2020-02-25.

Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer

Номер патента: PT3459560T. Автор: . Владелец: Us Health. Дата публикации: 2021-05-24.

Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer

Номер патента: IL228686A0. Автор: . Владелец: Us Health. Дата публикации: 2013-12-31.

Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer

Номер патента: US20160200819A1. Автор: Steven A. Rosenberg,Richard A. Morgan. Владелец: US Department of Health and Human Services. Дата публикации: 2016-07-14.

Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer

Номер патента: US20210388113A1. Автор: Steven A. Rosenberg,Richard A. Morgan. Владелец: US Department of Health and Human Services. Дата публикации: 2021-12-16.

Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer

Номер патента: IL285335B2. Автор: . Владелец: Us Health. Дата публикации: 2023-12-01.

Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer

Номер патента: IL285335B1. Автор: . Владелец: Us Secretary Department Of Health And Human Services. Дата публикации: 2023-08-01.

Anti-epidermal growth factor receptor variant III chimeric antigen receptors and their use for treating cancer

Номер патента: CN107188969B. Автор: 理查德·A·摩根,史蒂文·A·罗森堡. Владелец: US Department of Health and Human Services. Дата публикации: 2021-08-27.

Anti-epidermal growth factor receptor (EGFR) antibodies

Номер патента: US10584171B2. Автор: Wei-Dong Jiang,pei-hua Lin. Владелец: Henlix Biotech Co Ltd. Дата публикации: 2020-03-10.

Compound, process for its preparation, a pharmaceutical solution containing the compound, a method of determining the presence of cancer, a kit for cancer detection, and the use of hydrolysis of the compound for the detection of cancer

Номер патента: EP3423111A1. Автор: Adam LESNER,Dawid NIDZWORSKI,Magdalena WYSOCKA. Владелец: INSTYTUT BIOTECHNOLOGII I MEDYCYNY MOLEKULARNEJ. Дата публикации: 2019-01-09.

Compound, process for its preparation, a pharmaceutical solution containing the compound, a method of determining the presence of cancer, a kit for cancer detection, and the use of hydrolysis of the compound for the detection of cancer

Номер патента: US20190248835A1. Автор: Adam LESNER,Dawid NIDZWORSKI,Magdalena WYSOCKA. Владелец: INSTYTUT BIOTECHNOLOGII I MEDYCYNY MOLEKULARNEJ. Дата публикации: 2019-08-15.

Compound, process for its preparation, a pharmaceutical solution containing the compound, a method of determining the presence of cancer, a kit for cancer detection, and the use of hydrolysis of the compound for the detection of cancer

Номер патента: WO2017150997A1. Автор: Adam LESNER,Dawid NIDZWORSKI,Magdalena WYSOCKA. Владелец: INSTYTUT BIOTECHNOLOGII I MEDYCYNY MOLEKULARNEJ. Дата публикации: 2017-09-08.

Compound, process for its preparation, a pharmaceutical solution containing the compound, a method of determining the presence of cancer, a kit for cancer detection, and the use of hydrolysis of the compound for the detection of cancer

Номер патента: US10556925B2. Автор: Adam LESNER,Dawid NIDZWORSKI,Magdalena WYSOCKA. Владелец: INSTYTUT BIOTECHNOLOGII I MEDYCYNY MOLEKULARNEJ. Дата публикации: 2020-02-11.

Use of tweak modulators and inhibitors for the treatment of neurological conditions

Номер патента: EP1721157A1. Автор: Armin Schneider,Moritz Rossner,Markus Schwaninger,Gerhart Vogt. Владелец: Axaron Bioscience AG. Дата публикации: 2006-11-15.

Use of tweak modulators and inhibitors for the treatment of neurological conditions

Номер патента: IL177285A0. Автор: . Владелец: Axaron Bioscience AG. Дата публикации: 2006-12-10.

Use of tweak modulators and inhibitors for the treatment of neurological conditions

Номер патента: CA2558770A1. Автор: Armin Schneider,Gerhard Vogt,Moritz Rossner,Markus Schwaninger. Владелец: Individual. Дата публикации: 2005-09-01.

Use of tweak modulators and inhibitors for the treatment of neurological conditions

Номер патента: AU2005214843A1. Автор: Armin Schneider,Moritz Rossner,Markus Schwaninger,Gerhart Vogt. Владелец: Axaron Bioscience AG. Дата публикации: 2005-09-01.

Use of histamine h4 receptor modulators for the treatment of allergy and asthma

Номер патента: EP1545596A2. Автор: Lars Karlsson,Ping Ling,Wai-Ping Leung,Robin L. Thurmond,Paul J. Dunford,Pragnya J. Desai,Claudia L. Hofstra. Владелец: Janssen Pharmaceutica NV. Дата публикации: 2005-06-29.

Use of histamine h4 receptor modulators for the treatment of allergy and asthma

Номер патента: WO2004021999A3. Автор: Lars Karlsson,Ping Ling,Robin L Thurmond,Wai-Ping Leung,Pragnya J Desai,Paul J Dunford,Claudia L Hofstra. Владелец: Claudia L Hofstra. Дата публикации: 2004-10-07.

Compound - diagnostic marker for ovarian cancer, method for detecting enzymatic activity, method for diagnosis of ovarian cancer, kit comprising the compound, uses of the compound and method for the treatment of ovarian cancer

Номер патента: WO2024072241A4. Автор: Adam LESNER,Natalia Gruba. Владелец: Urteste S.A.. Дата публикации: 2024-06-06.

Compound-diagnostic marker for uterine body cancer, method for detecting enzymatic activity, method for diagnosis of uterine body cancer, kit comprising the compound, uses of the compound and method for the treatment of uterine body cancer

Номер патента: WO2024005658A1. Автор: Adam LESNER,Natalia Gruba. Владелец: Urteste S.A.. Дата публикации: 2024-01-04.

Compound - diagnostic marker for ovarian cancer, method for detecting enzymatic activity, method for diagnosis of ovarian cancer, kit comprising the compound, uses of the compound and method for the treatment of ovarian cancer

Номер патента: WO2024072241A1. Автор: Adam LESNER,Natalia Gruba. Владелец: Urteste S.A.. Дата публикации: 2024-04-04.

Compound - diagnostic marker for kidney cancer, method lor detecting enzymaticactivity, method for diagnosis of kidney cancer, kit comprising the compound, uses of the compound and method for the treatment of kidney cancer

Номер патента: WO2023204721A1. Автор: Adam LESNER,Natalia Gruba. Владелец: Urteste S.A.. Дата публикации: 2023-10-26.

Antibodies and related molecules and uses thereof

Номер патента: AU2017235783B2. Автор: Steven Lee,Roy Bicknell. Владелец: Cancer Research Technology LTD. Дата публикации: 2024-05-23.

ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) ANTIBODIES

Номер патента: US20170218073A1. Автор: LIN Pei-Hua,JIANG Wei-Dong. Владелец: . Дата публикации: 2017-08-03.

ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) ANTIBODIES

Номер патента: US20200223929A1. Автор: JIANG Weidong,LIN Pei-Hua. Владелец: . Дата публикации: 2020-07-16.

Recombinant anti-epidermal growth factor receptor antibody compositions

Номер патента: PL2132229T3. Автор: Mikkel Wandahl Pedersen,Lucilla Steinaa,Allan Jensen,Klaus Koefoed,Per-Johan Meijer,Robert Carlsson,Charles Pyke,Lars Soegaard Nielsen. Владелец: . Дата публикации: 2016-12-30.

Conditionally active anti-epidermal growth factor receptor antibodies and methods of use thereof

Номер патента: KR101721678B1. Автор: 게 웨이,그레고리 프로스트,레이 황,에이치. 마이클 셰퍼드,다니엘 에드워드 버간. Владелец: 할로자임, 아이엔씨. Дата публикации: 2017-03-31.

Condition-dependent active anti-epidermal growth factor receptor antibody and method of use thereof

Номер патента: JP6181089B2. Автор: ダニエル・エドワード・ボーン,グァ・ウェイ,グレゴリー・フロスト,ホアン・レイ,エイチ・マイケル・シェパード. Владелец: ハロザイム インコーポレイテッド. Дата публикации: 2017-08-16.

Anti-epidermal growth factor receptor (egfr) antibodies

Номер патента: HUE047113T2. Автор: Wei-Dong Jiang,pei-hua Lin. Владелец: Henlix Biotech Co Ltd. Дата публикации: 2020-04-28.

Conditionally active anti-epidermal growth factor receptor antibodies and methods of use thereof

Номер патента: WO2013134743A1. Автор: Ge Wei,Lei Huang,H. Michael Shepard,Daniel Edward Vaughn,Gregory Frost. Владелец: Halozyme, Inc.. Дата публикации: 2013-09-12.

Conditionally active anti-epidermal growth factor receptor antibodies and methods of use thereof

Номер патента: EP3296320A1. Автор: Ge Wei,Lei Huang,H. Michael Shepard,Daniel Edward Vaughn,Gregory Frost. Владелец: Halozyme Inc. Дата публикации: 2018-03-21.

Anti-epidermal growth factor receptor (egfr) antibodies

Номер патента: EP3613433A1. Автор: Wei-Dong Jiang,pei-hua Lin. Владелец: Henlix Biotech Co Ltd. Дата публикации: 2020-02-26.

Anti-epidermal growth factor receptor (EGFR) antibodies

Номер патента: US11261255B2. Автор: Weidong Jiang,pei-hua Lin. Владелец: Shanghai Henlius Biotech Inc. Дата публикации: 2022-03-01.

Anti-epidermal growth factor receptor (egfr) antibodies

Номер патента: KR102366644B1. Автор: 웨이-동 장,페이-화 린. Владелец: 상하이 헨리우스 바이오테크, 인크.. Дата публикации: 2022-02-22.

Anti-epidermal growth factor receptor (egfr) antibodies

Номер патента: WO2015184403A3. Автор: Wei-Dong Jiang,pei-hua Lin. Владелец: Henlius Biotech Co., Ltd.. Дата публикации: 2016-01-21.

Conditionally active anti-epidermal growth factor receptor antibodies and methods of use thereof

Номер патента: CN104379602A. Автор: H·M·谢泼德,G·卫,L·黄,G·弗罗斯特,D·E·沃恩. Владелец: Halozyme Inc. Дата публикации: 2015-02-25.

Recombinant anti-epidermal growth factor receptor antibody compositions

Номер патента: CA2676049A1. Автор: Mikkel Wandahl Pedersen,Lucilla Steinaa,Allan Jensen,Klaus Koefoed,Per-Johan Meijer,Robert Carlsson,Charles Pyke,Lars Soegaard Nielsen. Владелец: Individual. Дата публикации: 2008-09-04.

Recombinant anti-epidermal growth factor receptor antibody compositions

Номер патента: IL216850A0. Автор: . Владелец: Symphogen AS. Дата публикации: 2012-01-31.

Conditionally active anti-epidermal growth factor receptor antibodies and methods of use thereof

Номер патента: CN104379602B. Автор: H·M·谢泼德,G·卫,L·黄,G·弗罗斯特,D·E·沃恩. Владелец: Halozyme Inc. Дата публикации: 2017-05-03.

Anti-epidermal growth factor receptor (EGFR) antibody

Номер патента: JP6691872B2. Автор: ウェイ−トン チアン，,ペイ−ホア リン，. Владелец: ヘンリクス バイオテック カンパニー リミテッド. Дата публикации: 2020-05-13.

Recombinant Anti-Epidermal Growth Factor Receptor Antibody Compositions

Номер патента: US20110129855A1. Автор: Mikkel Wandahl Pedersen,Lucilla Steinaa,Allan Jensen,Klaus Koefoed,Per-Johan Meijer,Robert Carlsson,Charles Pyke,Lars Søgaard Nielsen. Владелец: Symphogen AS. Дата публикации: 2011-06-02.

Anti-S100A7 antibodies for the treatment and diagnosis of cancer

Номер патента: US09914768B2. Автор: Jaume Adan Plana,Laura Barbera Ferrando,Carme Calvis Calpe,Antonio Coll Manzano,Sheila Dakhel Plaza,Jose Luis Hernandez Miguez,Rosa Ma Hervas Villegas,Josep Maria Martinez Escola,Marc Masa Alvarez,Ramon Messeguer Peypoch,Francesc Mitjans Prat,Laura Padilla Garcia,Manuel Rivas Canas,Lourdes Tatiana Roque Navarro. Владелец: LYKERA BIOMED SA. Дата публикации: 2018-03-13.

ANTIBODY ANTI-EPIDERMAL GROWTH FACTOR (EGFR) ANTIBODY ISOLATED AND IMMUNOCONJUGATE COMPRISING A CYTOTOXIC AGENT AND SUCH ANTIBODY

Номер патента: BRPI1012340B1. Автор: Terrance Grant Johns,Lloyd J. Old,Con Panousis,Andrew Mark Scott,Christoph Renner,Achim Jungbluth,Elizabeth Stockert,Webster K. Cavenee,Antony Wilks Burgess,Edouard Collins Nice,Anne Murray,George Mark,Gerd Ritter,Peter Collins,Hueijen Su Huang. Владелец: Ludwig Institute for Cancer Research Ltd.. Дата публикации: 2021-06-01.

Monoclonal antibody for the diagnosis, treatment and/or prevention of brain tumors and brain lesions

Номер патента: WO2016097213A1. Автор: Augusto Silva Gonzalez,José Alberto García Sanz. Владелец: Althia Health, S.L. Дата публикации: 2016-06-23.

Use of ligands of the antigen CDw52 for the treatment of diseases that are related to degenerated macrophages

Номер патента: US20060110396A1. Автор: Gerhard Gaedicke,Holger Lode,Veit Krenn,Raphaela Guenther. Владелец: Charite Universitaetsmedizin Berlin. Дата публикации: 2006-05-25.

Monoclonal antibody for the diagnosis, treatment and/or prevention of brain tumors and brain lesions

Номер патента: US20180011095A1. Автор: Augusto Silva Gonzalez,José Alberto García Sanz. Владелец: Althia Health SL. Дата публикации: 2018-01-11.

Use of CBP/EP300 bromodomain inhibitors for cancer immunotherapy

Номер патента: AU2014331697A1. Автор: Jean-Christophe Harmange,Benjamin Fauber,Srimoyee GHOSH,James Edmund Audia,Brian K. Albrecht,Alexandre Cote,F. Anthony Romero,Terry CRAWFORD,Alexander M. Taylor,Steven Magnuson,Vickie Tsui,Steven Bellon,Jeong Kim,Andrea Cochran,Jose M. Lora,Georgia Hatzivassiliou,Hariharan JAYARAM,Ira Mellman. Владелец: Constellation Pharmaceuticals Inc. Дата публикации: 2016-05-05.

Composition and use of humoral immune suppressor antagonists for the treatment of humoral immuno-suppressed diseases

Номер патента: WO2021026376A1. Автор: Luigi Grasso,Nicholas C. Nicolaides,James Bradford Kline. Владелец: Navrogen. Inc.. Дата публикации: 2021-02-11.

Composition and Use of Humoral Immune Suppressor Antagonists for the Treatment of Humoral Immune Suppressed Diseases

Номер патента: US20210040174A1. Автор: Luigi Grasso,Nicholas C. Nicolaides,James Bradford Kline. Владелец: Navrogen Inc. Дата публикации: 2021-02-11.

Use of the antibody i-3859 for the detection and diagnosis of cancer

Номер патента: KR20140047127A. Автор: 알쌍드라 주앙노,크리스땅 끌렝귀에르-앙무르. Владелец: 피에르 파브르 메디카먼트. Дата публикации: 2014-04-21.

Composition and use of humoral immune suppressor antagonists for the treatment of humoral immuno-suppressed diseases

Номер патента: EP4010359A4. Автор: Luigi Grasso,Nicholas C. Nicolaides,James Bradford Kline. Владелец: Navrogen Inc. Дата публикации: 2023-08-02.

Duffy antigen receptor for chemokines and use thereof

Номер патента: WO2006047242A8. Автор: Asok Chaudhuri. Владелец: Asok Chaudhuri. Дата публикации: 2007-06-21.

Duffy antigen receptor for chemokines and use thereof

Номер патента: CA2585156A1. Автор: Asok Chaudhuri. Владелец: Asok Chaudhuri. Дата публикации: 2006-05-04.

Materials and methods relating to the diagnosis and treatment of pre-eclampsia and diabetes

Номер патента: US20030091581A1. Автор: Thomas Rademacher,Patricia Mclean. Владелец: Rodaris Pharmaceuticals Ltd. Дата публикации: 2003-05-15.

Materials and methods relating to the diagnosis and treatment of pre-eclampsia and diabetes

Номер патента: AU715884B2. Автор: Thomas William Rademacher,Patricia Mclean. Владелец: Rademacher Group Ltd. Дата публикации: 2000-02-10.

Antigen binding protein and use thereof as addressing product for treatment of cancer

Номер патента: RU2659094C2. Автор: Лилиан ГЁТШ,Шарлотт БО-ЛАРВОР,Николя БУТ. Владелец: Пьер Фабр Медикамент. Дата публикации: 2018-06-28.

Affinity matured cd22-specific monoclonal antibody and uses thereof

Номер патента: CA3105694A1. Автор: Zhongyu Zhu,Dimiter S. Dimitrov,Terry J. FRY,Sneha RAMAKRISHNA. Владелец: US Department of Health and Human Services. Дата публикации: 2020-01-16.

Affinity matured CD22-specific monoclonal antibody and uses thereof

Номер патента: US11939377B2. Автор: Zhongyu Zhu,Dimiter S. Dimitrov,Terry J. FRY,Sneha RAMAKRISHNA. Владелец: US Department of Health and Human Services. Дата публикации: 2024-03-26.

Chimeric antigen receptor targeting BCMA and uses thereof

Номер патента: CN111727373A. Автор: J·J·梅勒霍斯特,M·C·米伦,B·恩格斯,I·普鲁泰亚努-马利尼奇,K·曼斯菲尔德,A·D·科恩,E·A·斯塔德莫尔,A·加法尔,J·A·弗拉伊塔. Владелец: University of Pennsylvania Penn. Дата публикации: 2020-09-29.

Antibody or antigen binding fragment thereof for specifically recognizing b cell malignancy, chimeric antigen receptor comprising same, and use thereof

Номер патента: EP3722313A2. Автор: Ki Hyun Kim,Kyu Tae Kim,Jong Seo Lee,Bong Kook Ko. Владелец: AbClon Inc. Дата публикации: 2020-10-14.

Antibody or antigen binding fragment thereof for specifically recognizing B cell malignancy, chimeric antigen receptor comprising same and use thereof

Номер патента: US12090171B2. Автор: Ki Hyun Kim,Kyu Tae Kim,Jong Seo Lee,Bong Kook Ko. Владелец: AbClon Inc. Дата публикации: 2024-09-17.

Antibody or antigen-binding fragment thereof that targets cotinine, chimeric antigen receptor comprising same, and uses thereof

Номер патента: AU2023230479A1. Автор: Jong-ho Lee,Jong-Seo Lee,Ki Hyun Kim,Young Ha Lee. Владелец: AbClon Inc. Дата публикации: 2024-10-10.

Msa2 affinity-enhanced biotin-binding chimeric antigen receptor (car)

Номер патента: US20190161520A1. Автор: Jason Lohmueller. Владелец: University of Pittsburgh. Дата публикации: 2019-05-30.

Chimeric antigen receptor targeting cd7 and use thereof

Номер патента: US20230390336A1. Автор: Gong Chen,LU Han,Jiangtao REN,Xiaoyan Jiang,Xiaohong He,Yanbin Wang,Yali ZHOU. Владелец: Bioheng Therapeutics Ltd. Дата публикации: 2023-12-07.

Cd28 hinge and transmembrane containing chimeric antigen receptors targeting gpc2 and use thereof

Номер патента: AU2023221836A1. Автор: Mitchell Ho,Rosandra N. Kaplan,Nan Li,Hong Ha Rosa NGUYEN,Carol J. THIELE. Владелец: US Government. Дата публикации: 2024-08-08.

Cd28 hinge and transmembrane containing chimeric antigen receptors targeting gpc2 and use thereof

Номер патента: AU2023221836A9. Автор: Mitchell Ho,Rosandra N. Kaplan,Nan Li,Hong Ha Rosa NGUYEN,Carol J. THIELE. Владелец: US Government. Дата публикации: 2024-08-15.

Chimeric antigen receptor targeting cd123 and use thereof

Номер патента: AU2021398871A9. Автор: Ting He,Feifei QI,Xin-An Lu,Yanping DING,Mengmeng LIANG. Владелец: Shandong Jinsai Co Ltd. Дата публикации: 2024-02-08.

Chimeric antigen receptor targeting cd123 and use thereof

Номер патента: AU2021398871A1. Автор: Ting He,Feifei QI,Xin-An Lu,Yanping DING,Mengmeng LIANG. Владелец: Shandong Jinsai Co Ltd. Дата публикации: 2023-07-06.

Anti-psma single-chain antibody, chimeric antigen receptor associated therewith and use thereof

Номер патента: WO2024037531A1. Автор: Lung-Ji Chang. Владелец: Beijing Meikang Geno-Immune Biotechnology Co., Ltd.. Дата публикации: 2024-02-22.

Chimeric antigen receptor targeting cd123 and use thereof

Номер патента: EP4265638A1. Автор: Ting He,Feifei QI,Xin-An Lu,Yanping DING,Mengmeng LIANG. Владелец: Shandong Jinsai Co Ltd. Дата публикации: 2023-10-25.

Cells expressing multiple chimeric antigen receptor (car) molecules and uses therefore

Номер патента: US20240139244A1. Автор: Glenn Dranoff. Владелец: University of Pennsylvania Penn. Дата публикации: 2024-05-02.

Chimeric antigen receptors targeting cd19 and use thereof

Номер патента: US20230346938A1. Автор: Michel Sadelain,Gary Shapiro,Xingyue He,Mei Rosa NG,Isabelle Riviere,Loic Vincent,Jorge MANSILLA-SOTO,Judith FEUCHT,Dan Tavares. Владелец: Memorail Hospital For Cancer And Allied Diseases. Дата публикации: 2023-11-02.

Human and mouse very low density lipoprotein receptors and methods for use of such receptors

Номер патента: WO1995013374A3. Автор: Lawrence C B Chan. Владелец: Baylor College Medicine. Дата публикации: 1995-08-24.

Myeloid cells modified by chimeric antigen receptor with cd40 and uses thereof for anti-cancer therapy

Номер патента: WO2023194607A1. Автор: Philippe Benaroch,Jovan Nikolic. Владелец: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE. Дата публикации: 2023-10-12.

Use of selective cox-2 inhibitors for the treatment of urinary incontinence

Номер патента: CA2443031A1. Автор: Amedeo Leonardi,Rodolfo Testa,Luciano Guarneri. Владелец: Individual. Дата публикации: 2002-10-17.

Use of a cox-2 inhibitor for the treatment of a cox-2 dependent disorder in a patient not carrying hla alleles associated with hepatotoxicity

Номер патента: EP2318545A1. Автор: Steven Lewitzky,Joanne Meyer,Charles Paulding,Jonathan Benjamin Singer. Владелец: NOVARTIS AG. Дата публикации: 2011-05-11.

Use of relaxin in cardiovascular therapy and in the treatment of neurodegenerative diseases

Номер патента: CA2114250C. Автор: David G. Ward,Michael Cronin,G. Roger Thomas,Phyllis L. Osheroff. Владелец: Genentech Inc. Дата публикации: 2007-10-16.

Use of relaxin in cardiovascular therapy and in the treatment of neurodegenerative diseases

Номер патента: CA2114250A1. Автор: David G. Ward,Michael Cronin,G. Roger Thomas,Phyllis L. Osheroff. Владелец: Phyllis L. Osheroff. Дата публикации: 1993-03-04.

Use of common .gamma. chain cytokines for the visualization, isolation and genetic modification of memory t lymphocytes

Номер патента: CA2618580A1. Автор: Attilio Bondanza,Maria Chiara Bonini. Владелец: Maria Chiara Bonini. Дата публикации: 2007-02-15.

Fully human anti-epidermal growth factor receptor antibodies

Номер патента: US20110280883A1. Автор: Sung Young JEONG,Sang Won Seo,A. Yeon CHO. Владелец: SAMSUNG ELECTRONICS CO LTD. Дата публикации: 2011-11-17.

Anti-epidermal growth factor receptor antibodies and uses thereof

Номер патента: US20120321643A1. Автор: Cheng Cao,David Weaver,Yanwen Jin,Michael Rynkiewicz. Владелец: Guangzhou Recomgen Biotech Co Ltd. Дата публикации: 2012-12-20.

Use of microparticles containing genetically modified cells in the treatment of neurodegenerative diseases

Номер патента: US20110212060A1. Автор: Rosa Maria Hernandez Martin,Jose Luis Pedraz Muñoz,Gorka Orive Arroyo,Carlos Spuch Calvar,Felix Bermejo-Pareja,Desiree Antequera Tienda,Eva Carro Diaz. Владелец: Fundacion Investigacion Biomedica Hospital Universitario 12 Octubre. Дата публикации: 2011-09-01.

Genetically modified recombinant fibroblast growth factor (fgf1) conjugated with metal or metal oxide nanoparticles, its dna and amino acid sequences and use

Номер патента: WO2013157973A1. Автор: Piotr JAKIMOWICZ,Małgorzata ZAKRZEWSKA,Jacek OTLEWSKI,Anna SZLACHCIC,Katarzyna PALA. Владелец: Wrocławskie Centrum Badań Eit+ Sp Z. O.O.. Дата публикации: 2013-10-24.

Use of pegylated igf-i variants for the treatment of neuromuscular disorders

Номер патента: CA2720408C. Автор: Michael Sendtner,Friedrich Metzger,Bettina Holtmann. Владелец: F Hoffmann La Roche AG. Дата публикации: 2016-09-06.

The use of wnt5-a peptide derivates for the treatment of melanoma and gastric cancer

Номер патента: CA2733636A1. Автор: Tommy Andersson. Владелец: WNTRESEARCH AB. Дата публикации: 2010-02-18.

Use of peptides as transporters intended for the internalization of molecules of interest into target cells

Номер патента: US20130116201A1. Автор: Jean-Luc Lenormand,Romy Rothe Walther. Владелец: Universite Joseph Fourier Grenoble 1. Дата публикации: 2013-05-09.

ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III CHIMERIC ANTIGEN RECEPTORS AND USE OF SAME FOR THE TREATMENT OF CANCER

Номер патента: US20170174771A1. Автор: Rosenberg Steven A.,Morgan Richard A.. Владелец: The United States of America, as represented by the Secretary, Department of Health and Human Serv. Дата публикации: 2017-06-22.

Chimeric antigen receptor T cells (CAR-T) for the treatment of cancer

Номер патента: AU2019279021A1. Автор: Matthew Cooper,Julie O'NEAL,John F. DiPersio. Владелец: Washington University in St Louis WUSTL. Дата публикации: 2020-12-10.

Anti-L1CAM antibody or antigen-binding fragment thereof and chimeric antigen receptor comprising same

Номер патента: AU2019361631B2. Автор: Jin-A CHAE,Dae Young Kim,Jae-Gyun Jeong,Yu Jung Kim,Bin Yoo. Владелец: Cartexell Inc. Дата публикации: 2024-08-15.

Anti-l1cam antibody or antigen-binding fragment thereof and chimeric antigen receptor comprising same

Номер патента: CA3116294C. Автор: Jin-A CHAE,Dae Young Kim,Jae-Gyun Jeong,Yu Jung Kim,Bin Yoo. Владелец: Cartexell Inc. Дата публикации: 2023-10-24.

Chimeric antigen receptor t cells (car-t) for the treatment of cancer

Номер патента: EP3802798A1. Автор: Matthew Cooper,Julie O'NEAL,John F. DiPersio. Владелец: Washington University in St Louis WUSTL. Дата публикации: 2021-04-14.

Cd2 recruiting chimeric antigen receptors and fusion proteins

Номер патента: WO2024019961A1. Автор: Matthew SIEGEL,Michael Bethune. Владелец: Cargo Therapeutics, Inc.. Дата публикации: 2024-01-25.

CHIMERIC ANTIGEN RECEPTOR EFFECTOR CELL SWITCHES WITH HUMANIZED TARGETING MOIETIES AND/OR OPTIMIZED CHIMERIC ANTIGEN RECEPTOR INTERACTING DOMAINS AND USES THEREOF

Номер патента: US20220073597A1. Автор: Schultz Peter G.,PRESTA Leonard,Wright Timothy,Rodgers David,HAMPTON Eric,YOUNG Travis S.,LABORDA Eduardo,KHIALEEVA Elvira,VIAUD Sophie. Владелец: . Дата публикации: 2022-03-10.

CHIMERIC ANTIGEN RECEPTOR EFFECTOR CELL SWITCHES WITH HUMANIZED TARGETING MOIETIES AND/OR OPTIMIZED CHIMERIC ANTIGEN RECEPTOR INTERACTING DOMAINS AND USES THEREOF

Номер патента: US20190359697A1. Автор: Schultz Peter G.,PRESTA Leonard,Wright Timothy,Rodgers David,HAMPTON Eric,YOUNG Travis S.,LABORDA Eduardo,KHIALEEVA Elvira,VIAUD Sophie. Владелец: . Дата публикации: 2019-11-28.

Treatment of neurological of neurodegenerative disorder

Номер патента: WO2011023249A1. Автор: Denis Vivien,Karl-Uwe Petersen,Benoit Roussel,Carine Ali,José Lopez Atalaya,Yannick Hommet. Владелец: Paion Deutschland GmbH. Дата публикации: 2011-03-03.

Chimeric antigen receptor targeting cd7 and use thereof

Номер патента: EP4219693A4. Автор: Gong Chen,LU Han,Jiangtao REN,Xiaoyan Jiang,Xiaohong He,Yanbin Wang,Yali ZHOU. Владелец: Bioheng Therapeutics Ltd. Дата публикации: 2024-10-02.

Antibody Or Antigen Binding Fragment Thereof For Specifically Recognizing B Cell Malignancy, Chimeric Antigen Receptor Comprising Same And Use Thereof

Номер патента: US20200384023A1. Автор: KIM Ki Hyun,KIM Kyu Tae,LEE Jong Seo,KO Bong Kook. Владелец: . Дата публикации: 2020-12-10.

Antibody or antigen-binding fragment thereof that specifically recognizes b cell malignancies, chimeric antigen receptor comprising same, and uses thereof

Номер патента: EP3730519B1. Автор: Ki Hyun Kim,Kyu Tae Kim,Jong Seo Lee,Bong Kook Ko. Владелец: AbClon Inc. Дата публикации: 2023-09-13.

CHIMERIC ANTIGEN RECEPTOR T CELLS AND USES THEREOF

Номер патента: US20220265715A1. Автор: Liu Hong,XU YIYANG,Li Shan,HORAN Lucas,Cui Jun,Zhang Pengbo,Xu Yixiang,Xiong Guangyan,Yun Hongruo,Xu Shaohua. Владелец: . Дата публикации: 2022-08-25.

METHODS FOR IDENTIFYING CHIMERIC ANTIGEN RECEPTOR-TARGETING LIGANDS AND USES THEREOF

Номер патента: US20210340524A1. Автор: Wittrup Karl Dane,Irvine Darrell J.,MA Leyuan,Mehta Naveen,COSSETTE Benjamin. Владелец: . Дата публикации: 2021-11-04.

CELLS EXPRESSING MULTIPLE CHIMERIC ANTIGEN RECEPTOR (CAR) MOLECULES AND USES THEREFORE

Номер патента: US20200281973A1. Автор: Dranoff Glenn. Владелец: . Дата публикации: 2020-09-10.

CHIMERIC ANTIGEN RECEPTOR TARGETING CLL1 AND USE THEREOF

Номер патента: US20220354890A1. Автор: LI Guangchao. Владелец: . Дата публикации: 2022-11-10.

Chimeric antigen receptor targeting CD22 and uses thereof

Номер патента: CN107964549B. Автор: 黄飞,金涛,王海鹰,何凤,史子啸. Владелец: Shanghai Hrain Biotechnology Co ltd. Дата публикации: 2020-12-08.

Chimeric antigen receptor T cell and use thereof

Номер патента: JP2022541320A. Автор: ユン、ホンルオ,ツイ、チュン,チャン、ポンポー,シュイ、イーヤン,ホーラン、ルーカス,シュイ、シャオホア,シオン、コアンヤン,リー、シャン,シュイ、イーシアン,リウ、ホン. Владелец: エウレカ セラピューティクス インコーポレイテッド. Дата публикации: 2022-09-22.

Chimeric Antigen Receptors Targeting CD19 and Uses Thereof

Номер патента: KR20230008144A. Автор: 마이클 새들레인,유디트 포이히트,조지 만실라-소토,이사벨 리비에르,로익 빈센트,게리 샤피로,메이 로사 응,댄 타바레스,싱위에 허. Владелец: 메모리얼 하스피틀 포 캔서 앤드 얼라이드 디지즈스. Дата публикации: 2023-01-13.

Cells expressing multiple chimeric antigen receptor (car) molecules and uses therefore

Номер патента: WO2017149515A1. Автор: Glenn Dranoff. Владелец: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA. Дата публикации: 2017-09-08.

Chimeric antigen receptor t cells and uses thereof

Номер патента: WO2021016606A9. Автор: SHAN Li,Jun Cui,HONG Liu,Shaohua Xu,Yiyang XU,Lucas HORAN,Pengbo Zhang,Hongruo YUN,Guangyan XIONG,Yixiang XU. Владелец: Eureka Therapeutics, Inc.. Дата публикации: 2021-04-08.

Chimeric antigen receptor T cells and uses thereof

Номер патента: CN114286825A. Автор: 刘宏,李珊,崔俊,许少华,张鹏博,云泓若,徐义翔,许奕阳,卢卡斯·霍兰,熊光焰. Владелец: Eureka Therapeutics Inc. Дата публикации: 2022-04-05.

Chimeric antigen receptor targeting CD30 and use thereof

Номер патента: KR102290335B1. Автор: 신나라,이성영. Владелец: 주식회사 인투앱. Дата публикации: 2021-08-18.

Chimeric antigen receptor targeting GPC3 and uses thereof

Номер патента: CN113248616A. Автор: 李洋,何霆,齐菲菲,鲁薪安,丁艳萍. Владелец: Beijing Yimiao Shenzhou Pharmaceutical Technology Co ltd. Дата публикации: 2021-08-13.

Chimeric antigen receptor targeting GPC3 and uses thereof

Номер патента: CN113248616B. Автор: 李洋,何霆,齐菲菲,鲁薪安,丁艳萍. Владелец: Beijing Yimiao Shenzhou Pharmaceutical Technology Co ltd. Дата публикации: 2022-04-12.

Chimeric antigen receptors targeting cd19 and use thereof

Номер патента: EP4138865A4. Автор: Michel Sadelain,Gary Shapiro,Xingyue He,Mei Rosa NG,Isabelle Riviere,Loic Vincent,Jorge MANSILLA-SOTO,Judith FEUCHT,Dan Tavares. Владелец: Memorial Hospital for Cancer and Allied Diseases. Дата публикации: 2024-05-22.

Osteoclastogenesis inhibitory factor, sequence coding for it and uses

Номер патента: WO2002098908A3. Автор: Xiangfu Wu. Владелец: Xiangfu Wu. Дата публикации: 2003-05-08.

Osteoclastogenesis inhibitory factor, sequence coding for it and uses

Номер патента: WO2002098908A2. Автор: Xiangfu Wu. Владелец: Genemedix PLC. Дата публикации: 2002-12-12.

Osteoclastogenesis inhibitory factor, sequence coding for it and uses

Номер патента: WO2002098908A9. Автор: Xiangfu Wu. Владелец: Xiangfu Wu. Дата публикации: 2003-01-23.

Anti-mesothelin chimeric antigen receptor (CAR) constructs and uses thereof

Номер патента: US11932698B2. Автор: Chen Hu,Jian Liu,Qing Dai,Kun Jiang,Shuai Yang,Shu Wu,Yuanyuan Peng. Владелец: Nanjing Legend Biotechnology Co Ltd. Дата публикации: 2024-03-19.

Anti-mesothelin chimeric antigen receptor (car) constructs and uses thereof

Номер патента: EP3844282A1. Автор: Chen Hu,Jian Liu,Qing Dai,Kun Jiang,Shuai Yang,Shu Wu,Yuanyuan Peng. Владелец: Nanjing Legend Biotechnology Co Ltd. Дата публикации: 2021-07-07.

Synthetic antigens as chimeric antigen receptor (car) ligands and uses thereof

Номер патента: EP4228660A1. Автор: Ji-Ho Park,Gabriel Kwong,Marielena GAMBOA,Ali ZAMAT,Heegon KIM,Phillip J. Santangelo,Daryll A. Vanover. Владелец: Georgia Tech Research Institute. Дата публикации: 2023-08-23.

Modified anti-epidermal growth factor receptor antibodies and methods of use thereof

Номер патента: WO2015038984A2. Автор: Ge Wei,Gregory Ian Frost,Harold Michael Shepard,Christopher D. Thanos. Владелец: Halozyme, Inc.. Дата публикации: 2015-03-19.

Chimeric antigen receptor targeting gprc5d and use thereof

Номер патента: AU2023207739A1. Автор: Yue Yang,Xiaowen He,Siye CHEN,Jincai ZHOU,Zhongjun SHI. Владелец: Oricell Therapeutics Co Ltd. Дата публикации: 2024-08-29.

Bispecific chimeric antigen receptors, encoding polynucleotides and use of receptors thereof to treat cancer

Номер патента: US12091459B2. Автор: Michael Jensen. Владелец: Seattle Childrens Hospital. Дата публикации: 2024-09-17.

Synthetic antigens as chimeric antigen receptor (car) ligands and uses thereof

Номер патента: US20230390335A1. Автор: Ji-Ho Park,Gabriel Kwong,Marielena GAMBOA,Ali ZAMAT,Heegon KIM,Phillip J. Santangelo,Daryll A. Vanover. Владелец: Georgia Tech Research Corp. Дата публикации: 2023-12-07.

Compound - diagnostic marker for biliary tract cancer, method for detecting enzymatic activity, method for diagnosis of biliary tract cancer, kit comprising the compound, uses of the compound and method for the treatment of biliary tract cancer

Номер патента: WO2024151174A2. Автор: Adam LESNER,Natalia Gruba. Владелец: Urteste S.A.. Дата публикации: 2024-07-18.

Compound - diagnostic marker for intestinal cancer, method for detecting enzymatic activity, method for diagnosis of intestinal cancer, kit comprising the compound, uses of the compound and method for the treatment of intestinal cancer

Номер патента: AU2023241522A1. Автор: Adam LESNER,Natalia Gruba. Владелец: Urteste S A. Дата публикации: 2024-08-15.

Compound, diagnostic marker for stomach cancer, method for detecting enzymatic activity, method for the diagnosis of stomach cancer, kit comprising the compound, uses of the compound and method for the treatment of stomach cancer

Номер патента: WO2024177524A1. Автор: Adam LESNER,Natalia Gruba. Владелец: Urteste S.A.. Дата публикации: 2024-08-29.

Compound - diagnostic marker for biliary tract cancer, method for detecting enzymatic activity, method for diagnosis of biliary tract cancer, kit comprising the compound, uses of the compound and method for the treatment of biliary tract cancer

Номер патента: WO2024151174A3. Автор: Adam LESNER,Natalia Gruba. Владелец: Urteste S.A.. Дата публикации: 2024-08-22.

Use of anti-il-36r antibodies for the treatment of hidradentitis suppurativa (hs)

Номер патента: US20240301074A1. Автор: Nathalie Ivanoff,Ahmed Karim FARAG,Sree KURUP,Xiujiang LI,Sutirtha MUKHOPADHYAY,Usha RANGANATHAN. Владелец: Boehringer Ingelheim Pharmaceuticals Inc. Дата публикации: 2024-09-12.

Use of anti-il-36r antibodies for the treatment of hidradentitis suppurativa (hs)

Номер патента: WO2024187058A1. Автор: Nathalie Ivanoff,Ahmed Karim FARAG,Sree KURUP,Xiujiang LI,Sutirtha MUKHOPADHYAY,Usha RANGANATHAN. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2024-09-12.

Use of anti-her2 antibody-drug conjugate in the treatment of urothelial carcinoma

Номер патента: RU2750817C1. Автор: Цзяньминь ФАН. Владелец: Ремеджен, Лтд. Дата публикации: 2021-07-05.

Chimeric antigen receptor cell preparation and uses thereof

Номер патента: EP3630980A1. Автор: LEI XIAO,ZHAO Wu,Chengfei PU,Zhiyuan CAO. Владелец: Innovative Cellular Therapeutics Co Ltd. Дата публикации: 2020-04-08.

Methods for the use of CD32B x CD79B-binding molecules in the treatment of inflammatory diseases and disorders

Номер патента: AU2017278329B2. Автор: Wei Chen,Paul A. Moore,Ezio Bonvini,Jon Marc Wigginton,Naimish Bharat Pandya. Владелец: Macrogenics Inc. Дата публикации: 2024-08-08.

Compound - diagnostic marker for intestinal cancer, method for detecting enzymatic activity, method for diagnosis of intestinal cancer, kit comprising the compound, uses of the compound and method for the treatment of intestinal cancer

Номер патента: WO2023191647A1. Автор: Adam LESNER,Natalia Gruba. Владелец: Urteste S.A.. Дата публикации: 2023-10-05.

Use of at least one biomarker for the in vitro prognosis or diagnosis of lymphoproliferative episodes associated with the epstein-barr virus (ebv)

Номер патента: US20140342349A1. Автор: Emmanuel Drouet,Felix Agbalika,Mohammed Habib. Владелец: Universite Joseph Fourier Grenoble 1. Дата публикации: 2014-11-20.

Use of anti-trem1 neutralizing antibodies for the treatment of motor neuron neurodegenerative disorders

Номер патента: US20230406924A1. Автор: Irena KADIU,Julien GASSER,James Martin KEANEY,Anastasios SPILIOTOPOULOS,Jonathan Mark Phillips. Владелец: UCB Biopharma SRL. Дата публикации: 2023-12-21.

Use of anti-trem1 neutralizing antibodies for the treatment of motor neuron neurodegenerative disorders

Номер патента: AU2020475443A9. Автор: Irena KADIU,Julien GASSER,James Martin KEANEY,Anastasios SPILIOTOPOULOS,Jonathan Mark Phillips. Владелец: UCB Biopharma SRL. Дата публикации: 2024-02-08.

Engineered human t cells comprising a switchable chimeric antigen cell surface receptor and methods for generating them

Номер патента: WO2023247727A3. Автор: Reynald LESCARBEAU,Marc CARTELLIERI,Gerhard Ehninger,Andrew Schiermeier,Dr. Armin EHNINGER. Владелец: Ehninger Dr Armin. Дата публикации: 2024-02-08.

Use of modified pore-forming proteins for the preparation of a medicament for treating or preventing benign prostatic hyperplasia

Номер патента: IL188143A. Автор: . Владелец: Protox Therapeutics Inc. Дата публикации: 2012-10-31.

Engineered human t cells comprising a switchable chimeric antigen cell surface receptor and methods for generating them

Номер патента: EP4295860A1. Автор: Armin Ehninger,Reynald LESCARBEAU,Marc CARTELLIERI,Gerhard Ehninger,Andrew Schiermeier. Владелец: Individual. Дата публикации: 2023-12-27.

Engineered human t cells comprising a switchable chimeric antigen cell surface receptor and methods for generating them

Номер патента: WO2023250433A2. Автор: Yong Zhang,Armin Ehninger,Srijani SRIDHAR,Surbhi Goel,Reynald Michael Lescarbeau,Marc CARTELLIERI,William Frederick HARRINGTON,Gerhard Ehninger,Andrew Schiermeier. Владелец: Cartellieri Marc. Дата публикации: 2023-12-28.

Engineered human t cells comprising a switchable chimeric antigen cell surface receptor and methods for generating them

Номер патента: WO2023247727A2. Автор: Reynald LESCARBEAU,Marc CARTELLIERI,Gerhard Ehninger,Andrew Schiermeier,Dr. Armin EHNINGER. Владелец: Ehninger Dr Armin. Дата публикации: 2023-12-28.

Engineered human t cells comprising a switchable chimeric antigen cell surface receptor and methods for generating them

Номер патента: WO2023250433A3. Автор: Yong Zhang,Armin Ehninger,Srijani SRIDHAR,Surbhi Goel,Reynald Michael Lescarbeau,Marc CARTELLIERI,William Frederick HARRINGTON,Gerhard Ehninger,Andrew Schiermeier. Владелец: Cartellieri Marc. Дата публикации: 2024-01-18.

Mat-directed chimeric antigen receptor systems for sorting/depleting the engineered immune cells

Номер патента: RU2732925C2. Автор: Арвинд РАДЖПАЛ,Джулиен ВАЛТОН,Александре ДЖЮЛЛЕРАТ,Филипп ДЮШАТО,Барбра Джонсон САСУ. Владелец: Аллоджин Терапьютикс, Инк.. Дата публикации: 2020-09-24.

Novel polypeptide and uses thereof.

Номер патента: EP3057607A1. Автор: Marinus Van Eijk,Hendrik Peter HAAGSMAN. Владелец: U Protein Express BV. Дата публикации: 2016-08-24.

Novel polypeptide and uses thereof.

Номер патента: WO2015057068A1. Автор: Marinus Van Eijk,Hendrik Peter HAAGSMAN. Владелец: Stichting voor de Technische Wetenschappen. Дата публикации: 2015-04-23.

New egfrviii-binding peptides, conjugates and uses thereof

Номер патента: WO2023118447A1. Автор: Thomas Delacroix,Gauthier ERRASTI,Raj Chakrabarti,Coralie LEBLEU,Sourour MANSOUR,Indranil ADHYA,Rama Krishna DUMPATI. Владелец: Nanothera Biosciences, Inc.. Дата публикации: 2023-06-29.

Use of alveolar or airway organoids for the treatment of lung diseases and disorders

Номер патента: US12109242B2. Автор: Carla F. KIM,David RAISER,Sharon M. LOUIE,Erhan ARARAT. Владелец: Childrens Medical Center Corp. Дата публикации: 2024-10-08.

Novel polypeptide and uses thereof

Номер патента: US20160333074A1. Автор: Marinus Van Eijk,Hendrik Peter HAAGSMAN. Владелец: U Protein Express BV. Дата публикации: 2016-11-17.

Oligo-trap fusion proteins (ofps) and uses thereof

Номер патента: WO2024186690A2. Автор: H. Michael Shepard,Pei Jin. Владелец: Enosi Therapeutics Corporation. Дата публикации: 2024-09-12.

Proteic acid polymer, production processes, use of proteic acid polymer, pharmaceutical composition and method of treatment

Номер патента: EP2326667A1. Автор: Tatiana Lobo Coelho De Sampaio. Владелец: Universidade Federal do Rio de Janeiro UFRJ. Дата публикации: 2011-06-01.

Proteic acid polymer, production processes, use of proteic acid polymer, pharmaceutical composition and method of treatment

Номер патента: WO2010025530A9. Автор: Tatiana Lobo Coelho De Sampaio. Владелец: Universidade Federal Do Rio De Janeiro - Ufrj. Дата публикации: 2010-07-29.

Proteic acid polymer, production processes, use of proteic acid polymer, pharmaceutical composition and method of treatment

Номер патента: WO2010025530A1. Автор: Tatiana Lobo Coelho De Sampaio. Владелец: Universidade Federal Do Rio De Janeiro - Ufrj. Дата публикации: 2010-03-11.

Glypican-3 antibody and use thereof

Номер патента: RU2744245C2. Автор: Хуамао ВАН,Бо СУН. Владелец: Кафа Терапьютикс Лимитед. Дата публикации: 2021-03-04.

Cosmetic use of an active substance for stimulating type 2 and / or type 3 human beta-defensins, use of such an active substance for the preparation of a pharmaceutical composition containing such an active substance and use of such an active substance in the field of tissue reconstruction

Номер патента: DE10262193B4. Автор: Eric Perrier,Corinne Reymermier,Anne Guezennec,Joelle Guesnet,Ingrid Pernet. Владелец: Engelhard Lyon SA. Дата публикации: 2019-06-27.

Pharmaceutical combinations comprising a kras g12c inhibitor and uses of a kras g12c inhibitor for the treatment of cancers

Номер патента: US20240082218A1. Автор: BO LIU,Stefan Stutz,Andreas Weiss,Pascal Rigollier,Nadine Schneider,Marc Gerspacher,Robert Mah,Vasileios Askoxylakis,Rainer Wilcken,Diana Graus Porta,Catherine Leblanc,Rainer Machauer,Jeffrey Engelman,Padmaja YERRAMILLI-RAO,Simona Cotesta,Edwige Liliane Jeanne Lorthiois,Christophe MURA,Nicolas WARIN,Saskia Maria Brachmann,Xiaoming Cui,Anna FARAGO,Andrea Helga Emmi VAUPEL. Владелец: NOVARTIS AG. Дата публикации: 2024-03-14.

Pharmaceutical combinations comprising a kras g12c inhibitor and uses of a kras g12c inhibitor for the treatment of cancers

Номер патента: EP4267134A1. Автор: BO LIU,Stefan Stutz,Andreas Weiss,Pascal Rigollier,Andrea Vaupel,Nadine Schneider,Marc Gerspacher,Robert Mah,Vasileios Askoxylakis,Rainer Wilcken,Diana Graus Porta,Catherine Leblanc,Rainer Machauer,Jeffrey Engelman,Padmaja YERRAMILLI-RAO,Simona Cotesta,Edwige Liliane Jeanne Lorthiois,Christophe MURA,Nicolas WARIN,Saskia Maria Brachmann,Xiaoming Cui,Anna FARAGO. Владелец: NOVARTIS AG. Дата публикации: 2023-11-01.

Antiviral compounds, methods for the manufacturing of compounds, antiviral pharmaceutical composition, use of the compounds and method for the oral treatment of coronavirus infection and related diseases thereof

Номер патента: US20240207302A1. Автор: Joao Batista Calixto,Jaime Alberto RABI NALLAR,Thiago Moreno LOPES E SOUZA. Владелец: Individual. Дата публикации: 2024-06-27.

Use of tri-substituted glycerol compounds for the treatment of hematological malignancies

Номер патента: EP2117555A1. Автор: Wolfgang Richter,Lutz Weber,Axel Rolf Zander,Francis Ayuk Ayuketang. Владелец: Universitatsklinikum Hamburg Eppendorf. Дата публикации: 2009-11-18.

Use of hyperforin and hyperforin-containing extracts in the treatment and prophylaxis of dementing diseases

Номер патента: AU3252699A. Автор: Clemens Erdelmeier,Michael Noldner,Shyam Sunder Chatterjee. Владелец: Dr Willmar Schwabe GmbH and Co KG. Дата публикации: 1999-08-30.

Use of sodium 2-(3-pentylphenyl)acetate in the treatment of alström syndrome

Номер патента: WO2020113340A1. Автор: Lyne Gagnon,Pierre Laurin,Frank CESARI. Владелец: Liminal Biosciences Limited. Дата публикации: 2020-06-11.

Use of sodium 2-(3-pentylphenyl)acetate in the treatment of alström syndrome

Номер патента: EP3890717A1. Автор: Lyne Gagnon,Pierre Laurin,Frank CESARI. Владелец: Liminal Biosciences Ltd. Дата публикации: 2021-10-13.

Use of rnai inhibiting parp activity for the manufacture of a medicament for the treatment of cancer

Номер патента: CA2533423C. Автор: Thomas Helleday. Владелец: University of Sheffield. Дата публикации: 2014-07-22.

Use of a phosphodiesterase 10 inhibitor for the treatment of tourette syndrome

Номер патента: US11883385B2. Автор: George GARIBALDI. Владелец: Noema Pharma Ag. Дата публикации: 2024-01-30.

Antiviral compounds, methods for the manufacturing of compounds, antiviral pharmaceutical composition, use of the compounds and method for the oral treatment of coronavirus infection and related diseases thereof

Номер патента: EP4314001A1. Автор: Joao Batista Calixto,Jaime Alberto RABI NALLAR,Thiago Moreno LOPES E SOUZA. Владелец: Individual. Дата публикации: 2024-02-07.

Antiviral compounds, methods for the manufacturing of compounds, antiviral pharmaceutical composition, use of the compounds and method for the oral treatment of coronavirus infection and related diseases thereof

Номер патента: WO2022204770A1. Автор: Joao Batista Calixto,Jaime Alberto RABI NALLAR,Thiago Moreno LOPES E SOUZA. Владелец: Souza Thiago Moreno Lopes E. Дата публикации: 2022-10-06.

Use of cyanoglucosides and pharmaceutical formulations thereof in the treatment of diabetes

Номер патента: WO2018000057A1. Автор: Wagner Vilegas,Emerson Ferreira Queiroz,Luiz Leonardo Saldanha,Anne Ligia Dokkedal Bosqueiro,Jose Roberto Bosqueiro,Nathalia Aparecida De Paula Camaforte Henriques,Priscilla Maria Ponce Vareda,Laurence MARCOURT,Jean-Luc WOLFENDER. Владелец: Universidade Estadual Paulista Julio De Mesquita Filho. Дата публикации: 2018-01-04.

Use of benzo(c)quinolizinium derivatives for the treatment of diseases that are linked to smooth muscle cell constriction

Номер патента: AU2003255646A1. Автор: Frederic Becq,Jean Michel Vierfond,Renaud Robert,Yvette Mettey,Michel Joffre,Cecile Marivingt-Mounir,Laurence Pignoux,Christian Rogier. Владелец: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS. Дата публикации: 2003-12-22.

Use of tri-substituted glycerol compounds for the treatment of radiation injuries

Номер патента: CA2668923C. Автор: Wolfgang Richter,Lutz Weber. Владелец: Radioprotect Alphaptose Ug (haftungsbeschraenkt) & Co KG. Дата публикации: 2015-01-13.

Use of rapamycin and rapamycin derivatives for the treatment of bone loss

Номер патента: CA2531454C. Автор: Michaela Kneissel,Mira Susa Spring. Владелец: NOVARTIS AG. Дата публикации: 2011-10-25.

Use of a tyrosine kinase inhibitor for the treatment of hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension

Номер патента: WO2024112656A1. Автор: Edda SPIEKERKOETTER,Md Khadem ALI,Adam M. ANDRUSKA. Владелец: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY. Дата публикации: 2024-05-30.

The use of an ester of inositoltrisphosphate for the preparing of medicaments

Номер патента: WO1997023229A1. Автор: Matti Siren. Владелец: PERSTORP AB. Дата публикации: 1997-07-03.

Use of 1,2-diaryl benzimidazoles for the preparation of pharmaceutical compositions for treating illnesses associated with a microglia activation and some such novel compounds

Номер патента: IL150150A. Автор: . Владелец: Bayer Ip Gmbh. Дата публикации: 2014-03-31.

Use of benzo[c]quinolizinium derivatives for the treatment of diseases that are linked to smooth muscle cell constriction

Номер патента: US7897610B2. Автор: Frederic Becq,Jean Michel Vierfond,Renaud Robert,Yvette Mettey,Michel Joffre,Cecile Marivingt-Mounir,Laurence Pignoux,Christian Rogier. Владелец: Universite De Poitiers. Дата публикации: 2011-03-01.

Use of cyanoglucosides and pharmaceutical formulations thereof in the treatment of diabetes

Номер патента: US20190160085A1. Автор: Wagner Vilegas,Emerson Ferreira Queiroz,Luiz Leonardo Saldanha,Anne Ligia Dokkedal Bosqueiro,Jose Roberto Bosqueiro,Nathalia Aparecida De Paula Camaforte Henriques,Priscilla Maria Ponce Vareda,Laurence MARCOURT,Jean-Luc WOLFENDER. Владелец: Universidade Estadual Paulista Julio de Mesquita Filho UNESP. Дата публикации: 2019-05-30.

1,2,4-Trioxane compounds and compositions comprising the same for use in the treatment of COVID-19

Номер патента: US20210292296A1. Автор: Peter Seeberger,Kerry Gilmore,Adam Jeffrey Maust. Владелец: Artemiflow GmbH. Дата публикации: 2021-09-23.

Heterocyclic compounds, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for the treatment of ccr2b mediated conditions

Номер патента: IL183665A. Автор: David Waterson,Paul Turner,Jeffrey Philip Poyser,Justin Fairfield Bower,Jon Winter. Владелец: Jon Winter. Дата публикации: 2012-02-29.

Methods for the treatment, diagnosis, and prognosis of cancer

Номер патента: US20060160762A1. Автор: Bruce Zetter,Sonia Kim,Ursula Mangold. Владелец: Childrens Medical Center Corp. Дата публикации: 2006-07-20.

Recombinant anti-epidermal growth factor receptor antibody compositions

Номер патента: EP2331577B1. Автор: Mikkel Wandahl Pedersen,Michael Kragh,Adam S. Hey,Helle Jacobsen. Владелец: Symphogen AS. Дата публикации: 2017-06-07.

Recombinant anti-epidermal growth factor receptor antibody compositions

Номер патента: IL210348A. Автор: . Владелец: Symphogen AS. Дата публикации: 2016-04-21.

Recombinant anti-epidermal growth factor receptor antibody compositions

Номер патента: KR101706255B1. Автор: 미켈 반달 페데르센,미카엘 크래프,아담 에스. 헤이,헬레 자코브센. Владелец: 심포젠 에이/에스. Дата публикации: 2017-02-14.

Recombinant anti-epidermal growth factor receptor antibody compositions

Номер патента: EP2331577A2. Автор: Mikkel Wandahl Pedersen,Michael Kragh,Adam S. Hey,Helle Jacobsen. Владелец: Symphogen AS. Дата публикации: 2011-06-15.

Recombinant anti-Epidermal Growth Factor Receptor antibody compositions

Номер патента: AU2009287163B2. Автор: Mikkel Wandahl Pedersen,Michael Kragh,Adam S. Hey,Helle Jacobsen. Владелец: Laboratoires Servier SAS. Дата публикации: 2014-11-13.

Methods and compositions relating to chimeric antigen receptors

Номер патента: US20180346541A1. Автор: Jang Hwan Cho,Wilson W. WONG. Владелец: Boston University. Дата публикации: 2018-12-06.

Suppression of cytokine release syndrome in chimeric antigen receptor cell therapy

Номер патента: EP3802578A1. Автор: Matthew Cooper,John F. DiPersio,Alun CARTER. Владелец: Washington University in St Louis WUSTL. Дата публикации: 2021-04-14.

Peptide for medical treatment of pancreatic diabetes of 2nd type and its complications

Номер патента: RU2573933C1. Автор: Марина Николаевна Макарова,Валерий Геннадьевич Макаров,Иван Иванович Елисеев,Михаил Иванович Титов,Елена Васильевна Шекунова,Владимир Александрович Кашкин. Владелец: Дафот Энтерпрайсис Лимитед. Дата публикации: 2016-01-27.

Hepcidin analogues and uses thereof

Номер патента: US09822157B2. Автор: Brian T. Frederick,Gregory Thomas Bourne,Mark Leslie Smythe,Anne Pernille Tofteng SHELTON,Jacob Ulrik Fog,Simone VINK,Praveen Madala. Владелец: Protagonist Therapeutics Inc. Дата публикации: 2017-11-21.

Modulators of tnf receptor associated factor (traf), their preparation and use

Номер патента: CA2250085C. Автор: Igor Mett,Mark Boldin,David Wallach,Andrei Kovalenko,Nikolai Malinin. Владелец: Yeda Research and Development Co Ltd. Дата публикации: 2009-10-20.

Composition for increasing expression of a growth factor gene, comprising core-shell structured microparticles as active ingredient

Номер патента: CA3093538C. Автор: Su Jin Park,Seong-Hyun Ho. Владелец: G&p Bioscience Co Ltd. Дата публикации: 2024-02-27.

SUMO and uses thereof

Номер патента: WO2017163203A1. Автор: Luca COLNAGHI,Luana Fioriti,Amir Levine. Владелец: Plico Biotech Inc.. Дата публикации: 2017-09-28.

SUMO and uses thereof

Номер патента: EP3432909A1. Автор: Luca COLNAGHI,Luana Fioriti,Amir Levine. Владелец: Plico Biotech Inc. Дата публикации: 2019-01-30.

Insulinotropic hormones and uses thereof

Номер патента: US5958909A. Автор: Joel F. Habener. Владелец: General Hospital Corp. Дата публикации: 1999-09-28.

Insulinotropic hormone and uses thereof

Номер патента: US6849708B1. Автор: Joel F. Habener. Владелец: General Hospital Corp. Дата публикации: 2005-02-01.

Therapy of respiratory tract diseases using basic fibroblast growth factor

Номер патента: US5514652A. Автор: Tsutomu Nakamura,Masaru Ogawa,Mitsuru Watanuki. Владелец: Kaken Pharmaceutical Co Ltd. Дата публикации: 1996-05-07.

Hepcidin analogues and uses thereof

Номер патента: US11807674B2. Автор: Gregory Thomas Bourne,Brian Troy FREDERICK,Mark Leslie Smythe,Anne Pernille Tofteng SHELTON,Jacob Ulrik Fog,Simone VINK,Praveen Madala. Владелец: Protagonist Therapeutics Inc. Дата публикации: 2023-11-07.

Hepcidin analogues and uses thereof

Номер патента: US20240174726A1. Автор: Gregory Thomas Bourne,Brian Troy FREDERICK,Mark Leslie Smythe,Anne Pernille Tofteng SHELTON,Jacob Ulrik Fog,Simone VINK,Praveen Madala. Владелец: Protagonist Therapeutics Inc. Дата публикации: 2024-05-30.

Use of an anti-microbial composition

Номер патента: WO1999009835A1. Автор: Johan de Faire. Владелец: Micro Active Protein In Sweden Ab. Дата публикации: 1999-03-04.

Treatment of X-linked hypohidrotic ectodermal dysplasia with a fusion EDA1 protein

Номер патента: US09925239B2. Автор: Pascal Schneider,Christine Kowalczyk-Quintas. Владелец: Edimer Pharmaceuticals Inc. Дата публикации: 2018-03-27.

Use of compounds having gip activity for the treatment of disorders associated with abnormal loss of cells and/or for the treatment of obesity

Номер патента: AU2003237933A8. Автор: Peter Eriksson,Jenny Nyberg. Владелец: CELLARTIS AB. Дата публикации: 2003-12-22.

Use of microparticles containing genetically modified cells in the treatment of neurodegenerative diseases

Номер патента: EP2322147A4. Автор: Munoz José Luis Pedraz,Calvar Carlos Spuch,Martin Rosa Maria Hernandez,Arroyo Gorka Orive,Tienda Desiree Antequera,Felix Bermejo-Pareja,Diaz Eva Carro. Владелец: Fundacion Investigacion Biomedica Hospital Universitario 12 Octubre. Дата публикации: 2011-12-14.

The use of Wnt5-a peptide derivates for the treatment of melanoma and gastric cancer

Номер патента: AU2009282525A1. Автор: Tommy Andersson. Владелец: WNTRESEARCH AB. Дата публикации: 2010-02-18.

The use of wnt5-a peptide derivates for the treatment of melanoma and gastric cancer

Номер патента: EP2328604A4. Автор: Tommy Andersson. Владелец: WNTRESEARCH AB. Дата публикации: 2012-03-14.

The use of wnt5-a peptide derivates for the treatment of melanoma and gastric cancer

Номер патента: EP2328604B1. Автор: Tommy Andersson. Владелец: WNTRESEARCH AB. Дата публикации: 2014-10-08.

Use of a fragment of rasgap peptide in the treatment or prevention of metastasis

Номер патента: EP2391378A1. Автор: Christian Widmann. Владелец: UNIVERSITÉ DE LAUSANNE. Дата публикации: 2011-12-07.

Conditionally active chimeric antigenic receptors for modified t cells

Номер патента: RU2759957C2. Автор: Джей М. Шорт. Владелец: Байоатла, Ллк. Дата публикации: 2021-11-19.

Epidermal growth factor receptor antibody

Номер патента: RU2652880C2. Автор: Цзе Лю,Чжобин ЧЖАН,Цзикуань ШАНЬ,Вэй СО. Владелец: Байоэкс Терапьютикс Инк.. Дата публикации: 2018-05-03.

Antigen-binding molecules which bind epidermal growth factor receptor (egfr), vectors coding them and using them

Номер патента: RU2457219C2. Автор: Пабло УМАНА,Эккехард МОССНЕР. Владелец: Гликарт Биотехнологи Аг. Дата публикации: 2012-07-27.

Combination therapy for the treatment of cancer comprising an anti-egfr antibody and an axl-inhibitor

Номер патента: EP4359439A1. Автор: Yosef Yarden,Ashish NORONHA. Владелец: Yeda Research and Development Co Ltd. Дата публикации: 2024-05-01.

COMBINATION THERAPY FOR THE TREATMENT OF CANCER COMPRISING AN ANTl-EGFR ANTIBODY AND AN AXL-INHIBITOR

Номер патента: US20240156959A1. Автор: Yosef Yarden,Ashish NORONHA. Владелец: Yeda Research and Development Co Ltd. Дата публикации: 2024-05-16.

Immune cell comprising chimeric antigen receptor and use thereof

Номер патента: US20230242877A1. Автор: LU Han,Wen Jiang,Jiangtao REN,Xiaohong He,Yanbin Wang,Qiping SHI. Владелец: Bioheng Therapeutics Ltd. Дата публикации: 2023-08-03.

Use of Anti-EGFR/Anti-Met Antibody to Treat Gastric or Esophageal Cancer

Номер патента: US20240317866A1. Автор: Roland Knoblauch,Joshua CURTIN,Meena Thayu. Владелец: Janssen Biotech Inc. Дата публикации: 2024-09-26.

Use of anti-egfr/anti-met antibody to treat gastric or esophageal cancer

Номер патента: WO2024003837A1. Автор: Roland Knoblauch,Joshua CURTIN,Meena Thayu. Владелец: JANSSEN BIOTECH, INC.. Дата публикации: 2024-01-04.

Use of Anti-EGFR/Anti-Met Antibody to Treat Liver Cancer

Номер патента: US20240067736A1. Автор: Sheri Moores. Владелец: Janssen Biotech Inc. Дата публикации: 2024-02-29.

Antibody drug conjugate formulation and use thereof

Номер патента: EP4403188A1. Автор: CHAOHONG HU,Lili XIAO. Владелец: Shanghai Miracogen Inc. Дата публикации: 2024-07-24.

Antibody drug conjugate formulation and use thereof

Номер патента: US20240335552A1. Автор: CHAOHONG HU,Lili XIAO. Владелец: Shanghai Miracogen Inc. Дата публикации: 2024-10-10.

Pharmaceutical kit and uses thereof

Номер патента: WO2019029351A1. Автор: Yi-Chun Huang,Hsin-Chien Chiang,Kwan-Hwa Chi,Yu-Shan Wang. Владелец: Johnpro Biotech Inc.. Дата публикации: 2019-02-14.

Covalent diabodies and use thereof

Номер патента: RU2744176C2. Автор: Лесли С. Джонсон,Лин Хуан. Владелец: Макродженикс, Инк.. Дата публикации: 2021-03-03.

Covalent diantibodies and use thereof

Номер патента: RU2593720C2. Автор: Лесли С. Джонсон,Лин Хуан. Владелец: Макродженикс, Инк.. Дата публикации: 2016-08-10.

Human anti-epidermal growth factor receptor antibody

Номер патента: CA2560305C. Автор: Zhenping Zhu,Meilin Liu. Владелец: ImClone LLC. Дата публикации: 2016-07-05.

Antibody drug conjugate formulation and use thereof

Номер патента: CA3232092A1. Автор: CHAOHONG HU,Lili XIAO. Владелец: Shanghai Miracogen Inc. Дата публикации: 2023-03-23.

Treatment of leukemia by combining a hypomethylating agent in combination with engineered car-nk cells

Номер патента: EP4450614A1. Автор: Robert Zeiser,Evelyn Ullrich,Philipp Wendel,Tobias Bexte. Владелец: Goethe Universitaet Frankfurt am Main. Дата публикации: 2024-10-23.

Novel anti-igf-ir antibodies and uses thereof

Номер патента: CA2575348A1. Автор: Liliane Goetsch,Nathalie Corvaia. Владелец: Nathalie Corvaia. Дата публикации: 2006-02-09.

MODIFIED ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODIES AND METHODS OF USE THEREOF

Номер патента: US20150071923A1. Автор: Frost Gregory I.,Wei Ge,Thanos Christopher D.,Shepard H. Michael. Владелец: . Дата публикации: 2015-03-12.

Human anti-epidermal growth factor receptor antibody

Номер патента: JP4734319B2. Автор: リュー，メイリン,チュー，チェンピン. Владелец: ImClone LLC. Дата публикации: 2011-07-27.

Human anti-epidermal growth factor receptor antibody

Номер патента: WO2005090407A1. Автор: Zhenping Zhu,Meilin Liu. Владелец: Imclone Systems Incorporated. Дата публикации: 2005-09-29.

Humanized and chimeric anti-epidermal growth factor receptor monoclonal antibodies

Номер патента: US5558864A. Автор: Jose Saldanha,Mary M. Bendig,Catherine A. Kettleborough. Владелец: Merck Patent GmBH. Дата публикации: 1996-09-24.

Modified anti-epidermal growth factor receptor antibodies and methods of use thereof

Номер патента: CA2922562A1. Автор: Ge Wei,Gregory Ian Frost,Harold Michael Shepard,Christopher Dennis Thanos. Владелец: Halozyme Inc. Дата публикации: 2015-03-19.

Human anti-epidermal growth factor receptor single-chain antibodies

Номер патента: WO2002030984A1. Автор: David T. Curiel,Kevin Paul Raisch,James Alan Bonner. Владелец: UAB RESEARCH FOUNDATION. Дата публикации: 2002-04-18.

Human anti-epidermal growth factor receptor antibody

Номер патента: EP1735348B1. Автор: Zhenping Zhu,Meilin Liu. Владелец: ImClone LLC. Дата публикации: 2012-06-20.

Modified anti-epidermal growth factor receptor antibody and method of use thereof

Номер патента: JP6282745B2. Автор: グレゴリー・イアン・フロスト,グァ・ウェイ,ハロルド・マイケル・シェパード,クリストファー・ディ・サノス. Владелец: ハロザイム インコーポレイテッド. Дата публикации: 2018-02-21.

Human anti-epidermal growth factor receptor single-chain antibodies

Номер патента: US7045127B2. Автор: David T. Curiel,Kevin Paul Raisch,James Alan Bonner. Владелец: UAB RESEARCH FOUNDATION. Дата публикации: 2006-05-16.

Therapeutic compositions to improve the effect of the therapy with anti-epidermal growth factor receptor antibodies

Номер патента: CA2664795A1. Автор: Rolando Perez Rodriguez,Luis Enrique Fernandez Molina,Belinda SÁNCHEZ RAMÍREZ,Audry FERNÁNDEZ GÓMEZ,Alejandro Lopez Requena,Greta Garrido Hidalgo,Irene Beausoleil Delgado. Владелец: Irene Beausoleil Delgado. Дата публикации: 2008-04-03.

Human anti-epidermal growth factor receptor antibody

Номер патента: US7598350B2. Автор: Zhenping Zhu,Meilin Liu. Владелец: ImClone LLC. Дата публикации: 2009-10-06.

Modified anti-epidermal growth factor receptor antibodies and methods of use thereof

Номер патента: IL244518A0. Автор: . Владелец: Halozyme Inc. Дата публикации: 2016-04-21.

Therapeutic Composition To Improve The Effect Of The Therapy With Anti-Epidermal Growth Factor Receptor Antibodies

Номер патента: US20100047207A1. Автор: Rolando Perez Rodriguez,Luis Enrique Fernandez Molina,Audry FERNÁNDEZ GÓMEZ,Alejandro Lopez Requena,Greta Garrido Hidalgo,Irene Beausoleil Delgado,Belinda Sánchez Rodríguez. Владелец: Centro de Immunologia Molecular. Дата публикации: 2010-02-25.

Methods of treating colorectal cancer with anti-epidermal growth factor antibodies

Номер патента: US20080008704A1. Автор: Mark Rubin. Владелец: ImClone Systems Inc. Дата публикации: 2008-01-10.

Method for obtaining a platelet derived secretome and uses thereof

Номер патента: US20240263137A1. Автор: Laura GUTIÉRREZ GUTIÉRREZ,Andrea ACEBES HUERTA. Владелец: Fundacion Para La Investigacion E Innovacion Biosanitaria Del Principado De Asturias Finba. Дата публикации: 2024-08-08.

Method for obtaining a platelet derived secretome and uses thereof

Номер патента: EP4358979A1. Автор: Laura GUTIÉRREZ GUTIÉRREZ,Andrea ACEBES HUERTA. Владелец: Fundacion Para La Investigacion E Innovacion Biosanitaria Del Principado De Asturias Finba. Дата публикации: 2024-05-01.

Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof

Номер патента: CA3040343A1. Автор: Leonard Presta,Peter G. Schultz,David Rodgers,Timothy Wright,Travis S. YOUNG,Eric HAMPTON,Eduardo LABORDA,Elvira KHIALEEVA,Sophie Viaud. Владелец: California Institute for Biomedical Research. Дата публикации: 2018-04-26.

Use of vegf antagonist for treating retinopathy of prematurity

Номер патента: RU2676303C2. Автор: Сергей АКСЕНОВ,Габриэла БУРЬЯН. Владелец: НОВАРТИС АГ. Дата публикации: 2018-12-27.

Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof

Номер патента: AU2017345479B2. Автор: Leonard Presta,Peter G. Schultz,David Rodgers,Timothy Wright,Travis S. YOUNG,Eric HAMPTON,Eduardo LABORDA,Elvira KHIALEEVA,Sophie Viaud. Владелец: Scripps Research Institute. Дата публикации: 2024-03-21.

Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof

Номер патента: AU2024202046A1. Автор: Leonard Presta,Peter G. Schultz,David Rodgers,Timothy Wright,Travis S. YOUNG,Eric HAMPTON,Eduardo LABORDA,Elvira KHIALEEVA,Sophie Viaud. Владелец: Scripps Research Institute. Дата публикации: 2024-04-18.

A plasmid dna construct including the gene encoding a mammalian beta-nerve growth factor

Номер патента: WO1990013650A1. Автор: Håkan Persson,Lars Olson,Ted Ebendal. Владелец: Lope Medicine Ab. Дата публикации: 1990-11-15.

Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof

Номер патента: WO2018075807A1. Автор: Leonard Presta,Peter G. Schultz,David Rodgers,Timothy Wright,Travis S. YOUNG,Eric HAMPTON,Eduardo LABORDA,Elvira KHIALEEVA,Sophie Viaud. Владелец: California Institute for Biomedical Research. Дата публикации: 2018-04-26.

Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof

Номер патента: US11174306B2. Автор: Leonard Presta,Peter G. Schultz,David Rodgers,Timothy Wright,Travis S. YOUNG,Eric HAMPTON,Eduardo LABORDA,Elvira KHIALEEVA,Sophie Viaud. Владелец: Scripps Research Institute. Дата публикации: 2021-11-16.

Chimeric Antigen Receptor Effector Cell Switches with Humanized Targeting Moieties and/or Optimized Chimeric Antigen Receptor Interacting Domains and Uses Thereof

Номер патента: JP7149935B2. Автор: レオナルド プレスタ，,トラビス エス． ヤング，,デイビッド ロジャース，,エリック ハンプトン，,ティモシー ライト，,ピーター ジー． シュルツ，,エドゥアルド ラボーダ，,エルヴィラ キアリーヴァ，,ソフィー ヴィオー，. Владелец: ザ スクリプス リサーチ インスティテュート. Дата публикации: 2022-10-07.

Hmgb1 antagonist treatment of severe sepsis

Номер патента: US20210000908A1. Автор: Yousef Al-Abed. Владелец: Feinstein Institutes For Medical Research. Дата публикации: 2021-01-07.

Chimeric antigen receptor targeting bcma and use thereof

Номер патента: US20230346835A1. Автор: Siyoung Choi,Sangjin Lee,Chungyong Han,Eunjung Park,Hyeonseok EOM,Bumkyu CHOI,Soyoun RO,Seongwon Hong,Jeyoel CHO,Hyejin SUNG. Владелец: Protanbio Inc. Дата публикации: 2023-11-02.

Method for modifying the cell, tissue or host tropism of a microorganism; recombinant microorganisms obtained in this way and use thereof in medicine and veterinary medicine

Номер патента: AU8412291A. Автор: Robertus Jacobus Maria Moormann,Koenraad Luc Glazenburg. Владелец: Akzo NV. Дата публикации: 1992-03-17.

Method for modifying the cell, tissue or host tropism of a microorganism; recombinant microorganisms obtained in this way and use thereof in medicine and veterinary medicine

Номер патента: AU657698B2. Автор: Robertus Jacobus Maria Moormann,Koenraad Luc Glazenburg. Владелец: Akzo NV. Дата публикации: 1995-03-23.

Use of b cell depleting agents for the treatment of rheumatic heart disease

Номер патента: US20240270862A1. Автор: Xavier JOUVEN,Alexandre LOUPY. Владелец: Université Paris Cite. Дата публикации: 2024-08-15.

Materials and methods for the prevention and treatment of viral diseases

Номер патента: US20240197814A1. Автор: Marc M. Baum,Manjula GUNAWARDANA. Владелец: OAK CREST INSTITUTE OF SCIENCE. Дата публикации: 2024-06-20.

Treatment of fibrosis, cardiovascular disease and heart failure with modified relaxin polypeptides

Номер патента: US12097242B2. Автор: Gene M. Dubowchik,Claudio Mapelli,Dasa Lipovsek,Paul E. Morin,R. Michael Lawrence,Olafur S. Gudmundsson,Xiaojun Han,Cort S. Madsen,Michael C. Myers. Владелец: Bristol Myers Squibb Co. Дата публикации: 2024-09-24.

Chimeric Antigen Receptor Cell Preparation and Uses Thereof

Номер патента: US20180346876A1. Автор: Xiao Lei,Wu Zhao,Cao Zhiyuan,Pu Chengfei. Владелец: Innovative Cellular Therapeutics Co., Ltd.. Дата публикации: 2018-12-06.

Anti-mesothelin chimeric antigen receptor (car) constructs and uses thereof

Номер патента: CA3111087A1. Автор: Chen Hu,Jian Liu,Qing Dai,Kun Jiang,Shuai Yang,Shu Wu,Yuanyuan Peng. Владелец: Nanjing Legend Biotechnology Co Ltd. Дата публикации: 2020-03-05.

Tumor antigens, compounds comprising the tumor antigens and uses thereof

Номер патента: US20240033336A1. Автор: Paul Adam,Madiha DEROUAZI,Elodie BELNOUE,Tobias NOLDEN,Samuel LUKOWSKI,Imgard Rita Maria HOFMANN,Ralf Leonhardt,Francesca TRAPANI. Владелец: AMAL THERAPEUTICS, S.A.. Дата публикации: 2024-02-01.

Tumor antigens, compounds comprising the tumor antigens kras, tpx2 or aurka and uses thereof

Номер патента: WO2023174998A1. Автор: Paul Adam,Madiha DEROUAZI,Elodie BELNOUE,Tobias NOLDEN,Irmgard Maria Rita HOFMANN,Samuel LUKOWSKI,Ralf Leonhardt,Francesca TRAPANI. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2023-09-21.

Chimeric antigen receptor cell preparation and uses thereof

Номер патента: EP3630980B1. Автор: LEI XIAO,ZHAO Wu,Chengfei PU,Zhiyuan CAO. Владелец: Innovative Cellular Therapeutics Holdings Ltd. Дата публикации: 2023-11-01.

Anti-mesothelin chimeric antigen receptor (car) constructs and uses thereof

Номер патента: IL281098A. Автор: Chen Hu,Jian Liu,Qing Dai,Kun Jiang,Shuai Yang,Shu Wu,Yuanyuan Peng. Владелец: Nanjing Legend Biotech Co Ltd. Дата публикации: 2021-04-29.

Chimeric antigen receptors targeting cd127 and use thereof

Номер патента: EP4142777A4. Автор: Nicolas Poirier,Prasad S. Adusumilli. Владелец: OSE Immunotherapeutics SA. Дата публикации: 2024-06-12.

COMPOUND, PROCESS FOR ITS PREPARATION, A PHARMACEUTICAL SOLUTION CONTAINING THE COMPOUND, A METHOD OF DETERMINING THE PRESENCE OF CANCER, A KIT FOR CANCER DETECTION, AND THE USE OF HYDROLYSIS OF THE COMPOUND FOR THE DETECTION OF CANCER

Номер патента: US20190248835A1. Автор: NIDZWORSKI Dawid,LESNER Adam,WYSOCKA Magdalena. Владелец: INSTYTUT BIOTECHNOLOGII I MEDYCYNY MOLEKULARNEJ. Дата публикации: 2019-08-15.

Use of the FGFR1 ECD proteins for the treatment of cancer diseases characterized by ligand dependent activating mutations in FGFR2

Номер патента: DK2498799T3. Автор: Thomas Harding,Michael W Kavanaugh. Владелец: Five Prime Therapeutics Inc. Дата публикации: 2016-12-05.

Use of fasl or fasl transfected cd4+/fasl-/th1-cell lines for the treatment of th1/th2 diseases

Номер патента: CA2269034A1. Автор: Jurg Tschopp,Michael Hahne,Michael SCHRÖTER,Fatima Da Conceicao-Silva. Владелец: Apotech Sa. Дата публикации: 1998-04-30.

Antibodies and antibody-drug conjugates specific for CD123 and uses thereof

Номер патента: AU2018357221A1. Автор: Madan Katragadda,Lawrence Nathan Tumey,Manoj Baburao Charati,Nicole Melissa Piché-Nicholas,Yoon-Chi Han. Владелец: PFIZER INC. Дата публикации: 2020-04-30.

Bispecific antigen binding molecules that bind leptin receptor and/or GP130, and methods of use thereof

Номер патента: US11834500B2. Автор: Jesper Gromada,Panayiotis Stevis,Judith ALTAREJOS. Владелец: Regeneron Pharmaceuticals Inc. Дата публикации: 2023-12-05.

Antibodies and antibody-drug conjugates specific for cd123 and uses thereof

Номер патента: US20230357417A1. Автор: Madan Katragadda,Lawrence Nathan Tumey,Manoj Baburao Charati,Nicole Melissa Piché-Nicholas,Yoon-Chi Han. Владелец: PFIZER INC. Дата публикации: 2023-11-09.

Antibodies and antibody-drug conjugates specific for cd123 and uses thereof

Номер патента: CA3079788C. Автор: Madan Katragadda,Lawrence Nathan Tumey,Manoj Baburao Charati,Nicole Melissa Piché-Nicholas,Yoon-Chi Han. Владелец: PFIZER INC. Дата публикации: 2023-09-05.

Vitamin K2 compositions for the treatment of drug induced neuropathy

Номер патента: AU2018389092B2. Автор: Anselm De Souza,Dilip Mehta,Ashok Vaidya,Rama Vaidya,Yogesh Dound. Владелец: Synergia Life Sciences Pvt Ltd. Дата публикации: 2023-08-24.

Bispecific antigen binding molecules that bind leptin receptor and/or gp130, and methods of use thereof

Номер патента: US20240158497A1. Автор: Jesper Gromada,Panayiotis Stevis,Judith ALTAREJOS. Владелец: Regeneron Pharmaceuticals Inc. Дата публикации: 2024-05-16.

Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same

Номер патента: US9498530B2. Автор: Arnon Rosenthal,David Louis Shelton,Patricia Ann Walicke. Владелец: Rinat Neuroscience Corp. Дата публикации: 2016-11-22.

Rna containing composition for treatment of tumor diseases

Номер патента: EP3603661A2. Автор: Jochen Probst,Mariola Fotin-Mleczek,Patrick Baumhof,Regina HEIDENREICH,Karl-Josef Kallen,Aleksandra KOWALCZYK. Владелец: CureVac AG. Дата публикации: 2020-02-05.

POLYMIXIN DERIVATIVE OF THE GENERAL FORMULA (I); COMBINATION PRODUCT; PHARMACEUTICAL COMPOSITION; METHOD FOR THE TREATMENT, RELIEF OR IMPROVEMENT OF AN INFECTION, IN A PATIENT, CAUSED BY A GRAM-NEGATIVE BACTERIA; METHOD FOR SENSITIZING GRAM-NEGATIVE BACTERIA TO AN ANTIBACTERIAL AGENT; METHOD FOR THE DEVELOPMENT OF UNPUBLISHED ANTIBIOTICS; METHODS FOR REDUCING THE TOXICITY OF POLYMIXINS, NATURAL OCTAPEPTINS AND THEIR DERIVATIVES DURING THE APPLICATION OF THE SAME IN THE TREATMENT OF INFECTIONS IN AN INDIVIDUAL; METHOD TO IMPROVE PHARMACOKINETIC PROPERTIES, OF POLYMIXINS, NATURAL OCTAPEPTINS AND THEIR DERIVATIVES; METHOD FOR THE AWARENESS OF CLINICALLY IMPORTANT GRAM-NEGATIVE BACTERIA TO A DEFENSE MECHANISM COMPLEMENT IN THE SERUM; USE OF A DERIVATIVE; AND PROCESS FOR THE PREPARATION OF A POLYMIXIN DERIVATIVE OF FORMULA (I)

Номер патента: BRPI0715095A2. Автор: Timo Vaara,Martti Vaara. Владелец: Northern Antibiotics Oy. Дата публикации: 2013-10-15.

RNA containing composition for treatment of tumor diseases

Номер патента: AU2023251441A1. Автор: Jochen Probst,Mariola Fotin-Mleczek,Patrick Baumhof,Regina HEIDENREICH,Karl-Josef Kallen,Aleksandra KOWALCZYK. Владелец: Curevac SE. Дата публикации: 2023-11-23.

Rna containing composition for treatment of tumor diseases

Номер патента: US20230338579A1. Автор: Jochen Probst,Mariola Fotin-Mleczek,Patrick Baumhof,Regina HEIDENREICH,Karl-Josef Kallen,Aleksandra KOWALCZYK. Владелец: Curevac SE. Дата публикации: 2023-10-26.

Pharmaceutical compositions for the treatment of visceral pain

Номер патента: CA3238619A1. Автор: Michael Gerber,Carolyn HIGGINS. Владелец: Ironwood Pharmaceuticals Inc. Дата публикации: 2023-06-01.

Pharmaceutical compositions for the treatment of visceral pain

Номер патента: AU2022398687A1. Автор: Michael Gerber,Carolyn HIGGINS. Владелец: Ironwood Pharmaceuticals Inc. Дата публикации: 2024-06-06.

Treatment of pruritis employing anti-il13ra1 antibody or binding fragment thereof

Номер патента: EP4408466A1. Автор: Karen Veverka,Ferda CEVIKBAS. Владелец: ASLAN Pharmaceuticals PTE LTD. Дата публикации: 2024-08-07.

The use of tnf-alpha antagonist as drugs for the treatment of patients with sepsis and without suffering from total organ failure

Номер патента: WO2003070274A1. Автор: William T. Barchuk,Martin Kaul,Lothar Daum,Jürgen EISELSTEIN,Heidrun Dorothea Abdelghany,Lori L. Van Meter. Владелец: Abbott GmbH & Co. KG. Дата публикации: 2003-08-28.

USE OF N-CARBOXIMETABLE BENZOLACTAMES REPLACED FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE INHIBITION OF THE METALOPROTEINAS OF THE MATRIX, PARATRATATION OF A STATE OF NEOPLASIC DISEASE, FOR THE TREATMENT OF ATEROSCLEROSIS, FOR THE TREATMENT OF A INFRINGEMENT

Номер патента: AR023366A1. Автор: . Владелец: Hoechst Marion Roussel Inc. Дата публикации: 2002-09-04.

Bioactive conjugate, preparation method therefor and use thereof

Номер патента: US20210101906A2. Автор: LIANG XIAO,Jingyi Wang,Liping Liu,Jing Wang,Lichun Wang,Qiang Tian,Jiaqiang Cai,Shuai SONG,Tongtong XUE,Hanwen DENG,Dengnian LIU,Haimin YU,Zhouning YANG,Xu Cao,Guoqing ZHONG. Владелец: Sichuan Kelun Biotech Biopharmaceutical Co Ltd. Дата публикации: 2021-04-08.

HMGB1 antagonist treatment of severe sepsis

Номер патента: US11883461B2. Автор: Yousef Al-Abed. Владелец: Feinstein Institutes For Medical Research. Дата публикации: 2024-01-30.

Bioactive conjugate, preparation method therefor and use thereof

Номер патента: US20230357259A1. Автор: LIANG XIAO,Jingyi Wang,Liping Liu,Jing Wang,Lichun Wang,Qiang Tian,Jiaqiang Cai,Shuai SONG,Tongtong XUE,Hanwen DENG,Dengnian LIU,Haimin YU,Zhouning YANG,Xu Cao,Guoqing ZHONG. Владелец: Sichuan Kelun Biotech Biopharmaceutical Co Ltd. Дата публикации: 2023-11-09.

Anti-nectin-4 antibody, drug conjugate, and preparation method therefor and use thereof

Номер патента: EP4393951A1. Автор: Bing Yao,Can Yuan,Zhaopeng SUN,Xiwu HUI,Mo DAN,Mingyue SHEN,Yufen WU,Boning LIU,Yancui WANG. Владелец: Cspc Megalith Biopharmaceutical Co Ltd. Дата публикации: 2024-07-03.

Spiral steroids and precursors thereof for clinical diagnosis and treatment of necrotizing enterocolitis and pre-eclampsia

Номер патента: WO2024077253A3. Автор: Fred Chasalow. Владелец: Coddle Creek Capital, Llc. Дата публикации: 2024-07-18.

Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis

Номер патента: WO2002067974A1. Автор: Kerstin Uvnas-Moberg,Thomas Lundeberg. Владелец: Uvnaes-Moberg Kerstin. Дата публикации: 2002-09-06.

Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions

Номер патента: US09914937B2. Автор: Frédéric Tangy,Clarisse Lorin,Lucile Mollet,Frederic Delebecque. Владелец: Institut Pasteur de Lille. Дата публикации: 2018-03-13.

ORF7 deficient varicella virus, vaccine comprising the virus and use thereof

Номер патента: US09885020B2. Автор: TONG Cheng,Yimin Li,Ningshao Xia,Hua Zhu,Xiangzhong Ye. Владелец: Beijing WanTai Biological Pharmacy Enterprise Co Ltd. Дата публикации: 2018-02-06.

Genetically modified paramyxovirus for treatment of tumor diseases

Номер патента: US09821016B2. Автор: Sascha Bossow,Wolfgang Neubert,Michael Bitzer,Martina Zimmermann,Sorin Armeanu-Ebinger,Ulrich Manfred Lauer. Владелец: Universitaetsklinikum Tuebingen. Дата публикации: 2017-11-21.

USE OF THE ANTIBODY I-3859 FOR THE DETECTION AND DIAGNOSIS OF CANCER

Номер патента: US20140170677A1. Автор: Klinguer-Hamour Christine,Jouhanneaud Alexandra. Владелец: PIERRE FABRE MEDICAMENT. Дата публикации: 2014-06-19.

Conjugate vaccine against infections by gram-negative bacteria, method for its preparation and use

Номер патента: CA1276552C. Автор: Stanley J. Cryz,Emil Paul Furer. Владелец: Schweiz Serum und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten. Дата публикации: 1990-11-20.

Therapeutic uses of factors which inhibit or neutralize MIF activity

Номер патента: US6774227B1. Автор: Jason Chesney,Richard J. Bucala. Владелец: Cytokine Pharmasciences Inc. Дата публикации: 2004-08-10.

POLYMIXIN DERIVATIVE OF GENERAL FORMULA (I); COMBINATION PRODUCT; PHARMACEUTICAL COMPOSITION; Method for Sensitizing Gram-Negative Bacteria to an Antibacterial Agent; METHOD FOR DEVELOPING ANTIBIOTICS; METHOD FOR REDUCING THE TOXICITY OF POLYMIXINES, NATURAL OCTAPEPTINS AND THEIR DERIVATIVES DURING APPLICATION OF THE SAME IN THE TREATMENT OF INFECTIONS IN AN INDIVIDUAL; METHOD FOR IMPROVING PHARMACOKINETIC PROPERTIES OF POLYMIXINS, NATURAL OCTAPEPTINS AND THEIR DERIVATIVES; METHOD FOR SENSITIZING GRAM-NEGATIVE BACTERIA CLINICALLY IMPORTANT TO A DEFENSE MECHANISM COMPLEMENT IN SERUM; USE OF A DERIVATIVE; AND PROCESS FOR THE PREPARATION OF A FORMULA POLYMIXIN DERIVATIVE (I).

Номер патента: BRPI0715095B1. Автор: Vaara Martti,Vaara Timo. Владелец: Northern Antibiotics Oy. Дата публикации: 2018-08-07.

Materials and methods for the prevention and treatment of viral diseases

Номер патента: EP4308146A1. Автор: Marc M. Baum,Manjula GUNAWARDANA. Владелец: Oak Crest Inst of Science. Дата публикации: 2024-01-24.

Use of b cell depleting agents for the treatment of rheumatic heart disease

Номер патента: EP4347647A1. Автор: Xavier JOUVEN,Alexandre LOUPY. Владелец: Université Paris Cite. Дата публикации: 2024-04-10.

PHARMACEUTICAL SOLUTIONS OF ANTI-N3pGlu Aβ ANTIBODIES AND USES THEREOF

Номер патента: WO2024020470A1. Автор: Vincent John Corvari,Nicole H. DURBIN,Anant Navanithan Sharma. Владелец: ELI LILLY AND COMPANY. Дата публикации: 2024-01-25.

Materials and methods for the prevention and treatment of viral diseases

Номер патента: CA3215543A1. Автор: Marc M. Baum,Manjula GUNAWARDANA. Владелец: Individual. Дата публикации: 2022-11-03.

Antibodies broadly targeting coronaviruses and uses thereof

Номер патента: WO2022162012A3. Автор: Antonio Lanzavecchia,Federica SALLUSTO,Antonino Cassotta,Jun Siong LOW,Josipa JERAK. Владелец: Institute For Research in Biomedicine. Дата публикации: 2022-09-09.

Agents for the prevention and/or treatment of central nervous system damage

Номер патента: US09889150B2. Автор: Jeremy Ewan Turnbull,Scott Ernest Guimond,Sophie Marie Thompson,Susan Carol Barnett,Jennifer Rosemary Higginson. Владелец: University of Glasgow. Дата публикации: 2018-02-13.

Methods for the Use of CD32B x CD79B-Binding Molecules in the Treatment of Inflammatory Diseases and Disorders

Номер патента: US20190322741A1. Автор: Wei Chen,Paul A. Moore,Ezio Bonvini,Jon Marc Wigginton,Naimish Bharat Pandya. Владелец: Macrogenics Inc. Дата публикации: 2019-10-24.

USE OF ANTI-INTERLEUKIN-9 ANTIBODY FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF ASTHMA

Номер патента: DE69635305D1. Автор: Clifford Levitt,W Lee Maloy,U Kari,Nicolas Nicolaides. Владелец: Genaera Corp. Дата публикации: 2006-03-02.

Use of semaphorin-4D binding molecules for the treatment of Rett syndrome

Номер патента: AU2021297152A1. Автор: Maurice Zauderer,Elizabeth E. Evans,Wendy Gold,Matthew Yilin MAO. Владелец: Sydney Childrens Hospitals Network. Дата публикации: 2023-02-02.

Bispecific antibody to a-syn/igf1r and use thereof

Номер патента: EP3725806A1. Автор: Sang Hoon Lee,Jinhyung Ahn,Sungwon AN,Dongin Kim,Eunsil SUNG,Jaehyun EOM,Weonkyoo YOU,Jaeho Jung,Juhee Kim,Jinwon JUNG,Yeunju KIM,Byungje Sung,Hyejin Chung,Youngdon Pak,Seawon Ahn,Bora LEE,Daehae SONG,Donghoon YEOM,Kyungjin PARK,Jiseon YOO,Yong-Gyu Son,Yoseob LEE. Владелец: ABL Bio Inc. Дата публикации: 2020-10-21.

The use of histamine h4 receptor antagonist for the treatment of inflammatory response

Номер патента: WO2003057919A3. Автор: Lars Karlsson,Siquan Sun,Robin Thurmond. Владелец: Ortho Mcneil Pharm Inc. Дата публикации: 2003-10-30.

The use of histamine h4 receptor antagonist for the treatment of inflammatory response

Номер патента: EP1458885A2. Автор: Lars Karlsson,Siquan Sun,Robin Thurmond. Владелец: Ortho McNeil Pharmaceutical Inc. Дата публикации: 2004-09-22.

Antibodies against human csf-1r and uses thereof

Номер патента: RU2658603C2. Автор: Клаус КАЛУЦА,Георг ФЕРТИГ,Александер ФИДЛЕР,Карола РИС,Стефан ЗЕЕБЕР,Марлен ТОМАС. Владелец: Ф.Хоффманн-Ля Рош Аг. Дата публикации: 2018-06-21.

A human anti-epidermal growth factor receptor Fab antibody and a pharmaceutical composition for treating tumor comprising the same

Номер патента: KR101273918B1. Автор: 차상훈. Владелец: 강원대학교산학협력단. Дата публикации: 2013-06-13.

Antibodies targeting B-cell receptor complex membrane bound IGM and uses thereof

Номер патента: US09926381B2. Автор: Sydney Welt,David Kostyal,Virginia RAYMOND,Rachel S Welt,Jonathan A Welt. Владелец: WELT BIO-MOLECULAR PHARMACEUTICAL LLC. Дата публикации: 2018-03-27.

Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity

Номер патента: CA2163211C. Автор: Jürgen Bernhagen,Anthony Cerami,Richard J. Bucala,Robert A. Mitchell,Thierry F. Calandra. Владелец: Baxter International Inc. Дата публикации: 2012-05-08.

Antibodies targeting b-cell receptor complex membrane bound igm and uses thereof

Номер патента: CA2931779C. Автор: Sydney Welt,David Kostyal,Rachel S. Welt,Virginia RAYMOND,Jonathan A. Welt. Владелец: WELT BIO-MOLECULAR PHARMACEUTICAL LLC. Дата публикации: 2023-04-25.

Tryptophan- and phenylethylamine-derived betaxanthins for use in the treatment and/or prevention of cancer

Номер патента: WO2021009029A1. Автор: Francisco Garcia Carmona,Fernando Gandía Herrero,Paula Henarejos Escudero,Samanta Hernández García,María Alejandra Guerrero Rubio. Владелец: Universidad De Murcia. Дата публикации: 2021-01-21.

Amide-substituted pyridinyltriazole derivatives and uses thereof

Номер патента: EP3452463A1. Автор: Klemens Lustig,Pierre Wasnaire,Axel Kretschmer,Carsten Schmeck,Anja BUCHMÜLLER,Heiko Schirmer,Karoline DRÖBNER,Peter Kolkhof,Hanna Tinel,Marie-Pierre Collin,Chantal FÜRSTNER,Elisabeth Pook,Thomas Neubauer,Matthias Beat WITTWER,Thomas MONDRITZKI,Hana CERNECKA. Владелец: Bayer Pharma AG. Дата публикации: 2019-03-13.

Pharmaceutical combinations comprising a kras g12c inhibitor and uses of a kras g12c inhibitor for the treatment of cancers

Номер патента: EP4267134A4. Автор: Porta Diana Graus,BO LIU,Stefan Stutz,Andreas Weiss,Pascal Rigollier,Andrea Vaupel,Nadine Schneider,Marc Gerspacher,Robert Mah,Vasileios Askoxylakis,Rainer Wilcken,Catherine Leblanc,Rainer Machauer,Jeffrey Engelman,Padmaja YERRAMILLI-RAO,Simona Cotesta,Edwige Liliane Jeanne Lorthiois,Christophe MURA,Nicolas WARIN,Saskia Maria Brachmann,Xiaoming Cui,Anna FARAGO. Владелец: NOVARTIS AG. Дата публикации: 2024-11-06.

Amide-substituted pyridinyltriazole derivatives and uses thereof

Номер патента: US09988367B2. Автор: Klemens Lustig,Pierre Wasnaire,Axel Kretschmer,Carsten Schmeck,Anja BUCHMÜLLER,Heiko Schirmer,Karoline DRÖBNER,Peter Kolkhof,Hanna Tinel,Marie-Pierre Collin,Chantal FÜRSTNER,Elisabeth Pook,Thomas Neubauer,Matthias Beat WITTWER,Thomas MONDRITZKI,Hana CERNECKA. Владелец: Bayer Pharma AG. Дата публикации: 2018-06-05.

Azolopyrimidine for the treatment of cancer-related disorders

Номер патента: EP4310082A3. Автор: Debashis MANDAL,Jay Powers,Manmohan Reddy Leleti,Rhiannon THOMAS-TRAN,Joel Beatty,Laurent DEBIEN,Jenna JEFFREY,Dillon MILES,Brandon ROSEN,Ehesan SHARIF. Владелец: Arcus Biosciences Inc. Дата публикации: 2024-04-10.

Azolopyrimidine for the treatment of cancer-related disorders

Номер патента: EP4310082A2. Автор: Debashis MANDAL,Jay Powers,Manmohan Reddy Leleti,Rhiannon THOMAS-TRAN,Joel Beatty,Laurent DEBIEN,Jenna JEFFREY,Dillon MILES,Brandon ROSEN,Ehesan SHARIF. Владелец: Arcus Biosciences Inc. Дата публикации: 2024-01-24.

Azolopyrimidine for the treatment of cancer-related disorders

Номер патента: AU2022203515B2. Автор: Debashis MANDAL,Jay Powers,Manmohan Reddy Leleti,Rhiannon THOMAS-TRAN,Joel Beatty,Laurent DEBIEN,Jenna JEFFREY,Dillon MILES,Brandon ROSEN,Ehesan SHARIF. Владелец: Arcus Biosciences Inc. Дата публикации: 2024-02-22.

Azolopyrimidine for the treatment of cancer-related disorders

Номер патента: AU2024203366A1. Автор: Debashis MANDAL,Jay Powers,Manmohan Reddy Leleti,Rhiannon THOMAS-TRAN,Joel Beatty,Laurent DEBIEN,Jenna JEFFREY,Dillon MILES,Brandon ROSEN,Ehesan SHARIF. Владелец: Arcus Biosciences Inc. Дата публикации: 2024-06-06.

Azolopyrimidine for the treatment of cancer-related disorders

Номер патента: ZA202210004B. Автор: Debashis MANDAL,Jay Powers,Manmohan Reddy Leleti,Rhiannon THOMAS-TRAN,Joel Beatty,Laurent DEBIEN,Jenna JEFFREY,Dillon MILES,Brandon ROSEN,Ehesan SHARIF. Владелец: Arcus Biosciences Inc. Дата публикации: 2024-05-30.

6-substituted isoflavonoid compounds and uses thereof

Номер патента: EP2324003A1. Автор: Naresh Kumar,Michael James,Alan James Husband. Владелец: NOVOGEN RESEARCH PTY LTD. Дата публикации: 2011-05-25.

Uses of hydroquinone substituted polyunsaturated fatty acids as antioxidants

Номер патента: US20040162347A1. Автор: Edward Leonard. Владелец: Individual. Дата публикации: 2004-08-19.

PRODRUG OF 5α-HYDROXY-6β-[2-(1H-IMIDAZOL-4-YL)ETHYLAMINO]CHOLESTAN-3β-OL AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME FOR USE IN THE TREATMENT OF CANCER

Номер патента: AU2021391628A9. Автор: Stephane Silvente,Nicolas Caron,Dario Mosca,Quentin Marlier,Arnaud Rives,Hélène MICHAUX. Владелец: Dendrogenix. Дата публикации: 2024-09-12.

Pyropheophorbide conjugate and use thereof in the treatment of cancer and as a fluorescent marker

Номер патента: US11975072B2. Автор: Serge Mordon,Olivier Morales,Regis Vanderesse,Henri Azais,Pierre Collinet,Nadira Delhem-Fellahi,Celine Frochot,Aurelie Stallivieri. Владелец: Centre Hospitalier Regional Universitaire de Lille CHRU. Дата публикации: 2024-05-07.

Ionizable lipids and methods of manufacture and use thereof

Номер патента: EP4228658A1. Автор: Mikell Paige,Drew Weissman,Mohamad Gabriel ALAMEH,Suman Alishetty,Michael Daro BUSCHMANN,Manuel Carrasco. Владелец: George Mason Research Foundation Inc. Дата публикации: 2023-08-23.

Use of p38 inhibitors for the treatment of inflammation-enhanced cough

Номер патента: EP1337255A2. Автор: David C. Underwood,Don E. Griswold. Владелец: SmithKline Beecham Corp. Дата публикации: 2003-08-27.

Pharmaceutical combinations comprising a kras g12c inhibitor and uses of a kras g12c inhibitor for the treatment of cancers

Номер патента: WO2022135346A1. Автор: BO LIU,Stefan Stutz,Andreas Weiss,Pascal Rigollier,Andrea Vaupel,Nadine Schneider,Marc Gerspacher,Robert Mah,Vasileios Askoxylakis,Rainer Wilcken,Diana Graus Porta,Catherine Leblanc,Rainer Machauer,Jeffrey Engelman,Padmaja YERRAMILLI-RAO,Simona Cotesta,Edwige Liliane Jeanne Lorthiois,Christophe MURA,Nicolas WARIN,Saskia Maria Brachmann,Xiaoming Cui,Anna FARAGO. Владелец: NOVARTIS AG. Дата публикации: 2022-06-30.

Pharmaceutical combinations comprising a kras g12c inhibitor and uses of a kras g12c inhibitor for the treatment of cancers

Номер патента: TW202241414A. Автор: 劉波,瓦西里奧斯 阿斯克齊雷奇斯,賽斯吉婭 瑪麗亞 布拉克曼,席蒙娜 扣泰斯塔,曉鳴 崔,杰弗瑞 英格曼,安娜 法拉戈,馬克 吉史帕奇,波塔 黛安娜 葛羅斯,凱薩琳 萊柏蘭克,艾德維 莉莉安 珍 洛提維斯,雷奈 馬曲爾,羅伯 馬,克里斯托夫 穆拉,巴斯可 萊戈利爾,納丁 施耐德,史戴芬 史吐滋,安卓 維波,尼克拉斯 華林,安德烈亞斯 維斯,雷納 魏爾肯,拉奧 帕瑪賈 耶瑞米利. Владелец: 瑞士商諾華公司. Дата публикации: 2022-11-01.

Pharmaceutical combinations comprising a kras g12c inhibitor and uses of a kras g12c inhibitor for the treatment of cancers

Номер патента: AU2021408129A1. Автор: BO LIU,Stefan Stutz,Andreas Weiss,Pascal Rigollier,Andrea Vaupel,Nadine Schneider,Marc Gerspacher,Robert Mah,Vasileios Askoxylakis,Rainer Wilcken,Diana Graus Porta,Catherine Leblanc,Rainer Machauer,Jeffrey Engelman,Padmaja YERRAMILLI-RAO,Simona Cotesta,Edwige Liliane Jeanne Lorthiois,Christophe MURA,Nicolas WARIN,Saskia Maria Brachmann,Xiaoming Cui,Anna FARAGO. Владелец: NOVARTIS AG. Дата публикации: 2023-07-13.

Selective modulators of ataxia telangiectasia mutated (atm) kinase and uses thereof

Номер патента: CA3213823A1. Автор: Zheng Wang,DING Zhou,Ziqiang CHENG. Владелец: Suzhou Zanrong Pharma Ltd. Дата публикации: 2022-09-22.

Substituted triazole derivatives and uses thereof

Номер патента: CA3079771A1. Автор: Klemens Lustig,Pierre Wasnaire,Carsten Schmeck,Heiko Schirmer,Peter Kolkhof,Hanna Tinel,Chantal FÜRSTNER,Elisabeth Pook,Marie-Pierre Collin-Kropelin,Thomas Neubauer. Владелец: Bayer Pharma AG. Дата публикации: 2019-05-02.

Amine substituted triazole derivatives and uses thereof

Номер патента: US20200253961A1. Автор: Klemens Lustig,Pierre Wasnaire,Carsten Schmeck,Heiko Schirmer,Peter Kolkhof,Hanna Tinel,Chantal Fuerstner,Elisabeth Pook,Thomas Neubauer,Marie-Pierre COLLIN-KROEPELIN. Владелец: Bayer Pharma AG. Дата публикации: 2020-08-13.

Sting modulator compounds with sulfamate linkages, and methods of making and using

Номер патента: EP4242212A3. Автор: HE Xu,Stepan Vyskocil,Hirotake Mizutani,Zhan Shi,Dylan Bradley ENGLAND,Shih-Chung Huang,Paul Greenspan,Alexandra E. Gould,Kenneth M. Gigstad,Yongbo Hu,Jeffrey Ciavarri,Steven Paul LANGSTON. Владелец: Takeda Pharmaceutical Co Ltd. Дата публикации: 2023-11-15.

Sting modulator compounds with sulfamate linkages, and methods of making and using

Номер патента: EP4242212A2. Автор: HE Xu,Stepan Vyskocil,Hirotake Mizutani,Zhan Shi,Dylan Bradley ENGLAND,Shih-Chung Huang,Paul Greenspan,Alexandra E. Gould,Kenneth M. Gigstad,Yongbo Hu,Jeffrey Ciavarri,Steven Paul LANGSTON. Владелец: Takeda Pharmaceutical Co Ltd. Дата публикации: 2023-09-13.

Use of eribulin and histone deacetylase inhibitors in the treatment of cancer

Номер патента: WO2018016563A1. Автор: Bruce A. Littlefield,Gary HENDLER. Владелец: Eisai R&D Management Co., Ltd.. Дата публикации: 2018-01-25.

Use of eribulin and histone deacetylase inhibitors in the treatment of cancer

Номер патента: EP3487492A1. Автор: Bruce A. Littlefield,Gary HENDLER. Владелец: Eisai R&D Management Co Ltd. Дата публикации: 2019-05-29.

Use of RNAI Inhibiting PARP Activity for the Manufacture of a Medicament for the Treatment of Cancer

Номер патента: US20180000822A1. Автор: Helleday Thomas. Владелец: . Дата публикации: 2018-01-04.

USE OF RNAI INHIBITING PARP ACTIVITY FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF CANCER

Номер патента: US20220062286A1. Автор: Helleday Thomas. Владелец: . Дата публикации: 2022-03-03.

USE OF RNAI INHIBITING PARP ACTIVITY FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF CANCER

Номер патента: US20200237762A1. Автор: Helleday Thomas. Владелец: . Дата публикации: 2020-07-30.

Use of rnai inhibiting parp activity for the manufacture of a medicament for the treatment of cancer

Номер патента: KR101136702B1. Автор: 토마스 헬레데이. Владелец: 더 유니버시티 오브 셰필드. Дата публикации: 2012-04-20.

Use of rnai inhibiting parp activity for the manufacture of a medicament for the treatment of cancer

Номер патента: CA2533423A1. Автор: Thomas Helleday. Владелец: Thomas Helleday. Дата публикации: 2005-02-10.

Use of rnai inhibiting parp activity for the manufacture of a medicament for the treatment of cancer

Номер патента: PL1649017T5. Автор: Thomas Helleday. Владелец: Univ Sheffield. Дата публикации: 2015-02-27.

PRODRUG OF 5a-HYDROXY-6ß-[2-(1H-IMIDAZOL-4-YL)ETHYLAMINO]CHOLESTAN-3ß-OL AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME FOR USE IN THE TREATMENT OF CANCER

Номер патента: US20240002429A1. Автор: Stephane Silvente,Nicolas Caron,Dario Mosca,Quentin Marlier,Arnaud Rives,Hélène MICHAUX. Владелец: Dendrogenix. Дата публикации: 2024-01-04.

5alpha-hydroxy-6beta-[2-(1-h-imidazol-4-yl)-ethylamino]-cholestan-3beta-ol analogues and pharmaceutical compositions comprising same for use in the treatment of cancer

Номер патента: US20230391817A1. Автор: Stephane Silvente,Nicolas Caron,Dario Mosca,Quentin Marlier,Arnaud Rives,Hélène MICHAUX. Владелец: Dendrogenix. Дата публикации: 2023-12-07.

Polymeric fatty acid salt compounds for the treatment of fibrous amino acid-based substrates, especially hair

Номер патента: EP4355726A1. Автор: Roland Wagner,Christian Wenske,Katharina Streicher,Laura Rohmann,Shrutisagar Dattatraya HAVELI. Владелец: MOMENTIVE PERFORMANCE MATERIALS GMBH. Дата публикации: 2024-04-24.

Methods of Treatment of Fibrotic Diseases

Номер патента: US20240082271A1. Автор: Bernard Pau,Severine Loiseau,Ludovic Clarion,Karine CHORRO,Angel Argiles,Nathalie GAYRARD. Владелец: Phost'in Therapeutics. Дата публикации: 2024-03-14.

PRODRUG OF 5α-HYDROXY-6β-[2-(1H-IMIDAZOL-4-YL)ETHYLAMINO]CHOLESTAN-3β-OL AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME FOR USE IN THE TREATMENT OF CANCER

Номер патента: AU2021391628A1. Автор: Stephane Silvente,Nicolas Caron,Dario Mosca,Quentin Marlier,Arnaud Rives,Hélène MICHAUX. Владелец: Dendrogenix. Дата публикации: 2023-06-29.

5alpha-hydroxy-6beta-[2-(1-h-imidazol-4-yl)-ethylamino]-cholestan-3beta-ol analogues and pharmaceutical compositions comprising same for use in the treatment of cancer

Номер патента: AU2021372797A2. Автор: Stephane Silvente,Nicolas Caron,Dario Mosca,Quentin Marlier,Arnaud Rives,Hélène MICHAUX. Владелец: Dendrogenix. Дата публикации: 2023-06-29.

5alpha-hydroxy-6beta-[2-(1-h-imidazol-4-yl)-ethylamino]-cholestan-3beta-ol analogues and pharmaceutical compositions comprising same for use in the treatment of cancer

Номер патента: AU2021372797A1. Автор: Stephane Silvente,Nicolas Caron,Dario Mosca,Quentin Marlier,Arnaud Rives,Hélène MICHAUX. Владелец: Dendrogenix. Дата публикации: 2023-06-15.

Use of kynurenic acid amide derivatives for the treatment of huntington disease

Номер патента: HUP1000343A2. Автор: Istvan Dr Szatmari,Ferenc Dr Fueloep,Andras Szoenyi,Laszlo Dr Vecsei,Denes Dr Zadori,Peter Dr Klivenyi,Jozsef Dr Toldi,Tamas Dr Freund,Gabor Dr Nyiri. Владелец: Univ Szegedi. Дата публикации: 2012-02-28.

Use of cyclic phosphonic acid esters for the treatment of impaired cerebral function and depression

Номер патента: AU9162298A. Автор: Fritz Maurer,Bernard Schmidt,Franz-Josef Van Der Staay,Stephan Lensky. Владелец: Bayer AG. Дата публикации: 1999-03-16.

Use of derivatives of polyunsaturated fatty acids as medicaments

Номер патента: US09907772B2. Автор: Pablo Vicente Escribá Ruiz,María Laura MARTÍN,Xavier Busquets Xaubet,Victoria LLADÓ CAÑELLAS,Rafael ÁLVAREZ MARTÍNEZ. Владелец: Lipopharma Therapeutics SL. Дата публикации: 2018-03-06.

GPR120 RECEIVER AGONISTS AND USES OF THE SAME IN MEDICINES FOR THE TREATMENT OF DIABETES AND METABOLIC SYNDROME.

Номер патента: AR074760A1. Автор: Xin Chen,Jiangao Song,Jingyuan Ma,Aaron Novack,Dong Fang Shi,Phuongly Pham,Christopher J Rabbat,Imad Fayek Nashashibi. Владелец: Metabolex Inc. Дата публикации: 2011-02-09.

Use of 1h-quinazoline- 2, 4 -diones for use in the prevention or treatment photosensitive epilepsy

Номер патента: EP2753331A1. Автор: Donald Johns,Klaus KUCHER,George IMBERT. Владелец: NOVARTIS AG. Дата публикации: 2014-07-16.

Fused cycloalkyl amides and acids and their therapeutic applications for the treatment of i.a. epilepsy

Номер патента: EP1562575A1. Автор: Sanjay R. Chemburkar,Youssef L. Bennani,Michael J. Dart,Sou-Jen Chang,Timothy A. Grieme,Dilinie P. Fernanado. Владелец: ABBOTT LABORATORIES. Дата публикации: 2005-08-17.

Fused cycloalkyl amides and acids and their therapeutic applications for the treatment of i.a. epilepsy

Номер патента: WO2004037241A1. Автор: Sanjay R. Chemburkar,Youssef L. Bennani,Michael J. Dart,Sou-Jen Chang,Timothy A. Grieme,Dilinie P. Fernanado. Владелец: ABBOTT LABORATORIES. Дата публикации: 2004-05-06.

Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases

Номер патента: EP1572709A2. Автор: Holger Beckmann,Richard G. Wilde,Neil G. Almstead,Ellen M. Welch. Владелец: PTC Therapeutics Inc. Дата публикации: 2005-09-14.

Preparation and use of aryl alkyl acid derivatives for the treatment of obesity

Номер патента: US20040224997A1. Автор: Gan Wang,Stephen O'Connor,LEI Zhu,Roger Smith,Ning Su,Ann-Marie Campbell,Philip Coish,Miao Dai,Susan Jenkins,Derek Lowe,Mingbao Zhang. Владелец: Bayer Pharmaceuticals Corp. Дата публикации: 2004-11-11.

Benzofuranyl derivatives ,pharmaceutical formulations comprising the same and use thereof in the preparation of medicaments for the treatment of 5-ht6-receptor related disorders

Номер патента: IL187575A. Автор: . Владелец: Biovitrum Ab Publ. Дата публикации: 2012-12-31.

Selective modulators of ataxia telangiectasia mutated (atm) kinase and uses thereof

Номер патента: EP4308569A1. Автор: Zheng Wang,DING Zhou,Ziqiang CHENG. Владелец: Suzhou Zanrong Pharma Ltd. Дата публикации: 2024-01-24.

1-isopropyl-3-methyl-8- (pyridin-3-yl) -1, 3-dihydro-2h-imidazo (4, 5-c) cinnolin-2-one as selective modulators of ataxia telangiectasia mutated (atm) kinase and uses thereof

Номер патента: AU2019339006B2. Автор: DING Zhou,Ziqiang CHENG. Владелец: Suzhou Zanrong Pharma Ltd. Дата публикации: 2024-03-14.

Selective modulators of ataxia telangiectasia mutated (atm) kinase and uses thereof

Номер патента: AU2021433713A1. Автор: Zheng Wang,DING Zhou,Ziqiang CHENG. Владелец: Suzhou Zanrong Pharma Ltd. Дата публикации: 2023-09-28.

Use of a2a adenosine receptor agonists for the treatment of inflammatory diseases

Номер патента: WO2003086408A8. Автор: Joel M Linden,Jayson M Rieger,Timothy L Macdonald,Gail W Sullivan,W Michael Scheld,Tom G Obrig. Владелец: Tom G Obrig. Дата публикации: 2005-01-13.

Use of a2a adenosine receptor agonists for the treatment of inflammatory diseases

Номер патента: EP1496911A1. Автор: Joel M. Linden,Jayson M. Rieger,Gail W. Sullivan,Timothy L. MacDonald,Michael W. Scheld,Tom G. Obrig. Владелец: University of Virginia UVA. Дата публикации: 2005-01-19.

Selective modulators of ataxia telangiectasia mutated (atm) kinase and uses thereof

Номер патента: US20240207263A1. Автор: Zheng Wang,DING Zhou,Ziqiang CHENG. Владелец: Suzhou Zanrong Pharma Ltd. Дата публикации: 2024-06-27.

Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases

Номер патента: AU2003261237A8. Автор: Holger Beckmann,Neil G Almstead,Richard G Wilde,Ellen M Welch. Владелец: PTC Therapeutics Inc. Дата публикации: 2004-02-09.

Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension

Номер патента: US5889052A. Автор: Verney L. Sallee,Paul W. Zinke,John E. Bishop,Peter G. Klimko. Владелец: Alcon Laboratories Inc. Дата публикации: 1999-03-30.

The use of CI-994 and dinaline for the treatment of memory/cognition and anxiety disorders

Номер патента: CN102834002A. Автор: 蔡立慧,管吉松,斯蒂芬·J·哈格蒂,爱德华·赫尔森,弗洛伦斯·瓦格纳,约翰内斯·格雷夫. Владелец: Broad Institute Inc. Дата публикации: 2012-12-19.

The use of ci-994 and dinaline for the treatment of memory/cognition and anxiety disorders

Номер патента: CA2779497A1. Автор: Li-Huei Tsai,Edward Holson,Stephen J. Haggarty,Florence Wagner,Ji-Song Guan,Johannes Graeff. Владелец: Broad Institute Inc. Дата публикации: 2011-05-05.

Use of adenosine and analogues thereof for the manufacture of a medicament for the treatment of insulin resistance syndrome and diabetes mellitus

Номер патента: EE200300551A. Автор: HERLING Andreas,P. Maguire Martin,P. Spada Alfred,R. Myers Michael,Mi Choi-Sledeski Yong,W. Pauls Heinz,R. Ewing William,J�hne Gerhard. Владелец: Aventis Pharma Deutschland GmbH. Дата публикации: 2004-02-16.

Use of 3'-fluro-3' deoxythymidine for the manufacture of a medicament for the treatment of virus infections

Номер патента: EP0286825A3. Автор: Fritz Prof. Dr. Eckstein,Gerhard Prof. Dr. Hunsmann,Heinz Dr. Hartmann. Владелец: Deutsches Primatenzentrum GmbH. Дата публикации: 1989-04-12.

The use of AICA riboside and ribavirin for the preparation of a medicament for the treatment of allergies

Номер патента: EP0623348A1. Автор: Harry Edward Gruber. Владелец: GRUBER, Harry, Edward. Дата публикации: 1994-11-09.

Process for the preparation of a compound derived from etorphine; etorphine derivative compound; pharmaceutical composition comprising it; use of the compound as an analgesic in the treatment of pain.

Номер патента: CL2011001363A1. Автор: Steve Whitelock,Deborah Phyllis Harding,Carl David Turner. Владелец: Euro Celtique SA. Дата публикации: 2011-09-23.

Compound, pharmaceutical composition, use of a compound, and, processes for the treatment of a retrovirus infection in a human being and for the preparation of a compound.

Номер патента: BR9912156A. Автор: Hardev Singh,Ian Gordon Armitage,Andre David Searle. Владелец: Glaxo Group Ltd. Дата публикации: 2001-04-10.

Use of Phospholipase A2 from Elapidae snakes in the treatment of diabetic nephropathy

Номер патента: US20240245757A1. Автор: Zhankai QI. Владелец: Individual. Дата публикации: 2024-07-25.

Use of mir-92a or mir-145 in the treatment of angelman syndrome

Номер патента: EP3793567A1. Автор: Matthew During. Владелец: Ovid Therapeutics Inc. Дата публикации: 2021-03-24.

Use of mir-92a or mir-145 in the treatment of angelman syndrome

Номер патента: US20190382761A1. Автор: Matthew During. Владелец: Ovid Therapeutics Inc. Дата публикации: 2019-12-19.

Use of mir-92a or mir-145 in the treatment of angelman syndrome

Номер патента: WO2019241624A1. Автор: Matthew During. Владелец: Ovid Therapeutics Inc.. Дата публикации: 2019-12-19.

Use of microcapsules comprising an antigen for the manufacture of an ex-vivo medicament to initiate an immune response

Номер патента: WO2004062559A2. Автор: James Edward Eyles,Gareth David Healey,Ethel Diane Williamson,Angie Westwood. Владелец: The Secretary of State For Defence. Дата публикации: 2004-07-29.

Use of microcapsules comprising an antigen for the manufacture of an ex-vivo medicament to initiate an immune response

Номер патента: WO2004062559A3. Автор: James Edward Eyles,Gareth David Healey,Ethel Diane Williamson,Angie Westwood. Владелец: Angie Westwood. Дата публикации: 2004-09-02.

Use of a particular metal oxide for the photoconversion of organic compounds on keratin materials

Номер патента: WO2022112053A1. Автор: Henri Samain,Valérie Jeanne-Rose,Yiannis Deligiannakis,Maria Louloudi. Владелец: L'oreal. Дата публикации: 2022-06-02.

Use of a particular metal oxide for the photoconversoin of organic compounds on keratin materials

Номер патента: US20230414464A1. Автор: Henri Samain,Valérie Jeanne-Rose,Yiannis Deligiannakis,Maria Louloudi. Владелец: LOreal SA. Дата публикации: 2023-12-28.

Use of a particular metal oxide for the photoconversion of organic compounds on keratin materials

Номер патента: EP4251120A1. Автор: Henri Samain,Valérie Jeanne-Rose,Yiannis Deligiannakis,Maria Louloudi. Владелец: LOreal SA. Дата публикации: 2023-10-04.

Use of a silicone rubber composition for the manufacture of an insulator for high voltage direct current applications

Номер патента: US11908595B2. Автор: Harry Zumaque,Lada Bemert,Oliver Safarowsky,Beatrice Grau. Владелец: MOMENTIVE PERFORMANCE MATERIALS GMBH. Дата публикации: 2024-02-20.

Use of radiofrequency wave absorbing markers for the authentication of security documents

Номер патента: PH12013502034B1. Автор: JUEZ Vicente Garcia,ARANDA Javier Gamo,BARBERO Miguel Angel Rodriguez,Fanego Juan Jos‚ Romero,Lozano Jos‚ Francisco Fernandez. Владелец: F?Brica Nac De Moneda Y Timbre Real Casa De La Moneda. Дата публикации: 2014-01-06.

Use of a modulator of gene expression in the treatment of cancer

Номер патента: WO2005107782A2. Автор: Helen Louise ROGERS,Anne Willis,Martin Bushell. Владелец: THE UNIVERSITY OF NOTTINGHAM. Дата публикации: 2005-11-17.

Use of a modulator of gene expression in the treatment of cancer

Номер патента: WO2005107782A3. Автор: Helen Louise ROGERS,Anne Willis,Martin Bushell. Владелец: Martin Bushell. Дата публикации: 2006-02-02.

Cemtirestat disulfide, prodrug of aldo-keto reductase inhibitor, preparation, pharmaceutical composition and use thereof

Номер патента: EP4259152A1. Автор: Milan Štefek,Marta Šoltésová-Prnová,Lucia KOVÁCIKOVÁ,Gabriela ADDOVÁ,Andrej BOHÁC. Владелец: Centrum Experimentalnej Mediciny Sav. Дата публикации: 2023-10-18.

Substituted benzimidazole compounds and their use for the treatment of cancer

Номер патента: US20050014811A1. Автор: François CLERC,François HAMY,Isabelle Depaty,Odile Angouillant-Boniface,Stéphanie Deprets,Chantal Carrez,Manfred Roesner. Владелец: AVENTIS PHARMA SA. Дата публикации: 2005-01-20.

2-phenyl-benzimidazol and 2-phenyl-imidazo-`4,5!-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer

Номер патента: CA2522562C. Автор: J. Guy Breitenbucher,Michael K. Ameriks,Frank U. Axe,Kristen L. Arienti. Владелец: Janssen Pharmaceutica NV. Дата публикации: 2013-09-03.

Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments

Номер патента: EP2007729A1. Автор: Helmut Heinrich Buschmann,Jover Antonio Torrens,Prio Josep Mas,Casamitjana Adriana Port. Владелец: Laboratorios del Dr Esteve SA. Дата публикации: 2008-12-31.

Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments

Номер патента: CA2647024A1. Автор: Helmut Heinrich Buschmann,Antonio Torrens Jover,Josep Mas Prio,Adriana Port Casamitjana. Владелец: Individual. Дата публикации: 2007-09-27.

Substituted tetrahydroisoquinoline compound, their preparation and use in medicaments

Номер патента: US20090209528A1. Автор: Helmut Heinrich Buschmann,Josep Mas Prio,Adriana Port Casamitjana. Владелец: Laboratorios del Dr Esteve SA. Дата публикации: 2009-08-20.

Substituted indole sulfonamide compounds, their preparation and use as medicaments

Номер патента: WO2010012806A3. Автор: Matthias Beller,José Luis Díaz-Fernández,Karolin Alex. Владелец: LABORATORIOS DEL DR. ESTEVE, S.A.. Дата публикации: 2010-07-08.

Substituted indole sulfonamide compounds, their preparation and use as medicaments

Номер патента: EP2318397A2. Автор: Matthias Beller,José Luis Díaz-Fernández,Karolin Alex. Владелец: Laboratorios del Dr Esteve SA. Дата публикации: 2011-05-11.

Substituted indole sulfonamide compounds, their preparation and use as medicaments

Номер патента: WO2010012806A2. Автор: Matthias Beller,José Luis Díaz-Fernández,Karolin Alex. Владелец: LABORATORIOS DEL DR. ESTEVE, S.A.. Дата публикации: 2010-02-04.

Substituted n-(benzyl)phenylacetamide derivative compounds, preparation method thereof and uses of same as ppar ligands in the treatment of lipid and/or glucidic disorders

Номер патента: WO2006035157A2. Автор: Karine Caumont-Bertrand,Christophe Masson. Владелец: GENFIT. Дата публикации: 2006-04-06.

Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene, process for their preparation, pharmaceutical compositions comprising same and use thereof in the manufacture of medicaments for the treatment of central nervous system disorders

Номер патента: IL189383A. Автор: . Владелец: Otsuka Pharma Co Ltd. Дата публикации: 2013-03-24.

Compound, pharmaceutical formulation, use of a compound, and, processes for the preparation of a compound, to inhibit the secretion of gastric acid, for the treatment of inflammatory gastrointestinal diseases, and for the treatment or prophylaxis of conditions involving helicobacter pylori infection of the human gastric mucosa

Номер патента: BR9814755A. Автор: Kosrat Amin,Peter Nordberg,Ingemar Starke,Dahlstr M Mikael. Владелец: AstraZeneca AB. Дата публикации: 2000-10-03.

Compounds for the treatment of epilepsy, neurodegenerative disorders and other cns disorders

Номер патента: EP3621963A1. Автор: Arnaud Didier Marie Marchand,Patrick Chaltin,Johan Gerard Griffioen,Katrien Princen,Tom Francois L. Van Dooren,Amuri Kilonda,Sara Allasia. Владелец: REMYND NV. Дата публикации: 2020-03-18.

Compounds for the treatment of epilepsy, neurodegenerative disorders and other CNS disorders

Номер патента: US11939324B2. Автор: Arnaud Didier Marie Marchand,Patrick Chaltin,Johan Gerard Griffioen,Katrien Princen,Tom Francois L. Van Dooren,Amuri Kilonda,Sara Allasia. Владелец: REMYND NV. Дата публикации: 2024-03-26.

Compounds for the treatment of epilepsy, neurodegenerative disorders and other cns disorders

Номер патента: CA3060481C. Автор: Arnaud Didier Marie Marchand,Patrick Chaltin,Johan Gerard Griffioen,Katrien Princen,Tom Francois L. Van Dooren,Amuri Kilonda,Sara Allasia. Владелец: REMYND NV. Дата публикации: 2024-04-30.

Crystalline forms of the salts of esylate, oxalate, mesylate and maleate of 8 - [[1- (3,5-bis- (trifluoromethyl) phenyl) -ethoxy] -methyl] -8-phenyl-1,7-diaza-spiro [4.5] decan-2-one; pharmaceutical composition; and use in the preparation of a medicament for the treatment and / or prevention of emesis and / or nausea.

Номер патента: CL2007000947A1. Автор: Sunil Paliwal,Ingrid Mergelsberg,Frank Guenter,Mengwel Hu,Nen-Yang Shih. Владелец: Schering Corp. Дата публикации: 2008-01-25.

Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases

Номер патента: US6846815B2. Автор: Alfred P. Spada,Martin P. Maguire,Paul E. Persons,Michael R. Myers. Владелец: Aventis Pharmaceuticals Inc. Дата публикации: 2005-01-25.

Preparation and use of biphenyl amino acid derivatives for the treatment of obesity

Номер патента: CA2617055A1. Автор: Roger Smith,Philip Coish,Derek Lowe,Stephen J. O'connor,Tatiana Shelekhin,Georgiy Bondar. Владелец: Georgiy Bondar. Дата публикации: 2007-02-08.

Preparation and use of aryl alkyl acid derivatives for the treatment of obesity

Номер патента: CN101198333A. Автор: R·史密斯,G·王,M·帕特尔,D·罗维,P·夸什,A·-M·坎贝尔,G·邦达. Владелец: Bayer Pharmaceuticals Corp. Дата публикации: 2008-06-11.

Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases

Номер патента: US6159978A. Автор: Alfred P. Spada,Martin P. Maguire,Paul E. Persons,Michael R. Myers. Владелец: Aventis Pharmaceuticals Inc. Дата публикации: 2000-12-12.

Indoles active as modulators of nicotinic acetylcholin receptor subtype alpha-7, pharmaceutical compositions comprising them and use thereof in the manufacture of medicaments for the treatment of psychotic disorders

Номер патента: IL208574A. Автор: . Владелец: Glaxo Group Ltd. Дата публикации: 2014-04-30.

The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of cns disorders

Номер патента: EP2792681B1. Автор: Torbjorn Backstrom,Gianna Ragagnin. Владелец: UMECRINE AB. Дата публикации: 2016-10-19.

Use of imidazole-2-thione compounds, for the preparation of a composition for the treatment and/or prevention of hyperpigmentary disorders, melasma, chloasma, lentigines, senile lentigo and vitiligo

Номер патента: FR2903694A1. Автор: Isabelle Pelisson,Irene Erdelmeier,Jean Claude Yadan,Itaru Suzuki. Владелец: Galderma Research and Development SNC. Дата публикации: 2008-01-18.

The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of cns disorders

Номер патента: CA2833976A1. Автор: Torbjorn Backstrom,Gianna Ragagnin. Владелец: UMECRINE AB. Дата публикации: 2008-05-29.

Compound, pharmaceutical formulation, use of a compound, and, processes for the treatment of disorders in the central nervous system and / or urinary incontinence, vasospasm and tumor growth control and for the preparation of the compound

Номер патента: BR9811042A. Автор: Stefan Berg,Seth Olov Thorberg,Bengt Ulff,Svante Ross,Mats Linderberg. Владелец: Astra AB. Дата публикации: 2000-08-15.

Compound, use of it, pharmaceutical composition, process for the treatment of a human or non-human animal suffering or subject to conditions that can be improved by the administration of an a4b1-mediated cell adhesion inhibitor, and resin

Номер патента: BR9813331A. Автор: Barry Porter,Paul Joseph Cox,Andrew David Morley,Neil Victor Harris,David Edward Clark,Alan John Collis,Paul Joseph Eastwood,Justine Yen Quai Lai. Владелец: Aventis Pharma Ltd. Дата публикации: 2000-08-22.

The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of CNS disorders

Номер патента: AU2007322423B2. Автор: Torbjorn Backstrom,Gianna Ragagnin. Владелец: UMECRINE AB. Дата публикации: 2013-01-10.

The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of cns disorders

Номер патента: SI2097437T1. Автор: Torbjorn Backstrom,Gianna Ragagnin. Владелец: Umecrine Cognition AB. Дата публикации: 2015-10-30.

The use of pregnan and androstane steroids for the preparation of a pharmaceutical composition for the treatment of central nervous system disorders

Номер патента: ES2662500T3. Автор: Torbjorn Backstrom,Gianna Ragagnin. Владелец: ASARINA PHARMA AB. Дата публикации: 2018-04-06.

Use of a tetraphenylborate (tpb) salt for the separation of biomolecules

Номер патента: US20170183375A1. Автор: Roland Callens,Laurent Jeannin. Владелец: Corden Pharma Brussels SA. Дата публикации: 2017-06-29.

Use of a tetraphenylborate (TPB) salt for the separation of biomolecules

Номер патента: US20110098446A1. Автор: Roland Callens,Laurent Jeannin. Владелец: SOLVAY SA. Дата публикации: 2011-04-28.

Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation

Номер патента: WO2002058623A2. Автор: Elena Feinstein,Orit Segev,Dganit Bar. Владелец: Quark Biotech, Inc.. Дата публикации: 2002-08-01.

Sars-cov-2 infection biomarkers and uses thereof

Номер патента: US20210325407A1. Автор: Gang Huang. Владелец: Cincinnati Childrens Hospital Medical Center. Дата публикации: 2021-10-21.

SARS CoV2 infection biomarkers and uses thereof

Номер патента: AU2021201783A1. Автор: Gang Huang. Владелец: Cincinnati Childrens Hospital Medical Center. Дата публикации: 2021-10-28.

Method and compositions for treatment of stat3-responsive cancers and/or renal cancer

Номер патента: WO2012068412A2. Автор: Cynthia Tuthill,Israel Rios. Владелец: SCICLONE PHARMACEUTICALS, INC.. Дата публикации: 2012-05-24.

Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation

Номер патента: US6696454B2. Автор: Elena Feinstein,Orit Segev,Dganit Bar. Владелец: Quark Biotech Inc. Дата публикации: 2004-02-24.

Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation

Номер патента: WO2002058623A3. Автор: Elena Feinstein,Orit Segev,Dganit Bar. Владелец: Dganit Bar. Дата публикации: 2003-08-21.

Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation

Номер патента: US20040229886A1. Автор: Elena Feinstein,Orit Segev,Dganit Bar. Владелец: Quark Biotech Inc. Дата публикации: 2004-11-18.

Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation

Номер патента: US20020160978A1. Автор: Elena Feinstein,Orit Segev,Dganit Bar. Владелец: Quark Biotech Inc. Дата публикации: 2002-10-31.

Use of ccn protein family members for the treatment of disorder associated to an altered calcium and/or sodium flux

Номер патента: AU2003249541A8. Автор: Bernard Perbal. Владелец: Universite Paris Diderot Paris 7. Дата публикации: 2004-02-02.

Use of ccn protein family members for the treatment of disorder associated to an altered calcium and/or sodium flux

Номер патента: AU2003249541A1. Автор: Bernard Perbal. Владелец: Universite Paris Diderot Paris 7. Дата публикации: 2004-02-02.

Process of phytocannabinoids enrichment its formulation and use in the management of pain

Номер патента: WO2023223351A1. Автор: VISHWAKARMA Ram Asrey,AJAY Kumar,Rohit Singh,Deepika Singh,Pankaj Kumar,Sumit Roy,Dumbala Srinivasa REDDY,Mahendra Kumar Verma,Parvinder Pal SINGH,Gurdarshan Singh,Sanghapal Damodhar Sawant,Manmeet Singh,Pankaj Singh Cham,Pankul KOTWAL,Kuhu SHARMA,Durga Prasad MINDALA,Utpal Nandi,Radhika ANAND,Siya Ram MEENA,Aman Verma,Abhishek GOUR,Chandra Pal Singh,Vishav Prakash Rahul,Sumeet GAIROLA,Anil Kumar KATARE,Dhiraj Vyas,Pyare Lal SANGWAN. Владелец: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH. Дата публикации: 2023-11-23.

USE OF PROLACTINE MODULATORS AND DIET FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF FATIBLE ADJUSTMENT

Номер патента: DE69534084D1. Автор: H Meier,H Cincotta. Владелец: Pliva dd. Дата публикации: 2005-04-21.

USE OF PROLACTINAL MODULATORS AND DIET FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF FAT ADJUSTMENT

Номер патента: DE69534084T2. Автор: H. Anthony CINCOTTA,H. Albert MEIER. Владелец: Pliva dd. Дата публикации: 2006-02-09.

ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III CHIMERIC ANTIGEN RECEPTORS AND USE OF SAME FOR THE TREATMENT OF CANCER

Номер патента: US20140037628A1. Автор: Rosenberg Steven A.,Morgan Richard A.. Владелец: The United States of America, as rep., by the Secretary, Dept., of Health and Human Services.. Дата публикации: 2014-02-06.

Use of an estrogen agonist/antagonist for treating female sexual dysfunction

Номер патента: EP1149579A3. Автор: Andrew George Pfizer Global Lee,David Duane Pfizer Global Thompson,Wesley Warren Pfizer Global Day. Владелец: Pfizer Products Inc. Дата публикации: 2003-06-04.

Multispecific antigen binding proteins for tumor-targeting of nk cells and use thereof

Номер патента: WO2024056862A1. Автор: Robert Heinz Edward Friesen. Владелец: Avidicure Ip B.V.. Дата публикации: 2024-03-21.

ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF THAT SPECIFICALLY RECOGNIZES B CELL MALIGNANCIES, CHIMERIC ANTIGEN RECEPTOR COMPRISING SAME, AND USES THEREOF

Номер патента: US20210061907A1. Автор: KIM Ki Hyun,KIM Kyu Tae,LEE Jong Seo,KO Bong Kook. Владелец: . Дата публикации: 2021-03-04.

The use of histamine h4 receptor antagonist for the treatment of inflammatory response

Номер патента: AU2002348265A1. Автор: Siquan Sun,Robin Thurmond,Lars Karlson. Владелец: Ortho McNeil Pharmaceutical Inc. Дата публикации: 2003-07-24.

Use of human papillomavirus status in establishing use of an agent that binds egfr in the treatment of cancer

Номер патента: CA2848061A1. Автор: Jeffrey Scott Wiezorek,Bruce Allen Bach. Владелец: AMGEN INC. Дата публикации: 2013-05-10.

Use of human papillomavirus status in establishing use of an agent that binds EGFR in the treatment of cancer

Номер патента: AU2012333100A8. Автор: Jeffrey Scott Wiezorek,Bruce Allen Bach. Владелец: AMGEN INC. Дата публикации: 2014-04-10.

Biological culture of a strain of the species pseudomonas graminis and use of said culture as antagonist for the biocontrol of pathogenic bacteria

Номер патента: WO2015091643A1. Автор: Immaculada Vinas Almenar,Maria Isabel Abadias Sero,Josep Usall Rodie,Neus Teixido Espasa,Rosario TORRES SANCHIS. Владелец: Institut De Recerca I Tecnologia Agroalimentàries. Дата публикации: 2015-06-25.

Organic electronic component with dopant, use of a dopant and method for the production of the dopant

Номер патента: US09799840B2. Автор: Guenter Schmid,Andreas Kanitz,Benedict Sandmann,Jan Hauke Wemken,Renate KELLERMANN. Владелец: OSRAM OLED GmbH. Дата публикации: 2017-10-24.

Use of aryl- and heteroaryl piperazinyl carboxamides in the treatment of various central nervous system disorders

Номер патента: US5482940A. Автор: John P. Yardley,John A. Moyer,Wayne E. Childers, Jr.,Magid A.-M. Abou-Gharbia. Владелец: American Home Products Corp. Дата публикации: 1996-01-09.

Method for producing a laminated glass pane free of optical obstruction caused by warping, use of a particular carrier film for the production of the laminated glass pane and carrier films particularly suitable for the method or the use

Номер патента: CA2226969C. Автор: Peter Costa. Владелец: Flachglas Automotive GmbH. Дата публикации: 2002-04-30.

Organic Electronic Component with Dopant, Use of a Dopant and Method for the Production of the Dopant

Номер патента: US20140264313A1. Автор: Guenter Schmid,Andreas Kanitz,Benedict Sandmann,Jan Hauke Wemken,Renate KELLERMANN. Владелец: OSRAM Opto Semiconductors GmbH. Дата публикации: 2014-09-18.

pesticide mixture, pyrazole compound, methods for the control or control of pests, for the protection of plant propagating material, use of a pesticide mixture, methods for the control of plant pathogenic fungi, for the protection of plants, for the protection of animals against infestation and for the treatment of infested animals.

Номер патента: BR112014032078A2. Автор: Haden Egon,LANGEWALD Jürgen,Defieber Christian,Gunjima Koshi,GOCKEL Birgit,SÄLINGER Daniel,SÖRGEL Sebastian,L Culberston Deborah. Владелец: BASF SE. Дата публикации: 2017-06-27.

Methods for identifying, purifying and enriching immature or stem cancer-initiating cells from tumors and use thereof

Номер патента: EP2212699A1. Автор: Virginie Clement,Ivan Radovanovic. Владелец: HOPITAUX UNIVERSITAIRES DE GENEVE. Дата публикации: 2010-08-04.

Fluorescence resonance energy transfer-based biosensor for sensing chimeric antigen receptor activity and use thereof

Номер патента: US20240151728A1. Автор: Chang-Han Lee,Soojin Lee,Hang-Rae Kim,Jihye SEONG,Mihue JANG,Haenim Lee,Hyejin Yoo,Jiyun Jeong. Владелец: Korea Advanced Institute of Science and Technology KAIST. Дата публикации: 2024-05-09.

C-cbl and antagonists thereof for the treatment and diagnosis of cancer

Номер патента: EP2396407A1. Автор: Daniel Regnier,Serge Manie,Sadok Yakoub,Eric Tabone. Владелец: Universite Claude Bernard Lyon 1 UCBL. Дата публикации: 2011-12-21.

Nucleic acid-based assembly and use thereof in cancer therapy

Номер патента: AU2017371416B2. Автор: VOLKER Adam,Michael Famulok,Stephan Irsen,Deepak PRUSTY. Владелец: Univ Bonn Rheinische Friedrich Wilhelms. Дата публикации: 2023-11-09.

Nucleic acid-based assembly and use thereof in cancer therapy

Номер патента: EP3551229A1. Автор: VOLKER Adam,Michael Famulok,Stephan Irsen,Deepak PRUSTY. Владелец: Rheinische Friedrich Wilhelms Universitaet Bonn. Дата публикации: 2019-10-16.

Microparticles comprising PCL and uses thereof

Номер патента: US11998638B2. Автор: Dirk Wybe Grijpma,Henderikus Super,Paul Willem Mijnen,Pieter Gerard Zijlstra. Владелец: Aqtis IP BV. Дата публикации: 2024-06-04.

Methods for the production of committed cardiac progenitor cells

Номер патента: EP4402249A1. Автор: Steven Kattman,Chad KOONCE,Meghan BOYER,Ellen HEBRON,Kristen STACK. Владелец: Fujifilm Holdings America Corp. Дата публикации: 2024-07-24.

Method for the in vitro production of a hepatocyte organoid

Номер патента: NL2033783B1. Автор: Schneeberger Kerstin,Kelsey Marsee Ary,Spee Bart. Владелец: Univ Utrecht Holding Bv. Дата публикации: 2024-06-27.

Method for the in vitro production of a hepatocyte organoid

Номер патента: WO2024133751A1. Автор: Kerstin SCHNEEBERGER,Bart SPEE,Ary Kelsey MARSEE. Владелец: Universiteit Utrecht Holding B.V.. Дата публикации: 2024-06-27.

Mirna composition comprising 11 specific mirnas and its use in the treatment of cancer

Номер патента: EP4263830A1. Автор: Sebastien Jauliac. Владелец: Université Paris Cite. Дата публикации: 2023-10-25.

Mirna composition comprising 11 specific mirnas and its use in the treatment of cancer

Номер патента: US20240084300A1. Автор: Sebastien Jauliac. Владелец: Université de Paris. Дата публикации: 2024-03-14.

Use of the opposite cell differentiation program (ocdp) for the treatment of degenerated organs in the pathological state

Номер патента: CA2699624C. Автор: Christoph Gleiter,Lusine Danielyan,Rolf Gebhardt,Gayane Buniatian,Barbara Proksch. Владелец: UNIVERSITAET LEIPZIG. Дата публикации: 2017-11-21.

Dosing regimens for the treatment of fabry disease

Номер патента: CA2829947C. Автор: Douglas Stuart Greene,Kenneth Joseph Valenzano. Владелец: Amicus Therapeutics Inc. Дата публикации: 2019-01-15.

Use of oncolytic viruses and antiangiogenic agents in the treatment of cancer

Номер патента: US20090317456A1. Автор: Axel Mescheder,Matthias Karrasch. Владелец: MEDIGENE AG. Дата публикации: 2009-12-24.

Prophylaxis and treatment of coronavirus infection

Номер патента: US20230338395A1. Автор: Ludwig ENGLMEIER. Владелец: Individual. Дата публикации: 2023-10-26.

Compositions and methods for treatment of autoimmune and other diseases

Номер патента: CA2799202C. Автор: Scott D. Eliasof. Владелец: Cerulean Pharma Inc. Дата публикации: 2016-07-05.

Compositions and methods for treatment of autoimmune and other diseases

Номер патента: EP2571525A1. Автор: Scott D. Eliasof. Владелец: Cerulean Pharma Inc. Дата публикации: 2013-03-27.

Genetically engineered keratinocytes expressing at least one growth factor and/or activated egf receptor, skin equivalent comprising said keratinocytes and toxicity assay using said keratinocytes

Номер патента: WO2004001024A2. Автор: Eva Goedecke,Hans-Jürgen Stark,Norbert Fusenig,Iris Martin,Anja Starker,Nicole Maas-Szabowski. Владелец: Deutsches Krebsforschungszentrum Stiftung des offentlichen Rechts. Дата публикации: 2003-12-31.

Genetically engineered keratinocytes expressing at least one growth factor and/or activated egf receptor, skin equivalent comprising said keratinocytes and toxicity assay using said keratinocytes

Номер патента: WO2004001024A3. Автор: Eva Goedecke,Norbert Fusenig,Hans-Juergen Stark,Iris Martin,Nicole Maas-Szabowski,Anja Staerker. Владелец: Anja Staerker. Дата публикации: 2004-02-19.

Use of substituted pentose or hexose derivates in the treatment of aids and aids related neoplastic disorders

Номер патента: AU6247996A. Автор: Ake Dahlgren,Attila Dahlgren. Владелец: ISM INST FOR SOCIO MEDICAL RES. Дата публикации: 1997-01-22.

Use of mir-92a or mir-145 in the treatment of angelman syndrome

Номер патента: IL279391A. Автор: . Владелец: Ovid Therapeutics Inc. Дата публикации: 2021-01-31.

Use of a protein-bound polysaccharide For the manufacture of a medicament for the treatment of AIDS.

Номер патента: DE3855525D1. Автор: Kenichi Matsunaga,Masaaki Takahashi,Koichi Niimura,Chikao Yoshikumi,Yoshiharu Oguchi,Kunitaka Hirose,Takao Furusho,Shigeaki Muto,Minoru Oohara,Junji Kakuchi,Norifumi Sugita. Владелец: Kureha Corp. Дата публикации: 1996-10-17.

Use of n-myristoyl transferase (nmt) inhibitors in the treatment of cancer, autoimmune disorders, and inflammatory disorders

Номер патента: ZA202304512B. Автор: Erwan BEAUCHAMP,Luc G Berthiaume. Владелец: PACYLEX PHARMACEUTICALS Inc. Дата публикации: 2024-01-31.

Use of n-myristoyl transferase (nmt) inhibitors in the treatment of cancer, autoimmune disorders, and inflammatory disorders

Номер патента: US20240350481A1. Автор: Luc G. Berthiaume,Erwan BEAUCHAMP. Владелец: PACYLEX PHARMACEUTICALS Inc. Дата публикации: 2024-10-24.

Use of jumonji c demethylase inhibitors for the treatment and prevention of chemotherapy resistance and radioresistance in cancer

Номер патента: US20230255951A1. Автор: John D. Minna,Amit Das,Maithili P. DALVI,Elisabeth D. MARTINEZ,Juan BAYO-FINA. Владелец: University of Texas System. Дата публикации: 2023-08-17.

Use of jumonji c demethylase inhibitors for the treatment and prevention of chemotherapy resistance and radioresistance in cancer

Номер патента: US20190151296A1. Автор: Amit Das,John D Minna,Juan BAYO-FINA,Maithili P DALVI,Elisabeth D MARTINEZ. Владелец: University of Texas System. Дата публикации: 2019-05-23.

Use of substances with immunomodulating activity for the treatment of amyotrophic lateral sclerosis

Номер патента: US20010055592A1. Автор: Walter Schubert. Владелец: Individual. Дата публикации: 2001-12-27.

Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2

Номер патента: CA2428176C. Автор: Alberto Mantovani,Marco Presta,Marco Rusnati,Barbara Bottazzi. Владелец: Sigma Tau Industrie Farmaceutiche Riunite SpA. Дата публикации: 2013-02-05.

Use of n-myristoyl transferase (nmt) inhibitors in the treatment of cancer, autoimmune disorders, and inflammatory disorders

Номер патента: EP4232032A1. Автор: Luc G. Berthiaume,Erwan BEAUCHAMP. Владелец: PACYLEX PHARMACEUTICALS Inc. Дата публикации: 2023-08-30.

Use of 5,10-methylene tetrahydrofolate for the treatment of cancer

Номер патента: WO2005097086A3. Автор: Mark J Cantwell,Joan M Robbins. Владелец: Joan M Robbins. Дата публикации: 2006-05-18.

Use of human prostate cell lines for the treatment of prostate cancer

Номер патента: EP1137422B1. Автор: Angus George Onyvax Limited DALGLEISH,Peter Michael Onyvax Limited SMITH,Andrew Derek Onyvax Limited SUTTON,Anthony Ian Onyvax Limited WALKER. Владелец: Onyvax Ltd. Дата публикации: 2005-09-14.

Use of hydroxy tetrahydro-naphtalene derivates for the treatment of respiratory diseases

Номер патента: WO2006094627A3. Автор: Cristina Alonso-Alija,Jang Gupta,Berthold Hinzen. Владелец: Berthold Hinzen. Дата публикации: 2006-12-07.

Use of quercetin-3-o-glucoside for the treatment of flavivirus infections

Номер патента: WO2019185579A1. Автор: Philippe Despres,Chaker EL KALAMOUNI. Владелец: Universite de la Reunion Saint Denis. Дата публикации: 2019-10-03.

Use of histamine metabolites as markers for the treatment of ibs with h1-r antagonists

Номер патента: WO2017102640A1. Автор: Guy BOECKXSTAENS,Mira WOUTERS. Владелец: Katholieke Universiteit Leuven. Дата публикации: 2017-06-22.

Use of AMPK Inducers and Metformin for the Treatment of Fibromyalgia

Номер патента: US20150272911A1. Автор: Mario David Cordero Morales,Pedro BULLÓN FERNÁNDEZ,Elisabet ALCOCER GÓMEZ. Владелец: Universidad de Sevilla. Дата публикации: 2015-10-01.

Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections

Номер патента: AU8106794A. Автор: Malcolm Richard Boyd,Richard Anthony Vere Hodge. Владелец: SmithKline Beecham Ltd. Дата публикации: 1995-05-29.

Use of attenuated strains of parasites for the prevention or treatment of pathologies associated with an apicomplexan

Номер патента: US20150165008A1. Автор: Fabrice Laurent,Edouard Seche,Audrey Gnahoui-David,Marie-Noëlle MEVELEC. Владелец: VITAMFERO. Дата публикации: 2015-06-18.

USE OF 17-$g(a)-ESTRADIOL FOR THE TREATMENT OF AGED OR SUNDAMAGED SKIN AND/OR SKIN ATROPHY

Номер патента: EP1006996A1. Автор: James A. Mezick,Gerard J. Gendimenico. Владелец: Johnson and Johnson Consumer Companies LLC. Дата публикации: 2000-06-14.

Use of rho gtpase activating toxines for the treatment and/or prevention of symptomatology associated with rett syndrome

Номер патента: WO2011101881A2. Автор: Giovanni Laviola,Carla Fiorentini,Alessia Fabbri,Laura Ricceri,Bianca De Filippis. Владелец: Istituto Superiore Di Sanita'. Дата публикации: 2011-08-25.

Use of rho gtpase activating toxines for the treatment and/or prevention of symptomatology associated with rett syndrome

Номер патента: EP2536424A2. Автор: Giovanni Laviola,Carla Fiorentini,Alessia Fabbri,Laura Ricceri,Bianca De Filippis. Владелец: Istituto Superiore di Sanita ISS. Дата публикации: 2012-12-26.

Use of rho gtpase activating toxins for the treatment and/or prevention symptomatology associated with rett syndrome

Номер патента: WO2011101881A3. Автор: Giovanni Laviola,Carla Fiorentini,Alessia Fabbri,Laura Ricceri,Bianca De Filippis. Владелец: Istituto Superiore Di Sanita'. Дата публикации: 2011-10-27.

Use of toremifene and its metabolites for the reversal of multidrug resistance of cancer cells against cytotoxic drugs

Номер патента: CA2023630C. Автор: Adrian Llewellyn Harris,Lauri Veikko Matti Kangas,Michael William Degregorio. Владелец: Orion Yhtyma Oy. Дата публикации: 2002-02-19.

Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis

Номер патента: US20110112150A2. Автор: Manfred Bohn,Karl Kraemer,Astrid Markus. Владелец: Individual. Дата публикации: 2011-05-12.

Use of 4'-iodo-4'- deoxydoxorubicin for the treatment of amyloidosis.

Номер патента: MY111755A. Автор: Gianni Luca,Merlini Giampaolo. Владелец: Istituto Naz Per Lo Studio E La Cura Dei. Дата публикации: 2000-12-30.

Use of dpiv and apn inhibitors for the treatment of dermatalogical diseases involving the hyperproliferation and modified differentiation conditions of fibroblasts

Номер патента: US20070042938A1. Автор: Siegfried Ansorge,Klaus Neubert,Robert Vetter,Burkhart Schraven,Uwe Lendeckel,Dirk Reinhold,Harald Gollnick,Jürgen FAUST,Anja Thielitz. Владелец: INSTITUTE fur MEDIZINTECHONOLOGIE MAGDEBUR IMTM GmbH. Дата публикации: 2007-02-22.

Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis

Номер патента: US20110269801A1. Автор: Manfred Bohn,Astrid Markus,Karl Theodor Kraemer. Владелец: Individual. Дата публикации: 2011-11-03.

Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis

Номер патента: US20100076031A1. Автор: Manfred Bohn,Astrid Markus,Karl Theodor Kraemer. Владелец: Individual. Дата публикации: 2010-03-25.

Use of 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans

Номер патента: AU6739690A. Автор: Ernest Marshall,Helga Stolze,R. Douglas Thornes,Kurt ZÄNKER. Владелец: Schaper und Bruemmer GmbH and Co KG. Дата публикации: 1991-06-26.

Use of short chain fatty acids for the treatment and prevention of diseases and disorders

Номер патента: US11759442B2. Автор: Ira C. Spector,Mark A. Feitelson,Alla Arzumanyan. Владелец: Temple University of Commonwealth System of Higher Education. Дата публикации: 2023-09-19.

Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function

Номер патента: EP1596850A1. Автор: Jose Esteve-Soler,Javier Angulo-Frutos,Inigo S Enz De Tejada-Gorman. Владелец: Laboratorios del Dr Esteve SA. Дата публикации: 2005-11-23.

Use of umbilical vein endothelial cells for the treatment of lung injury

Номер патента: WO2024155791A1. Автор: John K. Fraser,Paul William FINNEGAN. Владелец: Angiocrine Bioscience, Inc.. Дата публикации: 2024-07-25.

Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of nk-1 receptor antagonists for the treatment of chronic fatigue syndrome

Номер патента: CA2339628C. Автор: Wolfgang Mueller,Lothar Farber,Thomas Stratz. Владелец: NOVARTIS AG. Дата публикации: 2008-06-03.

Use of 5-ht3 receptor antagonists for the treatment of inflammations of the respiratory tract

Номер патента: WO2001010423A3. Автор: Wolfgang Mueller,Lothar Faerber,Christian Stratz. Владелец: Christian Stratz. Дата публикации: 2001-09-07.

Use of a propargyl alcohol enantiomer for the treatment of dermatological disorders

Номер патента: WO2004032914A3. Автор: Jean-Claude Caron. Владелец: Jean-Claude Caron. Дата публикации: 2004-06-10.

Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin

Номер патента: US20080260667A1. Автор: Marcel Schnyder,Werner Baschong. Владелец: Individual. Дата публикации: 2008-10-23.

Method for the treatment of cerebral ischaemia and use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia

Номер патента: CA2353553C. Автор: Hannelore Ehrenreich,Christoph Gleiter. Владелец: Individual. Дата публикации: 2011-05-17.

Method for the treatment of cerebral ischaemia and use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia

Номер патента: AU766216B2. Автор: Hannelore Ehrenreich,Christoph Gleiter. Владелец: Individual. Дата публикации: 2003-10-09.

Method for the treatment of cerebral ischaemia and use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia

Номер патента: AU766216C. Автор: Hannelore Ehrenreich,Christoph Gleiter. Владелец: Individual. Дата публикации: 2004-11-11.

Use of compositions comprising sesquiterpene derivatives for the treatment of cancer

Номер патента: EP1372677B1. Автор: Jean-Claude Madelmont,André Pichette,Jean Legault. Владелец: FPL Pharma Inc. Дата публикации: 2008-04-30.

Use of polysaccharide polymers and cations for the preparation of wet wipes

Номер патента: EP2268362A2. Автор: Ifat Hammer,Miriam Kupermintz. Владелец: Albaad Massuot Yitzhak Ltd. Дата публикации: 2011-01-05.

Combined use of a fibrate and orlistat for the treatment of obesity

Номер патента: EP1601352A2. Автор: Alan Edgar. Владелец: Fournier Laboratories Ireland Ltd. Дата публикации: 2005-12-07.

Combined use of a fibrate and orlistat for the treatment of obesity

Номер патента: AU2004218938A1. Автор: Alan Edgar. Владелец: Fournier Laboratories Ireland Ltd. Дата публикации: 2004-09-23.

Use of a fibrate and orlistat for the treatment of obesity

Номер патента: IL170519A0. Автор: . Владелец: Fournier Lab Ireland Ltd. Дата публикации: 2006-10-05.

Use of a fibrate and orlistat for the treatment of obesity

Номер патента: US20070078179A1. Автор: Alan Edgar. Владелец: Fournier Laboratories Ireland Ltd. Дата публикации: 2007-04-05.

Method for the treatment of cerebral ischaemia and use of erythropodietin or erythropoietin derivatives for the treatment of cerebral ischaemia

Номер патента: NZ541591A. Автор: Hannelore Ehrenreich,Christoph Gleiter. Владелец: Christoph Gleiter. Дата публикации: 2007-08-31.

Use of guanabenz or derivates thereof for the treatment of type i ifn-dependent pathologies

Номер патента: WO2019215470A1. Автор: Philippe Pierre,Jessica PEREGO,Evelina GATTI. Владелец: Université D'aix Marseille. Дата публикации: 2019-11-14.

Use of guanabenz or derivates thereof for the treatment of type i ifn-dependent pathologies

Номер патента: EP3790539A1. Автор: Philippe Pierre,Jessica PEREGO,Evelina GATTI. Владелец: Aix Marseille Universite. Дата публикации: 2021-03-17.

Use of a bis-peroxovanadium compound for the treatment of immunosuppressed patients

Номер патента: CA2389348A1. Автор: Michel J. Tremblay,Jean-Francois Fortin,Benoit Barbeau. Владелец: Individual. Дата публикации: 2001-05-03.

Use of an H+, K+-ATPase inhibitor in the treatment of Widal's Syndrome

Номер патента: US6599927B2. Автор: Jan Trofast,Per Lindberg,Joan Piñas-Massó,Jordi Serra-Carreras. Владелец: AstraZeneca AB. Дата публикации: 2003-07-29.

Use of rhamnolipids in a composition for the treatment of signs of aging

Номер патента: CA2321926C. Автор: Goran Piljac,Tatjana Piljac. Владелец: Paradigm Biomedical Inc. Дата публикации: 2010-04-27.

Use of kynurenic acid and derivatives thereof in the treatment of conditions of the gastrointestinal tract accompanied by hypermotility and inflammation or gout or multiple sclerosis

Номер патента: WO2008087461A3. Автор: MIHALY Boros,Istvan Szatmari,Ferenc Fueloep,Laszlo Vecsei,Jozsef Kaszaki,Jozsef Toldi. Владелец: Jozsef Toldi. Дата публикации: 2008-09-18.

Use of bartonella quintana derived lipopolysaccharide for the treatment of autoimmune, autoinflammatory or infectious diseases

Номер патента: WO2008095679A1. Автор: Leonardus Antonius Bernardus Joosten,Mihai Gheorghe Netea,Johannes Willem Maarten van der Meer,Wilhelmus Bernard Van Den Berg,Bart-Julian Kullberg. Владелец: Stichting Katholieke Universiteit. Дата публикации: 2008-08-14.

Use of 10-hydroxy-2-decenoic acid in the treatment of autism spectrum disorders

Номер патента: CA2951288C. Автор: Steve Cheung,Wah Chin BOON. Владелец: Individual. Дата публикации: 2024-01-02.

Use of a transition metal complex for the treatment of septic shock

Номер патента: CA2162154A1. Автор: Wieslaw Mieczyslaw Kazmierski,Luis Molina. Владелец: Molichem Medicines, Inc.. Дата публикации: 1994-11-24.

The use of sustained-release buprenorphine formulations for the treatment of pain or opioid use disorders

Номер патента: CA2965895C. Автор: Azmi NASSER,Christian Heidbreder,Celine M. Laffont. Владелец: Indivior UK Ltd. Дата публикации: 2019-08-06.

Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome

Номер патента: CA2675442A1. Автор: Thomas Klabunde,Andreas Herling,Hubert Heuer,Siegfried Stengelin,Dieter Kadereit,Matthias Urmann,Harm Brummerhop,Susanne Kilp. Владелец: Susanne Kilp. Дата публикации: 2008-07-24.

Use of ifn-alpha and amantadine for the treatment of chronic hepatitis c

Номер патента: WO1999013894A2. Автор: Friederike Zahm. Владелец: F. Hoffmann-La Roche AG. Дата публикации: 1999-03-25.

Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases

Номер патента: CA2544332C. Автор: Linda Greensmith,Geoffrey Burnstock,Rudolf Urbanics. Владелец: Orphazyme AS. Дата публикации: 2014-09-23.

Use of erythropoietin and iron preparations for the production of pharmaceutical combination preparations for the treatment of rheumatic diseases

Номер патента: CA2297959A1. Автор: Paul Lehmann,Joachim Peter Kaltwasser. Владелец: Individual. Дата публикации: 1999-02-18.

Use of fused pyrrole carboxylic acids for the treatment of neurodegenerative and psychiatric diseases as d-amino acid oxidase inhibitors

Номер патента: CA2624795A1. Автор: Wei Zheng,Philip E. Brandish,Andrew Pike,Alister Campbell,Nicholas Brandon,Timothy Sparey. Владелец: Individual. Дата публикации: 2007-04-12.

Use of dopamine-d3 receptor ligands for the treatment of diseases of the central nervous system

Номер патента: US20030087917A1. Автор: Liliane Unger,Gerhard Gross,Hans-Jurgen Teschendorf,Hans-Jorg Treiber,Dorothea Strack. Владелец: Individual. Дата публикации: 2003-05-08.

Use of a derivative of imidazole for the treatment of leukotriene related disorders

Номер патента: WO2007028524A2. Автор: Josep Prous Blancafort. Владелец: Prous Institute For Biomedical Research S.A.. Дата публикации: 2007-03-15.

Use of 13-cis retinoic acid for the treatment of emphysema

Номер патента: EP1307187A2. Автор: Paula Nanette Belloni. Владелец: F Hoffmann La Roche AG. Дата публикации: 2003-05-07.

Use of 13-cis retinoic acid for the treatment of emphysema

Номер патента: WO2002009679A2. Автор: Paula Nanette Belloni. Владелец: F. Hoffmann-La Roche AG. Дата публикации: 2002-02-07.

Use of fla vone/fla vanone derivatives fn the treatment or prevention of respiratory conditions

Номер патента: WO2006030322A3. Автор: Edwin A Kroeger. Владелец: Edwin A Kroeger. Дата публикации: 2006-06-29.

Use of cns penetrating anticancer compounds for the treatment of protozan diseases

Номер патента: CA2635825A1. Автор: Matthias Dormeyer. Владелец: Individual. Дата публикации: 2007-07-19.

Use of cns penetrating anticancer compounds for the treatment of protozan diseases

Номер патента: EP1971335A2. Автор: Matthias Dormeyer. Владелец: Individual. Дата публикации: 2008-09-24.

Use of 5-ht7 receptor agonists for the treatment of pain

Номер патента: EP2049090A1. Автор: Helmut H. Buschmann,Jose Miguel Vela Hernandez,Antonio Torrens-Jover,Luz Romero-Alonso. Владелец: Laboratorios del Dr Esteve SA. Дата публикации: 2009-04-22.

Use of histamine h2 mimicking substances for the treatment of multiple sclerosis

Номер патента: WO2000000184A8. Автор: Elaine A Delack. Владелец: Elaine A Delack. Дата публикации: 2001-06-07.

Use of a derivative of imidazole for the treatment of leukotriene related disorders

Номер патента: WO2007028524A3. Автор: Blancafort Josep Prous. Владелец: Prous Inst For Biomedical Res. Дата публикации: 2007-05-31.

Use of 5-ht7 receptor agonists for the treatment of pain

Номер патента: US20090326014A1. Автор: Helmut H. Buschmann,Jose Miguel Vela Hernandez,Antonio Torrens-Jover,Luz Romero-Alonso. Владелец: Laboratorios del Dr Esteve SA. Дата публикации: 2009-12-31.

Use of benzo-heteroaryl sulfamide derivatives for the treatment of depression

Номер патента: WO2007095606A1. Автор: Virginia L. Smith-Swintosky. Владелец: Janssen Pharmaceutica, N.V.. Дата публикации: 2007-08-23.

Use of a nicotine receptor agonist for the manufacture of a medicament for the treatment of obsessive compulsive disorder

Номер патента: EP1126846B1. Автор: Arvid Carlsson,Maria Carlsson. Владелец: A Carlsson Research AB. Дата публикации: 2003-08-06.

Use of partly hydrolyzed fish gelatin for the preparation of topically administered pharmaceutical compositions

Номер патента: WO2009083768A3. Автор: Bruno Silvestrini,Michele Bonanomi. Владелец: Michele Bonanomi. Дата публикации: 2010-03-04.

Use of thiabendazole and derivatives thereof for the theraphy of neurological conditions

Номер патента: WO2010127878A2. Автор: Armin Schneider,Rico Laage,Anja Moraru,Carola Krüger. Владелец: SYGNIS BIOSCIENCE GmbH & Co. KG. Дата публикации: 2010-11-11.

Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease

Номер патента: CA2264097C. Автор: Panayotis Nikolas Gerolymatos. Владелец: PN Gerolymatos SA. Дата публикации: 2007-11-27.

Use of no scavengers, inhibitors or antagonists in the treatment of migraine

Номер патента: CA2189762C. Автор: Jes Olesen. Владелец: APS KBUS 17 NR 1797. Дата публикации: 2009-01-13.

Use of opioids or opioid mimetics for the treatment of resistant cancer patients

Номер патента: CA2732497C. Автор: Erich Miltner,Claudia Friesen,Andreas Alt. Владелец: Universitaet Ulm. Дата публикации: 2017-01-17.

Use of lupinus albus conglutin gamma for the treatment of type ii diabetes

Номер патента: CA2515607C. Автор: Paolo Morazzoni,Marcello Duranti. Владелец: Indena SpA. Дата публикации: 2013-10-15.

USE OF 4,9-ANHYDRO-TETRODOTOXIN FOR THE TREATMENT OF DISEASES RELATED TO THE VOLTAGE-GATED SODIUM CHANNEL α SUBUNIT NAV 1.6

Номер патента: WO2007110220A1. Автор: Helmut H. Buschmann,Jose Miguel Vela Hernandez,Wolfgang Screibmayer. Владелец: Wex Pharmaceuticals Inc.. Дата публикации: 2007-10-04.

The use of mmp-13 selective inhibitors for the treatment of osteoarthritis and other mmp-mediated disorders

Номер патента: CA2251197C. Автор: Lawrence Alan Reiter,Kim Francis Mcclure,Ralph Pelton Robinson,Lori Lynn Lopresti-Morrow,Peter Geoffrey Mitchell,Lisa Marie Reeves,Sue Ann Yocum. Владелец: Pfizer Products Inc. Дата публикации: 2004-07-27.

Use of an alkanoyl-L-carnitine for the treatment of glutamate mediated diseases

Номер патента: US6037372A. Автор: Sonia Moretti. Владелец: Mendes Srl. Дата публикации: 2000-03-14.

Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection

Номер патента: CA2176392C. Автор: Richard Anthony Vere Hodge. Владелец: SmithKline Beecham Ltd. Дата публикации: 2005-11-08.

Use of .beta.-lapachone and related naphthoquinones in the treatment of amp-activated protein kinase (ampk) mediated disorders

Номер патента: CA2595564C. Автор: In Geun Jo,Taehwan Kwak,Sang-Ku Yoo,Myunggyu Park. Владелец: KT&G Co Ltd. Дата публикации: 2015-03-31.

Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis

Номер патента: CA2267165C. Автор: Manfred Bohn,Astrid Markus,Karl Theodor Kraemer. Владелец: Aventis Pharma Deutschland GmbH. Дата публикации: 2003-12-16.

Use of isoxazole and crotonamide derivatives for the treatment of carcinomatous disorders

Номер патента: CA2188228C. Автор: Wilfried Schwab,Jorg Czech,Klaus Boslett. Владелец: Sanofi Aventis Deutschland GmbH. Дата публикации: 2008-08-12.

Use of isoxazole and crotonamide derivatives for the treatment of carcinomatous disorders

Номер патента: US6020372A. Автор: Wilfried Schwab,Jorg Czech,Klaus Boslett. Владелец: Hoechst AG. Дата публикации: 2000-02-01.

Use of low dosages of lipoic acid in the treatment of ocular disorders

Номер патента: CA2742973C. Автор: William Garner,Margaret Garner. Владелец: Encore Health LLC. Дата публикации: 2017-05-23.

Use of n-substituted azaheterocyclic compounds for the manufacture of a pharmaceutical composition for the treatment of indications related to angiogenesis

Номер патента: WO2000032193A1. Автор: Anker Jon Hansen,Uffe Bang Olsen,Tine Krogh Jorgensen. Владелец: Novo Nordisk A/S. Дата публикации: 2000-06-08.

Use of a vitamin d3 analogue for the treatment of autoimmune diabetes

Номер патента: AU2002314056A1. Автор: Milan Radoje Uskokovic,Luciano Adorini,Silvia Gregori,Nadia Giarratana,Simona Smiroldo. Владелец: Bioxell SpA. Дата публикации: 2002-12-03.

The use of a H3R inverse agonist for the treatment of excessive daytime sleepiness associated with parkinson's disease (PD)

Номер патента: AU2019359549A1. Автор: Donald Johns,Judit SOVAGO. Владелец: NOVARTIS AG. Дата публикации: 2021-03-25.

Use of a vitamin d3 analogue for the treatment of autoimmune diabetes

Номер патента: EP1392323A2. Автор: Milan Radoje Uskokovic,Luciano Adorini,Silvia Gregori,Nadia Giarratana,Simona Smiroldo. Владелец: Bioxell SpA. Дата публикации: 2004-03-03.

Use of kynurenine-3-hydroxylase inhibitors for the preparation of medicaments for the treatment of l-dopa induced movement disorders, dyskinesias, drug addiction, pain and cataract

Номер патента: EP1620084A1. Автор: Patricia Salvati,Emanuela Izzo. Владелец: Newron Pharmaceuticals SpA. Дата публикации: 2006-02-01.

Use of kynurenine-3-hydroxylase inhibitors for the preparation of medicaments for the treatment of l-dopa induced movement disorders, dyskinesias, drug addiction, pain and cataract

Номер патента: WO2004098585A1. Автор: Patricia Salvati,Emanuela Izzo. Владелец: NEWRON PHARMACEUTICALS S.P.A.. Дата публикации: 2004-11-18.

Use of disulfiram or its derivatives for the treatment of mitochondrial diseases or dysfunction

Номер патента: US20220241223A1. Автор: Marc Blondel,Vincent Procaccio,Agnès DELAHODDE,Déborah TRIBOUILLARD-TANVIER,Agnès RÖTIG,Geneviève DUJARDIN. Владелец: Univerdite de Bretagne Occidentale. Дата публикации: 2022-08-04.

Use of disulfiram or its derivatives for the treatment of mitochondrial diseases or dysfunction

Номер патента: AU2020294943A1. Автор: Marc Blondel,Vincent Procaccio,Agnès DELAHODDE,Déborah TRIBOUILLARD-TANVIER,Agnès RÖTIG,Geneviève DUJARDIN. Владелец: Univerdite de Bretagne Occidentale. Дата публикации: 2022-01-20.

Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prevention of cerebral degenerative disorders

Номер патента: US5827873A. Автор: Michael Shalmi,Birgitte Hjort Guldhammer,Niels Korsgaard. Владелец: Novo Nordisk AS. Дата публикации: 1998-10-27.

Use of disulfiram or its derivatives for the treatment of mitochondrial diseases or dysfunction

Номер патента: WO2020254632A1. Автор: Marc Blondel,Vincent Procaccio,Agnès DELAHODDE,Déborah TRIBOUILLARD-TANVIER,Agnès RÖTIG,Geneviève DUJARDIN. Владелец: Centre Hospitalier Universitaire D'angers. Дата публикации: 2020-12-24.

Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin

Номер патента: EP1755604A2. Автор: Helmut Schmidhammer. Владелец: AlcaSynn Pharmaceuticals GmbH. Дата публикации: 2007-02-28.

Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin

Номер патента: CA2566398A1. Автор: Helmut Schmidhammer. Владелец: Individual. Дата публикации: 2005-11-17.

The use of a h3r inverse agonist for the treatment of excessive daytime sleepiness associated with parkinson's disease (pd)

Номер патента: CA3112298A1. Автор: Donald Johns,Judit SOVAGO. Владелец: NOVARTIS AG. Дата публикации: 2020-04-16.

Use of disulfiram or its derivatives for the treatment of mitochondrial diseases or dysfunction

Номер патента: CA3143608A1. Автор: Marc Blondel,Vincent Procaccio,Agnès DELAHODDE,Déborah TRIBOUILLARD-TANVIER,Agnès RÖTIG,Geneviève DUJARDIN. Владелец: Univerdite de Bretagne Occidentale. Дата публикации: 2020-12-24.

Use of Inhibitors of Steroid Activity for the Treatment of Substance Related Disorders

Номер патента: US20080167282A1. Автор: Giuseppe La Pera. Владелец: Individual. Дата публикации: 2008-07-10.

Use of attenuated strains of parasites for the prevention or treatment of pathologies associates with an apicomplexan

Номер патента: US20160166662A1. Автор: Fabrice Laurent,Edouard Seche,Audrey Gnahoui-David,Marie-Noëlle MEVELEC. Владелец: VITAMFERO. Дата публикации: 2016-06-16.

Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections

Номер патента: WO1995013073A1. Автор: Malcolm Richard Boyd,Richard Anthony Vere Hodge. Владелец: Smithkline Beecham Plc. Дата публикации: 1995-05-18.

Use of inhibitors of ornithine aminotransferase for the manufacture of a medicament for the treatment of alzheimer's disease

Номер патента: WO1994017795A1. Автор: Jean-Bernard Ducep,Nikolaus Seiler,Karin C. Jund. Владелец: Merrell Dow Pharmaceuticals Inc.. Дата публикации: 1994-08-18.

Use of benzo-heteroaryl sulfamide derivatives for the treatment of mania and bipolar disorder

Номер патента: WO2007095609A2. Автор: Virginia L. Smith-Swintosky. Владелец: Janssen Pharmaceutica, N.V.. Дата публикации: 2007-08-23.

Use of cis- or transurocanic acid for the treatment of photodermatoses and immunogenic skin diseases

Номер патента: WO1994022441A3. Автор: James Ferguson,Michael Goodman. Владелец: Bioglan Ireland R & D Ltd. Дата публикации: 1994-11-24.

Use of cis- or transurocanic acid for the treatment of photodermatoses and immunogenic skin diseases

Номер патента: WO1994022441A2. Автор: James Ferguson,Michael Goodman. Владелец: Bioglan Ireland (R & D) Limited. Дата публикации: 1994-10-13.

Use of thiamphenicol and derivatives thereof for the preparation of pharmaceutical compositions useful in the treatment of chlamydia pneumoniae infections

Номер патента: US20030100614A1. Автор: Giovanni Colombo,Lorenzo Drago,Luciano Licciardello,Domenico Ungheri,Maria Gismondo. Владелец: Zambon Group SpA. Дата публикации: 2003-05-29.

Use of thiamphenicol and derivatives thereof for the preparation of pharmaceutical compositions useful in the treatment of Chlamydia pneumoniae infections

Номер патента: US6833389B2. Автор: Lorenzo Drago,Luciano Licciardello,Domenico Ungheri,Giovanni Battista Colombo,Maria Rita Gismondo. Владелец: Zambon Group SpA. Дата публикации: 2004-12-21.

Use of a phytosterol containing composition for the treatment of luts.

Номер патента: EP2091546A1. Автор: Lars Karnerud,Clas Tufvesson,Arata Paul Yamasaki. Владелец: Natumin Pharma AB. Дата публикации: 2009-08-26.

Use of a phytosterol containing composition for the treatment of luts.

Номер патента: WO2008073040A1. Автор: Lars Karnerud,Clas Tufvesson,Arata Paul Yamasaki. Владелец: Natumin Pharma AB. Дата публикации: 2008-06-19.

Use of attenuated strains of toxoplasma for the prevention or treatment of cryptosporidiosis

Номер патента: NZ705406A. Автор: Fabrice Laurent,Edouard Seche,Audrey Gnahoui-David,Marie-Noëlle MEVELEC. Владелец: Univ Francois Rabelais De Tours. Дата публикации: 2017-11-24.

Use of a lyophilised bacterial lysate for the prevention of tuberculosis relapse

Номер патента: EP1848448B8. Автор: Nataliya Dyachyk. Владелец: Parmeggiani Francesco. Дата публикации: 2010-09-15.

Use of α1A -selective adrenoceptor agonists for the treatment of urinary incontinence

Номер патента: US5610174A. Автор: Charles Gluchowski,Carlos C. Forray,Theresa A. Branchek,Douglas A. Craig. Владелец: Synaptic Pharmaceutical Corp. Дата публикации: 1997-03-11.

Use of isoxazole and crotonamide derivatives for the modulation of apoptosis

Номер патента: CA2212207C. Автор: Stefan Müllner,Claudia Dax. Владелец: Hoechst AG. Дата публикации: 2008-12-30.

The use of halofuginone and related compounds for the treatment of urethral stricture by local administration

Номер патента: CA2384331C. Автор: Israel Vlodavsky,Arnon Nagler,Mark Pines. Владелец: Agricultural Research Organization of Israel Ministry of Agriculture . Дата публикации: 2008-10-14.

Use of carbohydrates and compositions thereof for the treatment or prevention of diseases caused by imbalanced colon fermentation

Номер патента: CA2499665C. Автор: Juha Apajalahti,Nina Rautonen,Anu Kettunen,Osmo Siikanen. Владелец: Danisco AS. Дата публикации: 2012-02-28.

Use of angiotensin ii receptor antagonists for the preparation of medicaments for treating acute myocardial infarction

Номер патента: IL144216A. Автор: . Владелец: NOVARTIS AG. Дата публикации: 2007-07-04.

Use of n-(aryl-propionuyl)-sulfonamides for the treatment of spinal cord injury

Номер патента: ZA200608517B. Автор: Riccardo Bertini,Fransesco Colotta. Владелец: Dompe Pha Ma S P A. Дата публикации: 2008-04-30.

Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis

Номер патента: AU687432B2. Автор: Luca Gianni,Giampaolo Merlini. Владелец: POLICLINICO SAN MATTEO ISTITUT. Дата публикации: 1998-02-26.

Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin

Номер патента: WO2005013931B1. Автор: Marcel Schnyder,Werner Baschong. Владелец: Werner Baschong. Дата публикации: 2005-04-07.

Use of a pyruvate dehydrogenase activator for the treatment of ischaemia in limbs

Номер патента: AU4950296A. Автор: Paul Leonard Greenhaff,Dumitru Constantin-Teodosiu,Simon Martin Poucher,James Archibald Timmons. Владелец: Zeneca Ltd. Дата публикации: 1996-10-02.

Use of thiostrepton or its derivatives for the treatment of genetic diseases linked to a protein conformational disorder

Номер патента: WO2020151988A1. Автор: Isabelle Richard,Lucile Hoch,Xavier Nissan,Sara HENRIQUES. Владелец: Centre D'etude Des Cellules Souches (Cecs). Дата публикации: 2020-07-30.

Use of carvedilol or derivatives thereof for the manufacture of a medicament for the prevention and treatment of viral infections

Номер патента: WO1998038986A2. Автор: Akira Matsumori. Владелец: Roche Diagnostics GmbH. Дата публикации: 1998-09-11.

Use of Alverine or its derivatives for the treatment of mitochondrial diseases or dysfunction associated with mitochondrial complex I deficiencies

Номер патента: AU2021313398A1. Автор: Stéphane Azoulay,Vincent Procaccio,Carole SELLEM,Agnès DELAHODDE,Aurélie RENAUD,Déborah TRIBOUILLARD-TANVIER. Владелец: Universite Cote dAzur. Дата публикации: 2023-02-23.

Use of alverine or its derivatives for the treatment of mitochondrial diseases or dysfunction associated with mitochondrial complex i deficiencies

Номер патента: US20230310348A1. Автор: Stéphane Azoulay,Vincent Procaccio,Carole SELLEM,Agnès DELAHODDE,Aurélie RENAUD,Déborah TRIBOUILLARD-TANVIER. Владелец: Universite Cote dAzur. Дата публикации: 2023-10-05.

Use of tris(hydroxyquinolinolato)gallium(III) for the treatment of melanomas

Номер патента: NZ571119A. Автор: Bernhard Keppler. Владелец: Niiki Pharma Inc. Дата публикации: 2011-11-25.

Use of polysaccharide polymers and cations for the preparation of wet wipes

Номер патента: WO2009125405A2. Автор: Ifat Hammer,Miriam Kupermintz. Владелец: ALBAAD MASSUOT YITZHAK LTD.. Дата публикации: 2009-10-15.

Use of polysaccharide polymers and cations for the preparation of wet wipes

Номер патента: WO2009125405A9. Автор: Ifat Hammer,Miriam Kupermintz. Владелец: ALBAAD MASSUOT YITZHAK LTD.. Дата публикации: 2010-12-23.

Use of an NK-3 receptor antagonist in the treatment of conditions characterised by altered bowel function and/or visceral pain

Номер патента: NZ529462A. Автор: Douglas William Pierre Hay,Gareth John Sanger,Tadataka Yamada. Владелец: SmithKline Beecham Corp. Дата публикации: 2005-07-29.

Use of odc inhibitors, dacarbazine, and interferon in the treatment of malignant melanoma

Номер патента: AU1502388A. Автор: Sai P. Sunkara. Владелец: Merrell Dow Pharmaceuticals Inc. Дата публикации: 1988-10-27.

Use of ODC inhibitors, dacarbazine, and interferon in the¹treatment of malignant melanoma

Номер патента: IE881221L. Автор: Sai P Sunkara. Владелец: Desmond Joseph Crosdale. Дата публикации: 1988-10-23.

Use of ODC inhibitors, dacarbazine, and interferon in the treatment of malignant melanoma

Номер патента: IE61498B1. Автор: Sai P Sunkara. Владелец: Merrell Dow Pharma. Дата публикации: 1994-11-02.

Use of clonazepam in combination with antibiotic in the treatment of bacterially induced meningitis

Номер патента: CA2912453A1. Автор: Franck Mouthon,Matthieu Charveriat. Владелец: Commissariat a lEnergie Atomique et aux Energies Alternatives CEA. Дата публикации: 2014-11-20.

Use of the long pentraxin ptx3 for the prevention or treatment of viral diseases

Номер патента: WO2007104646A3. Автор: Francesco Bistoni,Luigina Romani,Paolo Carminati,Marica Sassano,Silvia Bozza. Владелец: Silvia Bozza. Дата публикации: 2007-11-15.

Use of partly hydrolyzed fish gelatin for the preparation of topically administered pharmaceutical compositions

Номер патента: EP2222316A2. Автор: Bruno Silvestrini,Michele Bonanomi. Владелец: Individual. Дата публикации: 2010-09-01.

Use of a lyophilised bacterial lysate for the prevention of tuberculosis relapse

Номер патента: EP1848448A1. Автор: Nataliya Dyachyk. Владелец: IFB Srl. Дата публикации: 2007-10-31.

Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies

Номер патента: WO2002036151A2. Автор: Angelo Manfredi,Alberto Mantovani,Giuseppe Peri,Barbara Bottazi. Владелец: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.. Дата публикации: 2002-05-10.

Use of the long pentraxin ptx3 for the prevention or treatment of viral diseases

Номер патента: CA2646419A1. Автор: Francesco Bistoni,Luigina Romani,Paolo Carminati,Marica Sassano,Silvia Bozza. Владелец: Individual. Дата публикации: 2007-09-20.

Use of the long pentraxin ptx3 for the prevention or treatment of viral diseases

Номер патента: EP1993585A2. Автор: Francesco Bistoni,Luigina Romani,Paolo Carminati,Marica Sassano,Silvia Bozza. Владелец: Tecnogen SpA. Дата публикации: 2008-11-26.

Use of the long pentraxin ptx3 for the prevention or treatment of viral diseases

Номер патента: WO2007104646A2. Автор: Francesco Bistoni,Luigina Romani,Paolo Carminati,Marica Sassano,Silvia Bozza. Владелец: Tecnogen S.P.A. Дата публикации: 2007-09-20.

Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies

Номер патента: EP1370279A2. Автор: Alberto c/o Ist. di Ricerche Farma. MANTOVANI,Barbara c/o Ist. di Ricerche Farma. BOTTAZI,Giuseppe c/o Ist. di Ricerche Farma. PERI,Angelo c/o Ist. di Ricerche Farma. MANFREDI. Владелец: Sigma Tau Industrie Farmaceutiche Riunite SpA. Дата публикации: 2003-12-17.

Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies

Номер патента: WO2002036151A3. Автор: Angelo Manfredi,Alberto Mantovani,Giuseppe Peri,Barbara Bottazi. Владелец: Barbara Bottazi. Дата публикации: 2003-10-16.

Use of the long pentraxin PTX3 for the preparation of medicament for the prevention and cure of autoimmune pathologies

Номер патента: AU2002215189B2. Автор: Angelo Manfredi,Alberto Mantovani,Giuseppe Peri,Barbara Bottazi. Владелец: Sigma Tau Industrie Farmaceutiche Riunite SpA. Дата публикации: 2006-08-03.

Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies

Номер патента: EP1370279B1. Автор: Alberto c/o Ist. di Ricerche Farma. MANTOVANI,Barbara c/o Ist. di Ricerche Farma. BOTTAZI,Giuseppe c/o Ist. di Ricerche Farma. PERI,Angelo c/o Ist. di Ricerche Farma. MANFREDI. Владелец: Sigma Tau Industrie Farmaceutiche Riunite SpA. Дата публикации: 2005-09-07.

Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies

Номер патента: US20040029803A1. Автор: Angelo Manfredi,Alberto Mantovani,Giuseppe Peri,Barbara Bottazzi. Владелец: Sigma Tau Industrie Farmaceutiche Riunite SpA. Дата публикации: 2004-02-12.

Use of thiabendazole and derivatives thereof for the theraphy of neurological conditions

Номер патента: WO2010127878A3. Автор: Armin Schneider,Rico Laage,Anja Moraru,Carola Krüger. Владелец: SYGNIS BIOSCIENCE GmbH & Co. KG. Дата публикации: 2011-02-03.

Use of 2,5-dihydroxybenzenesulfonic derivatives for the normalization of endothelial function

Номер патента: US6147112A. Автор: Jose Esteve-Soler. Владелец: Laboratorios del Dr Esteve SA. Дата публикации: 2000-11-14.

Use of a polyamine-poor composition for the production of a medical human food

Номер патента: CA2533690C. Автор: Guy Simonnet,Jacques-Philippe Moulinoux. Владелец: Universite Victor Segalen Bordeaux 2. Дата публикации: 2013-06-11.

The use of apolipoprotein A-I Milano, for the manufacture ofa composition for treating preventing or reducing ischemic reperfusion injury in a tissue or organ

Номер патента: NZ537006A. Автор: Charles L Bisgaier. Владелец: Esperion Therapeutics Inc. Дата публикации: 2008-01-31.

Use of carvedilol or derivatives thereof for the manufacture of a medicament for the prevention and treatment of viral infections

Номер патента: WO1998038986A3. Автор: Akira Matsumori. Владелец: Akira Matsumori. Дата публикации: 1999-01-14.

Diagnostic and treatment of a mental disorder

Номер патента: WO2005068649A1. Автор: Michel Cuenod,Kim Quang Do-Cuenod,Mirjana Tosic. Владелец: NOVARTIS FORSCHUNGSSTIFTUNG. Дата публикации: 2005-07-28.

Identification and use of effectors and allosteric molecules for the alteration of gene expression

Номер патента: US20050239061A1. Автор: Anastasia Khvorova,William Marshall,Sumedha Jayasena. Владелец: AMGEN INC. Дата публикации: 2005-10-27.

Method for the determination and use of a standard operational value for the delay time of a radiographic system

Номер патента: US20150085987A1. Автор: Walter Exelmans,Patrick Pandelaers,Patrick Lambrechts. Владелец: AGFA HEALTHCARE NV. Дата публикации: 2015-03-26.

Method for the determination and use of a standard operational value for the delay time of a radiographic system

Номер патента: US9474499B2. Автор: Walter Exelmans,Patrick Pandelaers,Patrick Lambrechts. Владелец: AGFA HEALTHCARE NV. Дата публикации: 2016-10-25.

Use of hte ubiquitin specific protease usp25 in the treatment, prophylaxis and diagnosis of cancer

Номер патента: WO2000079267A3. Автор: Dean Nizetic,Juergen Groet. Владелец: Univ London Pharmacy. Дата публикации: 2001-02-15.

Methods and systems for the use of photosynthetic microbes as mechanical transducers and sensors

Номер патента: US12012588B1. Автор: David Bortz,Jeffrey Carlyle Cameron,Kristin A. Moore,Evan B. Johnson,Jian Wei Tay,Janet B. Fox,Sabina Altus. Владелец: University of Colorado Boulder. Дата публикации: 2024-06-18.

Target of rapamycin modulators of and use thereof

Номер патента: EP2033968A1. Автор: Yann Barrandon,Michel Brouard,Fahd Azzabi Zouraq. Владелец: Ecole Polytechnique Federale de Lausanne EPFL. Дата публикации: 2009-03-11.

Methods for the use of inhibitors of co-repressors for the treatment of neoplastic diseases

Номер патента: AU1395999A. Автор: Laszlo Nagy,Ronald M Evans,Richard J. Lin. Владелец: SALK INSTITUTE FOR BIOLOGICAL STUDIES. Дата публикации: 1999-05-31.

Conditionally active anti-epidermal growth factor receptor antibodies and methods of use thereof

Номер патента: US20130266579A1. Автор: Frost Gregory I.,Vaughn Daniel Edward,HUANG Lei,Wei Ge,Shepard H. Michael. Владелец: . Дата публикации: 2013-10-10.

Conditionally active anti-epidermal growth factor receptor antibodies and methods of use thereof

Номер патента: US20140170159A9. Автор: Frost Gregory I.,Vaughn Daniel Edward,HUANG Lei,Wei Ge,Shepard H. Michael. Владелец: . Дата публикации: 2014-06-19.

Compositions of recombinant anti-epidermal growth factor receptor antibodies

Номер патента: RU2488596C2. Автор: Лусилла СТЕЙНО,Аллан ЕНСЕН,Клаус КОФОД,Пер-Йохан МЕЙЕР,Роберт КАРЛССОН,Чарльз ПАЙК,Ларс Согор НИЛЬСЕН,Миккель Ваннахль ПЕДЕРСЕН. Владелец: Симфоген А/С. Дата публикации: 2013-07-27.

Mutant cytochrome p450 2b6 proteins and uses thereof

Номер патента: US20140127180A1. Автор: Isabelle De Waziers,Philippe Beaune,Patrick Dansette,Walid TOUATI,Monique DIRY,Jean-Pierre FLINOIS. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 2014-05-08.

Mutant cytochrome p450 2b6 proteins and uses thereof

Номер патента: EP2705052A1. Автор: Isabelle De Waziers,Philippe Beaune,Patrick Dansette,Walid TOUATI,Monique DIRY,Jean-Pierre FLINOIS. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 2014-03-12.

Biocompatible three dimensional matrix for the immobilization of biological substances

Номер патента: US09926383B2. Автор: Stefan Margraf,Martin Scholz. Владелец: Leukocare AG. Дата публикации: 2018-03-27.

Biomarkers For The Prediction Of Treatment Outcomes In ADHD

Номер патента: US20170000400A1. Автор: Evian Gordon. Владелец: BRC OPERATIONS Pty Ltd. Дата публикации: 2017-01-05.

USE OF ACID PROTEASE INHIBITOR PEPTIDES FOR THE PREPARATION OF MEDICINES USEFUL FOR THE TREATMENT OF VIRAL DISEASES

Номер патента: FR2646354B1. Автор: Dino Nisato,Jean-Claude Chermann,Sylvie Marchetto. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 1994-06-10.

Use of an aqueous alkaline composition for the electroless deposition of a metal or metal alloy on a metal surface of a substrate

Номер патента: EP4444931A1. Автор: Heiko Brunner,Lars Kohlmann. Владелец: Atotech Deutschland GmbH and Co KG. Дата публикации: 2024-10-16.

Use of water as a catalyst for the polymerization of chlorocyclophosphazenes

Номер патента: US3937790A. Автор: Harry Rex Allcock,James Earl Gardner, deceased,Karen M. Smeltz. Владелец: Firestone Tire and Rubber Co. Дата публикации: 1976-02-10.

Use of heterogeneous catalysts in methods for the production of polymides

Номер патента: MY121875A. Автор: Ralf Dr Mohrschladt,Volker Dr Hildebrandt. Владелец: Basf Ag. Дата публикации: 2006-02-28.

Use of aralkyl polyalkylene glycol ethers for the preparation of aqueous coal slurries

Номер патента: US4547199A. Автор: Jan Mazanek,Gunther Boehmke,Gottfried Schneider,Hans-Jurgen Botsch. Владелец: Bayer AG. Дата публикации: 1985-10-15.

Use of synthetic granulate or powder for the removal of liquid, gaseous and/or dissolved constituents from a process stream

Номер патента: US5750030A. Автор: Johannes Bos,Elwin Schomaker,Erik Leonard Middelhoek. Владелец: Individual. Дата публикации: 1998-05-12.

Use of aralkyl polyalkylene glycol ethers for the preparation of aqueous coal slurries

Номер патента: CA1226202A. Автор: Jan Mazanek,Gunther Boehmke,Gottfried Schneider,Hansjurgen Botsch. Владелец: Bayer AG. Дата публикации: 1987-09-01.

The use of phosphonoalkanecarboxylic acid partial esters for the extraction of metals

Номер патента: AU1001388A. Автор: Helmut Blum,Werner Dr. Schwab. Владелец: Henkel AG and Co KGaA. Дата публикации: 1988-07-14.

The use of phosphonoalkanecarboxylic acid partial esters for the extraction of metals

Номер патента: AU596264B2. Автор: Helmut Blum,Werner Dr. Schwab. Владелец: Henkel AG and Co KGaA. Дата публикации: 1990-04-26.

Use of an aqueous coating composition for the manufacture of surface coatings of seals

Номер патента: EP1499691A1. Автор: Karl-Heinz Käsler,John Mitchell Huggins,Adrian-Malcolm Steedman. Владелец: GE Bayer Silicones GmbH and Co KG. Дата публикации: 2005-01-26.

Use of a self-healing material for the formation of a film bag

Номер патента: EP4257345A1. Автор: Omer Ozkul. Владелец: Henkel AG and Co KGaA. Дата публикации: 2023-10-11.

Phthalocyanine photosensitizers for photodynamic therapy and methods for their synthesis and use

Номер патента: CA2086942A1. Автор: Malcolm E. Kenney,Nancy L. Oleinick,Boris D. Rihter. Владелец: Individual. Дата публикации: 1992-01-18.

[1,2,4]-Dithiazoli(di)ne derivatives, inducers of gluthathione-S-transferase and NADPH quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in general and apoptosis in particular

Номер патента: US20060194846A1. Автор: Bernard Van Vliet,Hiskias Keizer,Gustaaf van Scharrenburg,Roelof Feenstra,Maria Pras-Raves. Владелец: Solvay Pharmaceuticals BV. Дата публикации: 2006-08-31.

Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites

Номер патента: US20070066634A2. Автор: Roelof Van Hes,Cornelis Kruse,Martinus Tulp,Pieter Smid. Владелец: Solvay Pharmaceuticals BV. Дата публикации: 2007-03-22.

Use of stereoisomers of calendula glycosides for the treatment of psoriasis

Номер патента: ZA98584B. Автор: William Howard Stimson,Alexander Irvine Gray,Chaman Lal Anand,Peter George Waterman,Solomon Habtermariam. Владелец: Univ Strathclyde. Дата публикации: 1998-08-03.

Use of stereoisomers of calendula glycosides for the treatment of psoriasis

Номер патента: AU5771198A. Автор: William Howard Stimson,Alexander Irvine Gray,Chaman Lal Anand,Solomon Habtemariam,Peter George Waterman. Владелец: UNIVERSITY OF STRATHCLYDE. Дата публикации: 1998-08-18.

Process for the depolymerization of polystyrene

Номер патента: US12116337B2. Автор: Norbert Niessner,Bianca WILHELMUS,Achim Schmidt-Rodenkirchen,Konstantin MIERDEL,Frank NEUNER. Владелец: INEOS STYROLUTION GROUP GMBH. Дата публикации: 2024-10-15.

Organofunctional siloxanes, process for preparing same and their use for the treatment of fillings and surfaces

Номер патента: US11773289B2. Автор: José Manuel Antelo Miguez,Benigno JANEIRO,Luis Angel ADRIO CASTIÑEIRA,Pablo BARREIRO GONZALEZ. Владелец: Abcr Laboratorios SL. Дата публикации: 2023-10-03.

Process for the carbonylation of epoxides

Номер патента: US20220204465A1. Автор: Christoph Guertler,Jens LANGANKE,Matthias LEVEN,Suresh Raju. Владелец: Covestro Intellectual Property GmbH and Co KG. Дата публикации: 2022-06-30.

Supported tantalum catalyst for the production of 1,3-butadiene

Номер патента: US12070738B2. Автор: Piotr Zapala,Ewelina JANKOWIAK,Szymon SKOWRONEK. Владелец: Synthos Dwory 7 Spolka Z Ograniczona Odpowiedzialnoscia. Дата публикации: 2024-08-27.

Pectin, process for producing the same, acidic protein foods with the use of the same and process for the production thereof

Номер патента: EP1291363B1. Автор: Taro c/o Fuji Oil Company Limited TAKAHASHI,Hitoshi c/o Fuji Oil Company Limited FURUTA,Junko c/o Fuji Oil Company Limited TOBE. Владелец: Fuji Oil Co Ltd. Дата публикации: 2011-07-06.

Method for catalytic oxidation of a natural composition including unsaturated fatty acids and/or esters thereof and the use of a mixture obtained therefrom for the production of mono-, oligo- and/or polyesters

Номер патента: EP2785677A1. Автор: Jukka Tulisalo,Salme Koskimies,Pauliina PITKÄNEN,Minni Pirttimaa. Владелец: Valtion teknillinen tutkimuskeskus. Дата публикации: 2014-10-08.

New process for the manufacture of mdm2-p53 antagonists

Номер патента: WO2024133619A1. Автор: Zhibin Zhu,Qing Xiao,Jidong Shao,Dihan ZHANG. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2024-06-27.

Antibody drug conjugate formulation and use thereof

Номер патента: AU2021464886A1. Автор: CHAOHONG HU,Lili XIAO. Владелец: Shanghai Miracogen Inc. Дата публикации: 2024-04-11.

Vitamin k for prevention and treatment of skin rash secondary to anti-egfr therapy

Номер патента: EP1871353A4. Автор: Roman Perez-Soler,Yi-He Ling. Владелец: ALBERT EINSTEIN COLLEGE OF MEDICINE. Дата публикации: 2009-06-24.

Phospholipase inhibitors for the treatment of cancer

Номер патента: EP1135141A1. Автор: Albert Peng Sheng Tseng,Kevin William Broady. Владелец: Analytica Ltd. Дата публикации: 2001-09-26.

Use of proteinase inhibitor in order to inhibit the cleavage of growth factor precursor

Номер патента: CA2380753A1. Автор: Axel Ullrich,Esther Zwick-Wallasch,Henrik Daub,Norbert Prenzel. Владелец: Individual. Дата публикации: 2001-02-22.

Combination for the treatment of endothelial damage

Номер патента: US20030099687A1. Автор: Carl-Henrik Heldin,Arne Östman,Kari Alitalo,Seppo Yla-Herttuala,Olli LEPPÄNEN. Владелец: LICENTIA OY. Дата публикации: 2003-05-29.

Use of adenosine aspartate for the preparation of pharmaceutical products for the treatment of liver cancer

Номер патента: US20110105425A1. Автор: Victoria-Eugenia Chagoya-Hazas,Rolando-Efraín Hernandez Muñoz,Saúl Villa-Treviño. Владелец: Universidad Nacional Autonoma De México. Дата публикации: 2011-05-05.

Use of adenosine aspartate for the preparation of pharmaceutical products for the treatment of liver cancer

Номер патента: US8507459B2. Автор: Victoria-Eugenia Chagoya-Hazas,Rolando-Efraín Hernandez Muñoz,Saúl Villa-Treviño. Владелец: Universidad Nacional Autonnoma de Mexico. Дата публикации: 2013-08-13.

Pharmaceutical composition for the treatment of alzheimer's disease, method for producing same and use thereof

Номер патента: EP2556833A4. Автор: Sousa Buck Hudson De,Nunes Marielza Andrade. Владелец: Fundação Arnaldo Vieira De Carvalho. Дата публикации: 2013-09-04.

Remedy for the treatment of endometritis in cows

Номер патента: RU2744919C1. Автор: Елена Николаевна Новикова,Игорь Сергеевич Коба,Омар Одех Абдль-Мути Аль-Равашдех. Владелец: Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный аграрный университет имени И.Т. Трубилина". Дата публикации: 2021-03-17.

Method for treatment of post-traumatic ankylosis of joints of hand

Номер патента: RU2750107C1. Автор: Андрей Алексеевич Богов,Рустем Ринатович Фасахов,Руслан Идусович Муллин. Владелец: Государственное автономное учреждение здравоохранения "Республиканская клиническая больница Министерства здравоохранения Республики Татарстан". Дата публикации: 2021-06-22.

Formulations of milciclib and therapeutic combinations of the same for use in the treatment of cancer

Номер патента: US20240285632A1. Автор: Kunwar Shailubhai. Владелец: Tiziana Life Sciences Ltd. Дата публикации: 2024-08-29.

Method for the treatment of keratin fibres employing alkali metal/alkaline earth metal ions, phosphate ions and an organic alkaline agent

Номер патента: WO2020260180A1. Автор: Christian Blaise. Владелец: L'oreal. Дата публикации: 2020-12-30.

Method of use of Xenon-133 for the treatment of AIDS, other viral and non-viral infections

Номер патента: US20050042301A1. Автор: Donald VanDeripe. Владелец: Individual. Дата публикации: 2005-02-24.

Pseudhymenochirins as agents for treatment of cancer and microbial infections

Номер патента: WO2016016686A1. Автор: John Michael Conlon,Milena Mechkarska. Владелец: UNITED ARAB EMIRATES UNIVERSITY. Дата публикации: 2016-02-04.

Use of angiotensin in the treatment of cancer metastasis

Номер патента: EP1104305B1. Автор: Gavin Paul Division of Biom. Sciences VINSON,John Richard Division of Biom. Science PUDDEFOOT,Miles Gordon Division of Biom. Sciences BERRY. Владелец: QUEEN MARY AND WESTFILED COLLEGE UNIVERSITY OF LONDON. Дата публикации: 2005-03-23.

Compounds for the treatment of diseases caused by oxalate accumulation

Номер патента: US20200197418A1. Автор: Jose Antonio Gomez Vidal,Miguel Xavier Fernandes,Mónica Díaz Gavilán,María Dolores Moya Garzón,Eduardo Salido Ruiz,Cristina Martín Higueras. Владелец: Universidad de Granada. Дата публикации: 2020-06-25.

Combined use of imiquimod and a casein hydrolysate for the treatment of condyloma

Номер патента: EP4401733A1. Автор: Guillermo LÓPEZ ZARCO. Владелец: Ntd Labs SLU. Дата публикации: 2024-07-24.

Treatment of bone marrow pathologies with polysulfated polysaccharides

Номер патента: AU2024204710A1. Автор: Paul Rennie,Ravi Krishnan. Владелец: Paradigm Biopharmaceuticals Ltd. Дата публикации: 2024-07-25.

Use of chemical compounds for the treatment of aids

Номер патента: WO2009063412A1. Автор: Xavier Morelli,Yves Collette. Владелец: Institut National de la Sante et de la Recherche Medicale (INSERM). Дата публикации: 2009-05-22.

Long-action implant for treatment of infectious diseases

Номер патента: EP3634583A1. Автор: Stephanie Elizabeth Barrett,Marian E. Gindy,Seth P. Forster,Jay A. Grobler,David Brian Olsen,Ryan Stevenson TELLER. Владелец: Merck Sharp and Dohme LLC. Дата публикации: 2020-04-15.

Composition for treatment and / or prevention of diseases of oral cavity, method for its preparation and use

Номер патента: RU2747983C1. Автор: Светлана Константиновна Матело,Александр Владимирович Гроссер,Татьяна Владимировна Купец. Владелец: Светлана Константиновна Матело. Дата публикации: 2021-05-18.

Topical use of valproic acid for the prevention or treatment of skin disorders

Номер патента: EP2039355A2. Автор: Pier Giuseppe Pelicci,Donatella Paolino,Sergio Chimenti,Antonio Costanzo,Steven Paul Department of Dermatology Nistico,Saverio Minucci. Владелец: Topotarget Germany Ag. Дата публикации: 2009-03-25.

Combination comprising pterostilbene for the treatment of cancer

Номер патента: US20180214390A1. Автор: José María ESTRELA ARIGÜEL,Maria Benlloch Garcia,María Elena PLÁ OBRADOR,Lilian Soraya VALLÉS MARTÍN,María Lucía RODRÍGUEZ ROMERO,Joan Antoni SIREROL TALENS,Javier Luis ALCÁCER GARCÍA,José Alfredo PELLICER ARTÉS,Rosario SALVADOR PALMER,Guillermo María SÁEZ TORMO,Concepción CERDÁ MICÓ. Владелец: Fundacio Investigacio Hospital General Universitari De Valencia Per A La Investigacio. Дата публикации: 2018-08-02.

Gap junction modulators and their use for the treatment of age-related macular degeneration

Номер патента: CA3240515A1. Автор: Ulrik Mouritzen,Bradford YOUNG. Владелец: Breye Therapeutics ApS. Дата публикации: 2023-06-29.

Use of thiamphenicol for the preparation of pharmaceutical compositions useful in the treatment of vancomycin-intermediates and multiresistant staphylococci

Номер патента: US20020183246A1. Автор: Luciano Licciardello,Domenico Ungheri. Владелец: Zambon Group SpA. Дата публикации: 2002-12-05.

Treatment of skin and mucosal superficial wounds using adrenergic receptor agonists

Номер патента: WO2010039827A3. Автор: Roman Kelner. Владелец: Roman Kelner. Дата публикации: 2010-06-10.

Formulation for use in a method of treatment of pain

Номер патента: US20190133981A1. Автор: Tao Zhang,Navneet Puri,Kumaresh Soppimath,Tushar HINGORANI,Jack Martin LIPMAN,Varun Khurana,Vlvek Yadav,Iouri V. Illtchev. Владелец: Nevakar Inc. Дата публикации: 2019-05-09.

Treatment of ocular diseases

Номер патента: US09795656B2. Автор: Ahmed Aftab,Thomas Mohr,Bernhard Lotz,Lucia Desser. Владелец: Marlyn Nutraceuticals Inc. Дата публикации: 2017-10-24.

Cannabinoid combinations and their use in the treatment of cancer

Номер патента: EP4203925A1. Автор: Carminita Lara FROST,Natasha BEUKES,Recardia Laken Simoney SCHOEMAN,Ruby-Ann LEVENDAL. Владелец: Nelson Mandela University. Дата публикации: 2023-07-05.

Use of thiamphenicol in the treatment of vancomycin-intermediates and multiresistant staphylococci infections

Номер патента: WO2001060344A2. Автор: Luciano Licciardello,Domenico Ungheri. Владелец: Zambon Group S.P.A.. Дата публикации: 2001-08-23.

Use of thiamphenicol in the treatment of vancomycin-intermediates and multiresistant staphylococci infections

Номер патента: EP1207871A2. Автор: Luciano Licciardello,Domenico Ungheri. Владелец: Zambon SpA. Дата публикации: 2002-05-29.

Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases

Номер патента: WO1996011005A3. Автор: Leon T Atlas. Владелец: Leon T Atlas. Дата публикации: 1996-05-30.

Combinations of tumor-associated antigens for the treatment of various types of cancers

Номер патента: AU2004249254B2. Автор: John J. L. Simard,David C. Diamond,Adrian Bot,Chih-Sheng Chiang. Владелец: MANNKIND CORP. Дата публикации: 2010-07-08.

Combinations of tumor-associated antigens for the treatment of various types of cancers

Номер патента: WO2004112825A3. Автор: Adrian Bot,David C Diamond,Chih-Sheng Chiang,John J L Simard. Владелец: John J L Simard. Дата публикации: 2005-05-06.

Treatment of a respiratory coronavirus infection with nitroxides

Номер патента: US20220280493A1. Автор: Peter Herbert Proctor. Владелец: Individual. Дата публикации: 2022-09-08.

Food composition comprising a satiety enhancing amount of triacylglycerol and use in the manufacture of a medicament for the treatment or prevention of obesity

Номер патента: AU2003295297A1. Автор: Bengt Herslöf,Annika Viberg. Владелец: LTP Lipid Technologies Provider AB. Дата публикации: 2004-07-22.

Use of hif-1α stabilizing agents for the treatment of type i interferonopathies

Номер патента: WO2024165507A1. Автор: Mickaël MENAGER,Maxime BATIGNES. Владелец: Université Paris Cite. Дата публикации: 2024-08-15.

Use of substances with immunomodulating activity for the treatment of amyotrophic lateral sclerosis

Номер патента: US20040053846A1. Автор: Walter Schubert. Владелец: Meltec Multi-Epitope-Ligand-Technologies GmbH. Дата публикации: 2004-03-18.

Use of echinacea or preparations thereof in compositions for the treatment of anxiety

Номер патента: US20090285907A1. Автор: József Haller,Tamas Freund. Владелец: Individual. Дата публикации: 2009-11-19.

Use of echinacea or preparations thereof in compositions for the treatment of anxiety

Номер патента: EP2043668A2. Автор: József Haller,Tamas Freund. Владелец: Individual. Дата публикации: 2009-04-08.

Use of echinacea or preparations thereof in compositions for the treatment of anxiety

Номер патента: WO2007144676A2. Автор: József Haller,Tamas Freund. Владелец: Haller Jozsef. Дата публикации: 2007-12-21.

Use of n-myristoyl transferase (nmt) inhibitors in the treatment of cancer, autoimmune disorders, and inflammatory disorders

Номер патента: EP4232032A4. Автор: Erwan BEAUCHAMP,Luc G Berthiaume. Владелец: PACYLEX PHARMACEUTICALS Inc. Дата публикации: 2024-10-02.

USE OF A GAMMA SECRETASE INHIBITOR FOR THE TREATMENT OF CANCER

Номер патента: MA33076B1. Автор: John Frederick Boylan,Kathryn E Packman,Leopoldo Ladores Luistro Iii. Владелец: Hoffmann La Roche. Дата публикации: 2012-03-01.

Formulations of milciclib and therapeutic combinations of the same for use in the treatment of cancer

Номер патента: EP3706869A1. Автор: Kunwar Shailubhai. Владелец: Tiziana Life Sciences Ltd. Дата публикации: 2020-09-16.

Composition comprising withania extract, omega-3 fatty acids and natural product extracts and uses thereof

Номер патента: CA3075833C. Автор: Angus Harding. Владелец: Bh Biotech Pty Ltd. Дата публикации: 2024-06-11.

Use of 4-pyridylmethyl-phthalazine derivatives for the manufacture of a medicament for the treatment of myelodysplastic syndromes

Номер патента: AU2003299065A1. Автор: Margaret Han Dugan,Alan List. Владелец: University of Arizona. Дата публикации: 2004-04-19.

Use of 4-pyridylmethyl-phthalazine derivatives for the manufacture of a medicament for the treatment of myelodysplastic syndromes

Номер патента: EP1545534A1. Автор: Margaret Han Dugan,Alan List. Владелец: University of Arizona. Дата публикации: 2005-06-29.

Use of 4-pyridylmethyl-phthalazine derivatives for the manufacture of a medicament for the treatment of myelodysplastic syndromes

Номер патента: AU2003299065B2. Автор: Margaret Han Dugan,Alan List. Владелец: University of Arizona. Дата публикации: 2006-10-26.

Use of 2-amino-N-(1,2-diphenyl-1-methylethyl)-acetamide (ie remacemide) in treating Parkinsons disease

Номер патента: NZ299042A. Автор: Peter Johnson,Barry Ernest Watkins,Eric William Harris. Владелец: Astra AB. Дата публикации: 2000-07-28.

Use of morphine derivatives as medicaments for the treatment of neuropathic problems

Номер патента: US20020165247A1. Автор: Helmut Buschmann,Wolfgang Strassburger,Thomas Krueger,Stephan Wnendt,Elke Reiss-Mueller. Владелец: GRUENENTHAL GmbH. Дата публикации: 2002-11-07.

CHIMERIC ANTIGEN RECEPTORS FOR MELANOMA AND USES THEREOF

Номер патента: US20180280437A1. Автор: Sievers Stuart A.,Wiltzius Jed J.W.. Владелец: . Дата публикации: 2018-10-04.

Isolation of n-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of n-butylbenzenesulfonamide and benzenesulfonamide derivatives for treating benign prostatic hyperplasia and/or prostate carcinoma

Номер патента: CA2596618C. Автор: Hans-Rainer Hoffmann,Rudolf Matusch,Aria Baniahmad. Владелец: LTS Lohmann Therapie Systeme AG. Дата публикации: 2013-05-07.

A nutrient pharmaceutical formulation comprising polyphenols and use in the manufacture of a medicament for the treatment of cancer

Номер патента: HK1086489A1. Автор: Aleksandra Niedzwiecki,Matthias Rath,Shrirang Netke. Владелец: Matthias Rath. Дата публикации: 2006-09-22.

Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2

Номер патента: HK1061209A1. Автор: Alberto Mantovani,Marco Presta,Marco Rusnati,Barbara Bottazzi. Владелец: Sigma Tau Ind Farmaceutche Riu. Дата публикации: 2004-09-10.

Combinations comprising a mek inhibitor and everolimus, kits comprising the same and use thereof in the manufacture of medicaments for the treatment of cancer

Номер патента: IL219786A. Автор: . Владелец: Glaxo Group Ltd. Дата публикации: 2016-05-31.

Use of low dose il-2 for treating autoimmune - related or inflammatory disorders

Номер патента: US20190351023A1. Автор: Claude Bernard,David Klatzmann,Eliane Piaggio,Gilbert BENSIMON,David SAADOUN,Patrice CACOUB,Michèle ROSENZWAJG. Владелец: Assistance Publique Hopitaux de Paris APHP. Дата публикации: 2019-11-21.

Use of 5-ht3 receptor antagonists for the treatment of inflammations of the respiratory tract

Номер патента: AU6991300A. Автор: Wolfgang Müller,Lothar Farber,Christian Stratz. Владелец: Novartis Erfindungen Verwaltungs GmbH. Дата публикации: 2001-03-05.

Dosage form for intra-articular injection comprising colchicine and an anesthesic agent in the treatment of crystal-and non-crystal associated acute inflammatory arthritis

Номер патента: EP4406531A1. Автор: designation of the inventor has not yet been filed The. Владелец: Pk Med Sas. Дата публикации: 2024-07-31.

Use of inhibitors of ornithine aminotransferase for the manufacture of a medicament for the treatment of alzheimer's disease

Номер патента: AU5614394A. Автор: Jean-Bernard Ducep,Nikolaus Seiler,Karin C Jund. Владелец: Merrell Dow Pharmaceuticals Inc. Дата публикации: 1994-08-29.

Use of mannan from saccharomyces cerevisiae for the treatment of asthma

Номер патента: US20050085442A1. Автор: D. Lew. Владелец: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION. Дата публикации: 2005-04-21.

Use of N-alkylamino-heterocylic compounds for the treatment of migraine

Номер патента: US20020169322A1. Автор: TAO Xin,Methvin Isaac,Abdelmalik Slassi,Louise Edwards,Ashok Tehim,Jalaj Arora,Anne O'brien. Владелец: NPS Allelix Corp Canada. Дата публикации: 2002-11-14.

The use of gonadoliberin and gonadoliberin agonists for the treatment of metabolic disorders which are attributable to the level of parathyroid hormone being too low

Номер патента: ZA847047B. Автор: Wolfgang Koenig,Horst Neubauer. Владелец: Hoechst AG. Дата публикации: 1985-04-24.

Use of mannan from saccharomyces cerevisiae for the treatment of asthma

Номер патента: WO2005037064A3. Автор: D Betty Lew. Владелец: Univ Tennessee Res Foundation. Дата публикации: 2005-06-16.

Compositions for the prevention or treatment of dry eyes

Номер патента: RU2763423C1. Автор: Нина ХА,Йоунг Ил ЧОЙ,Таек Хван ШИН. Владелец: Чонг Кун Данг Фармасьютикал Корп.. Дата публикации: 2021-12-29.

The use of acetyl CoA carboxylase inhibitors for the treatment of acne vulgaris

Номер патента: RU2016106829A. Автор: Уильям Пол ЭСЛЕР,Габриэль Элизабет СОННЕНБЕРГ. Владелец: Пфайзер Инк.. Дата публикации: 2017-10-17.

Use of inhibitors of yap/taz for the treatment of cancer

Номер патента: WO2020226919A1. Автор: Jeffrey Field,Chunling YI,Shannon M. WHITE. Владелец: GEORGETOWN UNIVERSITY. Дата публикации: 2020-11-12.

Use of polypeptides and nucleic acids for the preparation of medicaments for the treatment of cancer and/or arthritis

Номер патента: IL186754A0. Автор: . Владелец: Yorke Smith Melanie. Дата публикации: 2008-02-09.

Use of polypeptides of human origin for the treatment of microbial infectious diseases

Номер патента: AU2003219059A1. Автор: Hans Henning Von Horsten,Christiane Kirchhoff,Petra Derr. Владелец: LAGOW GmbH. Дата публикации: 2003-09-29.

Use of the gdf-5 mutant for the treatment of pain and cartilage destruction

Номер патента: IL293988A. Автор: Anne GIGOUT,Daniela WERKMANN,Kerstin Kleinschmidt-Doerr. Владелец: Kleinschmidt Doerr Kerstin. Дата публикации: 2022-08-01.

Use of selective progesterone receptor modulators for the treatment of androgen deficiency

Номер патента: EP1569655A1. Автор: Kristof Chwalisz. Владелец: Tap Pharmaceuticals Inc. Дата публикации: 2005-09-07.

Use of selective progesterone receptor modulators for the treatment of androgen deficiency

Номер патента: WO2004045620A1. Автор: Kristof Chwalisz. Владелец: Tap Pharmaceutical Products Inc.. Дата публикации: 2004-06-03.

Use of cyclopentadienyl metal-acido complexes for the treatment of cancer and pharmaceutical compositions containing said complexes

Номер патента: US4608387A. Автор: Hartmut Kopf,Petra Kopf-Maier. Владелец: Koepf Hartmut. Дата публикации: 1986-08-26.

Use of an adsorbate comprising tadalafil for the preparation of a dosage form and use thereof for the treatment of erectile dysfunction, as well as processes for the preparation of said adsorbate and said dosage form

Номер патента: EA031818B1. Автор: Рок Грахек,Андрей Бастарда,Миха Томаз Яклиц,Клемен Коцевар,Само Пирц. Владелец: Лек Фармасьютиклз Д.Д.. Дата публикации: 2019-02-28.

Use of nitric oxide/nucleophile complexes for the treatment of cancer

Номер патента: WO1993020806A1. Автор: Larry K. Keefer,Chris M. Maragos,Ji Ming Wang,Joost J. Oppenheim. Владелец: The United States Of America, Represented By The Secretary, Department Of Health And Human Services. Дата публикации: 1993-10-28.

Method for the treatment of cerebral ischaemia and use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia

Номер патента: PL349335A1. Автор: Hannelore Ehrenreich,Christoph Gleiter. Владелец: Christoph Gleiter. Дата публикации: 2002-07-15.

USE OF OPIOIDS OR OPIOID MIMETICS FOR THE TREATMENT OF PATIENTS WITH SUSTAINABLE MALIGNANT TUMOR

Номер патента: RU2011107280A. Автор: Эрих МИЛТНЕР,Клаудиа ФРИЗЕН,Андреас АЛЬТ,Эрих МИЛТНЕР (DE),Клаудиа ФРИЗЕН (DE),Андреас АЛЬТ (DE). Владелец: Универзитет Ульм (De). Дата публикации: 2012-09-10.

Method for the treatment of cerebral ischaemia and use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia

Номер патента: EP1140139A2. Автор: Hannelore Ehrenreich,Christophe Gleiter. Владелец: Christophe Gleiter. Дата публикации: 2001-10-10.

Combinations of tumor-associated antigens in compositions for various types of cancers

Номер патента: CA2529056A1. Автор: John J. L. Simard,David C. Diamond,Adrian Bot,Chih-Sheng Chiang. Владелец: Individual. Дата публикации: 2004-12-29.

Use of cyclopenta [G] quinazoline derivatives for the treatment of cancer

Номер патента: DK1420809T3. Автор: Vassilios Bavetsias,Ann Lesley Jackman. Владелец: Btg Int Ltd. Дата публикации: 2011-12-19.

Non-hormonal treatment of hot flashes

Номер патента: AU2020262851A1. Автор: Robert L. Knobler. Владелец: Individual. Дата публикации: 2021-11-18.

Pharmaceutical composition for the treatment of pulmonary vascular disease and/or cardiac dysfunction in fontan-palliated patients

Номер патента: US20230000865A1. Автор: Wassim Fares,Dénes Csonka,Hans Hoogkamer,Koen Torfs. Владелец: ACTELION PHARMACEUTICALS LTD. Дата публикации: 2023-01-05.

Pharmaceutical composition for the treatment of pulmonary vascular disease and/or cardiac dysfunction in fontan-palliated patients

Номер патента: EP4065081A1. Автор: Wassim Fares,Dénes Csonka,Hans Hoogkamer,Koen Torfs. Владелец: ACTELION PHARMACEUTICALS LTD. Дата публикации: 2022-10-05.

Non-hormonal treatment of hot flashes

Номер патента: US11903926B1. Автор: Robert L. Knobler. Владелец: Iris International Pharma LLC. Дата публикации: 2024-02-20.

Treatment of pain with a combination of an alpha2 -adrenoceptor antagonist such as atipemezole or fipamezoiie and an opioid receptor agonist, such as tramadol

Номер патента: WO2007057508A3. Автор: Mika Scheinin,Uemit Kazim Oezdogan,Janne Laehdesmaeki. Владелец: Janne Laehdesmaeki. Дата публикации: 2008-03-27.

Compounds for use in the treatment of dystrophinopathies

Номер патента: WO2023156645A1. Автор: Raúl INSA BORONAT,Núria REIG BOLAÑO,Oscar HUERTAS GAMBÍN,Yoko Asakura,Gal.La Pericot Mohr,Atsushi Asakura,Marisol Montolio Del Olmo. Владелец: Som Innovation Biotech, S.A.. Дата публикации: 2023-08-24.

(+)-alpha-dihydrotetrabenazine for use in the treatment a movement disorder

Номер патента: AU2018242134B2. Автор: Andrew John Duffield,Anant Pandya. Владелец: ADEPTIO PHARMACEUTICALS Ltd. Дата публикации: 2023-09-28.

Pharmaceutical composition for the treatment of pulmonary vascular disease and/or cardiac dysfunction in fontan-palliated patients

Номер патента: CA3158468A1. Автор: Wassim Fares,Dénes Csonka,Hans Hoogkamer,Koen Torfs. Владелец: TORFS Koen. Дата публикации: 2021-06-03.

Pharmaceutical composition for the treatment of pulmonary vascular disease and/or cardiac dysfunction in Fontan-palliated patients

Номер патента: AU2020393489A1. Автор: Wassim Fares,Dénes Csonka,Hans Hoogkamer,Koen Torfs. Владелец: ACTELION PHARMACEUTICALS LTD. Дата публикации: 2022-07-14.

Pharmaceutical composition for the treatment of pulmonary vascular disease and/or cardiac dysfunction in fontan-palliated patients

Номер патента: WO2021105164A1. Автор: Wassim Fares,Dénes Csonka,Hans Hoogkamer,Koen Torfs. Владелец: ACTELION PHARMACEUTICALS LTD. Дата публикации: 2021-06-03.

Use of 2-amino purine derivatives for the treatment and pro-phylaxis of human herpes virus 6 infections

Номер патента: ZA948907B. Автор: Malcolm Richard Boyd,Richard Anthony Vere Hodge. Владелец: Smithkline Beecham Plc. Дата публикации: 1995-08-17.

Use of an anti-microtubule agent for the treatment of uveitis

Номер патента: AU2002350362A1. Автор: Pierre E. Signore. Владелец: Angiotech Pharmaceuticals Inc. Дата публикации: 2003-07-30.

Use of mannuronic diacid composition in treatment of vascular dementia

Номер патента: AU2019296854A1. Автор: Jian Ding,Meiyu Geng,Zhenqing ZHANG,Xianliang Xin,Xiaoguang Du. Владелец: Shanghai Green Valley Pharmaceutical Co Ltd. Дата публикации: 2021-01-28.

Use of mannuronic diacid composition in treatment of pain

Номер патента: AU2019296850A1. Автор: Jian Ding,Meiyu Geng,Zhenqing ZHANG,Xianliang Xin. Владелец: Shanghai Green Valley Pharmaceutical Co Ltd. Дата публикации: 2021-01-28.

Use of gymnodimine, analogues and derviatives for the treatment and/or prevention of neurodegenerative diseases associated with tau and b-amyloid

Номер патента: EP2484362A4. Автор: Lopez Luis Miguel Botana,Lopez Eva Alonso,Gonzalez Carmen Vale. Владелец: UNIVERSIDADE DE SANTIAGO DE COMPOSTELA. Дата публикации: 2013-04-10.

Use of a propargyl alcohol enantiomer for the treatment of dermatological disorders

Номер патента: AU2003293295A8. Автор: Jean-Claude Caron. Владелец: Galderma Research and Development SNC. Дата публикации: 2004-05-04.

Combined use of a fibrate and orlistat for the treatment of obesity

Номер патента: ZA200507227B. Автор: Edgar Alan. Владелец: Fournier Lab Ireland Ltd. Дата публикации: 2006-11-29.

Combined use of a fibrate and orlistat for the treatment of obesity

Номер патента: HK1083767A1. Автор: Edgar Alan. Владелец: Fournier Lab Ireland Ltd. Дата публикации: 2006-07-14.

Use of salt-bromine-iodine waters for the nasal treatment of the inflammation of the three areas of the upper airways and medical devices adapted to such a treatment

Номер патента: EP4175616A1. Автор: Antonio De Laurentiis. Владелец: Adl Farmaceutici Srl. Дата публикации: 2023-05-10.

Use of salt-bromine-iodine waters for the nasal treatment of the inflammation of the three areas of the upper airways and medical devices adapted to such a treatment

Номер патента: WO2022003618A1. Автор: Antonio De Laurentiis. Владелец: Adl Farmaceutici S.R.L.. Дата публикации: 2022-01-06.

Use of akkermansia in the treatment of oral diseases

Номер патента: US20240293475A1. Автор: Salomon Amar,Willem M. deVOS. Владелец: Individual. Дата публикации: 2024-09-05.

Use of rho gtpase activating toxins for the treatment and/or prevention of symptomatology associated with rett syndrome

Номер патента: EP2536424B1. Автор: Giovanni Laviola,Carla Fiorentini,Alessia Fabbri,Laura Ricceri,Bianca De Filippis. Владелец: Istituto Superiore di Sanita ISS. Дата публикации: 2014-06-04.

USE OF FRACTIONATED PRODUCTS OF GAMBOGE RESIN IN THE TREATMENT OF CANCER, PAIN, AND INFLAMMATION

Номер патента: US20160089357A1. Автор: LEE Sen-Bin. Владелец: Taiwan Sunpan Biotechnology Development Co., Ltd.. Дата публикации: 2016-03-31.

USE OF ERIBULIN AND HISTONE DEACETYLASE INHIBITORS IN THE TREATMENT OF CANCER

Номер патента: US20190282541A1. Автор: LITTLEFIELD Bruce A.,HENDLER Gary. Владелец: . Дата публикации: 2019-09-19.

Use of serotonin agents for adjunct therapy in the treatment of cancer

Номер патента: US6927223B1. Автор: Gary G. Meadows,Tanja Obradovic. Владелец: Washington State University Research Foundation. Дата публикации: 2005-08-09.

Uses of DPP IV inhibitors

Номер патента: US11291668B2. Автор: Michael Mark,Frank Himmelsbach,Klaus Dugi. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2022-04-05.

Use of rotigotine for the treatment or prevention of dopaminergic neuron loss

Номер патента: CA2547645C. Автор: Dieter Scheller,Frank Dressen. Владелец: UCB PHARMA GMBH. Дата публикации: 2013-07-16.

USE OF IL-2 AND SYNTHETIC VECTORS IN THE TREATMENT OF CANCERS

Номер патента: FR2808193B1. Автор: Didier Betbeder,Mir Samir El,Frederic Trieble,Anne Casanova. Владелец: BIOVECTOR THERAPEUTICS SA. Дата публикации: 2004-05-07.

Use of n-myristoyl transferase (nmt) inhibitors in the treatment of cancer, autoimmune disorders, and inflammatory disorders

Номер патента: CA3195753A1. Автор: Luc G. Berthiaume,Erwan BEAUCHAMP. Владелец: PACYLEX PHARMACEUTICALS Inc. Дата публикации: 2022-04-28.

Use of fluoroquinolone antibiotics for the treatment of Q fever

Номер патента: GB2400033A. Автор: Graham Lloyd,Mark Stephen Lever,Kevin R Bewley,Barry Dowsett. Владелец: UK Secretary of State for Defence. Дата публикации: 2004-10-06.

Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl-[1,2,4] triazolo [4,3-a] quinoxaline compounds and pde 10 inhibitors for use in the treatment of neurological or metabolic disorders

Номер патента: CA2872216C. Автор: José Ignacio Andrés-Gil,Frederik Jan Rita Rombouts,Andrés Avelino Trabanco-Suárez,Greta Constantia Peter Vanhoof,Antonius Adrianus Hendrikus Petrus Megens,Xavier Jean Michel Langlois,Peter Jacobus Johannes Antonius Buijnsters,Meri De Angelis. Владелец: Janssen Pharmaceutica NV. Дата публикации: 2021-07-20.

Use of antisecretory factors for treating intraocular hypertension

Номер патента: CA2771087C. Автор: Stefan Lange,Hans-Arne Hansson,Eva Jennische. Владелец: LANTMANNEN AS-FAKTOR AB. Дата публикации: 2016-03-15.

Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia

Номер патента: AU7409900A. Автор: Reinhard Kirsch,Eugen Falk,Hans-Ludwig Schaefer,Norbert Krass. Владелец: Sanofi Aventis Deutschland GmbH. Дата публикации: 2001-03-26.

Treatment of arthritis disorders, rheumatoid arthritis and manifestations associated with rheumatoid disorders

Номер патента: CA2251114A1. Автор: James Murray,Ernir Snorrason. Владелец: Individual. Дата публикации: 1997-08-21.

Uses of helicin and other glucopyranosyloxy benzaldehydes in the treatment of cancer

Номер патента: NZ588668A. Автор: Joe Ernest Brown. Владелец: Cognate 3. Дата публикации: 2013-01-25.

A method of identifying therapeutic compounds for a treatment of hepatic disorders

Номер патента: CA2373935A1. Автор: Robert Clancy,Gerald Pang,Robert Batey. Владелец: Individual. Дата публикации: 2000-11-23.

Use of antisecretory protein to treat intraocular hypertension

Номер патента: CA2650344C. Автор: Stefan Lange,Hans-Arne Hansson,Eva Jennische. Владелец: LANTMANNEN AS-FAKTOR AB. Дата публикации: 2017-10-31.

Use of cox-2 inhibitors for the treatment of schizophrenia, delusional disorders, affective disorders, autism or tic disorders

Номер патента: CA2448025C. Автор: Norbert Mueller. Владелец: Individual. Дата публикации: 2011-07-05.

Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases

Номер патента: US20120076759A1. Автор: Yi Li,Michael Chopp. Владелец: HENRY FORD HEALTH SYSTEM. Дата публикации: 2012-03-29.

Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases

Номер патента: US20120195865A1. Автор: Yi Li,Michael Chopp. Владелец: HENRY FORD HEALTH SYSTEM. Дата публикации: 2012-08-02.

Microemulsion drug delivery system for treatment of acute respiratory distress syndrome

Номер патента: US20230270672A1. Автор: Michel Lonji KALOMBO,Tshepo Patric Nkuna,Yolandy Lemmer. Владелец: Council of Scientific and Industrial Research CSIR. Дата публикации: 2023-08-31.

Treatment of bone marrow pathologies with polysulfated polysaccharides

Номер патента: AU2022204567A1. Автор: Paul Rennie,Ravi Krishnan. Владелец: Paradigm Biopharmaceuticals Ltd. Дата публикации: 2022-07-21.

Use of n-myristoyl transferase (nmt) inhibitors in the treatment of cancer, autoimmune disorders, and inflammatory disorders

Номер патента: IL302193A. Автор: Erwan BEAUCHAMP,Luc G Berthiaume. Владелец: Luc G Berthiaume. Дата публикации: 2023-06-01.

Treatment of bone marrow pathologies with polysulfated polysaccharides

Номер патента: AU2022204567B2. Автор: Paul Rennie,Ravi Krishnan. Владелец: Paradigm Biopharmaceuticals Ltd. Дата публикации: 2024-05-02.

Phytochemical-antibiotic combination for the treatment of a bacterial infection

Номер патента: US20210060049A1. Автор: Jian Yang,Meena Kishor Sakharkar. Владелец: UNIVERSITY OF SASKATCHEWAN. Дата публикации: 2021-03-04.

Combined use of imiquimod and a casein hydrolysate for the treatment of condyloma

Номер патента: AU2022388863A1. Автор: Guillermo LÓPEZ ZARCO. Владелец: Ntd Labs S L U. Дата публикации: 2024-06-20.

The use of polyols in combating yeast infection and polyol preparations for said use

Номер патента: EP1035844A1. Автор: Tammy Pepper,David Saunders,Julita Pearson,Markku Tapio Virkki,Sergio Luis Infectious Disease Div. VARGAS MUNITA. Владелец: Xyrofin Oy. Дата публикации: 2000-09-20.

Pharmaceutical product for the treament of obesity and associated metabolic syndrome diseases, uses and methods of treatment

Номер патента: WO2023164752A1. Автор: Joao Batista Calixto,Melina Heller,Rodrigo Marcon,Jarbas Mota SIQUEIRA JUNIOR,Cristina Setim FREITAS,Edinéia LEMOS DE ANDRADE,Adara ÁUREA DOS SANTOS,Sérgio José MACEDO JÚNIOR. Владелец: Centro De Inovação E Ensaios Pré-Clínicos. Дата публикации: 2023-09-07.

Use of p-selectin glycoprotein ligand 1 in modulation of hematogenous metastasis of lymphomas

Номер патента: WO2007033959A3. Автор: Geert Raes,Baetselier Patrick De,Ghassabeh Gholamre Hassanzadeh. Владелец: Ghassabeh Gholamre Hassanzadeh. Дата публикации: 2007-11-22.

FORMULATIONS OF MILCICLIB AND THERAPEUTIC COMBINATIONS OF THE SAME FOR USE IN THE TREATMENT OF CANCER

Номер патента: US20190134044A1. Автор: Shailubhai Kunwar. Владелец: . Дата публикации: 2019-05-09.

FORMULATIONS OF MILCICLIB AND THERAPEUTIC COMBINATIONS OF THE SAME FOR USE IN THE TREATMENT OF CANCER

Номер патента: US20200390769A1. Автор: Shailubhai Kunwar. Владелец: . Дата публикации: 2020-12-17.

Method of medical therapeutic treatment of rhinitis, formed in patients receiving nasal decongestants

Номер патента: RU2684563C2. Автор: Евгений Альбертович Гилифанов,Татьяна Валерьевна Тилик,Лариса Борисовна Ардеева,Борис Андреевич Лепейко,Татьяна Николаевна Суровенко,Татьяна Петровна Клемешова,Александра Владимировна Прохоренко,Ирина Михайловна Острикова. Владелец: Федеральное государственное бюджетное образовательное учреждение высшего образования "Тихоокеанский государственный медицинский университет" Министерства здравоохранения Российской Федерации. Дата публикации: 2019-04-09.

Treatment of early stage idiopathic pulmonary fibrosis

Номер патента: CA2641952C. Автор: Sebastien Roux,Martine Clozel,John Gatfield. Владелец: ACTELION PHARMACEUTICALS LTD. Дата публикации: 2011-02-01.

Use of cabergoline in the treatment of restless legs syndrome

Номер патента: US6114326A. Автор: Peter Schueler. Владелец: Pharmacia and Upjohn Co. Дата публикации: 2000-09-05.

Use of helium-oxygen gas mixtures for treating pulmonary arterial hypertension

Номер патента: CA2741706A1. Автор: Eva-Maria Becker,Stefan Schaefer,Hubert Truebel,Katja Schaefer,Juergen Kohlmeyer. Владелец: Bayer Schering Pharma AG. Дата публикации: 2010-05-06.

Treatment of emphysema using rar selective retinoid antagonists

Номер патента: CA2387844C. Автор: Michael Klaus,Paula Nanette Belloni. Владелец: F Hoffmann La Roche AG. Дата публикации: 2009-04-14.

Use of glepp-1 inhibitor for the manufacture of a medicament for treatment of an autoimmune and/or inflammatory disorder

Номер патента: IL188735A. Автор: Catherine Jorand-Lebrun,Agnès Bombrun,Rob Hooft Van Huijsduijnen,Pierre-Alain Vitte,Patrick Gerber. Владелец: Patrick Gerber. Дата публикации: 2012-07-31.

Triple monoamine reuptake inhibitors for the treatment of chronic pain

Номер патента: CA2484482C. Автор: Gordon John Blackburn-Munro,Joergen Scheel-Krueger. Владелец: Neurosearch AS. Дата публикации: 2011-07-26.

Treatment of neuromuscular disorders and conditions with different botulinum serotype

Номер патента: EP1512411A1. Автор: Michael W. Grayston,Steven R. Carlson,Roger K. Aoki,Judith M Leon. Владелец: Allergan Inc. Дата публикации: 2005-03-09.

Treatment of neuromuscular disorders and conditions with different botulinum serotype

Номер патента: EP1099445A3. Автор: Michael W. Grayston,Steven R. Carlson,Judith M. Leon,Roger K. Aoki. Владелец: Allergan Inc. Дата публикации: 2001-09-05.

Use of donerezil for the treatment of functional and/or organic pain syndromes

Номер патента: US6608088B1. Автор: Maria Nicolodi,Federigo Sicuteri. Владелец: Eisai Co Ltd. Дата публикации: 2003-08-19.

Methods for the treatment and prevention of age-related retinal dysfunction

Номер патента: NZ600498A. Автор: Krzysztof Palczewski,Tadao Maeda,David Saperstein. Владелец: Univ Washington. Дата публикации: 2014-01-31.

Pharmaceutical compositions for the treatment of disease and/or symptoms in arthritis

Номер патента: CA2568997C. Автор: Geoffrey Guy,Philip Robson. Владелец: GW Pharma Ltd. Дата публикации: 2012-12-04.

Treatment of skin and mucosal superficial wounds using adrenergic receptor agonists

Номер патента: WO2010039827A2. Автор: Roman Kelner. Владелец: Roman Kelner. Дата публикации: 2010-04-08.

Use of low volume plasma exchange for treating the early and middle stages of alzheimer's disease

Номер патента: US20240115665A1. Автор: Victor Grifols Roura,Antonio Manuel Paez Regadera,Laura Nunez Domenech. Владелец: Grifols Worldwide Operations Ltd. Дата публикации: 2024-04-11.

Methods for the treatment of psoriatic arthritis

Номер патента: US20210299135A1. Автор: Pille HARRISON,Luc MEULENERS,Chantal Thérèse TASSET. Владелец: GALAPAGOS NV. Дата публикации: 2021-09-30.

Pharmaceutical compositions for the treatment of chronic obstructive pulmonary disease

Номер патента: WO2007042811A1. Автор: Geoffrey Guy,Philip Robson. Владелец: GW Pharma Limited. Дата публикации: 2007-04-19.

Method for the treatment of heart disease in mammals

Номер патента: AU2018253371B2. Автор: Jerome Guyonnet,Estelle Ayme-Dietrich,Roland Lawson,Luc Maroteaux,Laurent Monassier. Владелец: Ceva Sante Animale SA. Дата публикации: 2023-10-19.

Oregano for the treatment of internal parasites and protozoa

Номер патента: EP1089745A4. Автор: Daryl L Deluca,William S Sparks,Denis R Deluca,Robert A Ronzio. Владелец: Biotics Research Corp. Дата публикации: 2002-03-20.

Use of p38 inhibitors for the treatment of smoke inhalation

Номер патента: WO2002032862A3. Автор: Don E Griswold,David C Underwood. Владелец: David C Underwood. Дата публикации: 2002-08-22.

Methods for the treatment of psoriatic arthritis

Номер патента: CA3101386A1. Автор: Pille HARRISON,Luc MEULENERS,Chantal Thérèse TASSET. Владелец: GALAPAGOS NV. Дата публикации: 2019-11-28.

Methods for the treatment of psoriatic arthritis

Номер патента: EP3801548A1. Автор: Pille HARRISON,Luc MEULENERS,Chantal Thérèse TASSET. Владелец: GALAPAGOS NV. Дата публикации: 2021-04-14.

Use of thiamphenicol for the treatment of chlamydia pneumoniae infections

Номер патента: WO2001076585A3. Автор: Lorenzo Drago,Luciano Licciardello,Domenico Ungheri,Giovanni Battista Colombo,Maria Rita Gismondo. Владелец: Maria Rita Gismondo. Дата публикации: 2002-03-28.

Use of thiamphenicol for the treatment of chlamydia pneumoniae infections

Номер патента: WO2001076585A2. Автор: Lorenzo Drago,Luciano Licciardello,Domenico Ungheri,Giovanni Battista Colombo,Maria Rita Gismondo. Владелец: Zambon Group S.P.A.. Дата публикации: 2001-10-18.

Oregano for the treatment of internal parasites and protozoa

Номер патента: AU4442099A. Автор: Denis R. DeLuca,Robert A. Ronzio,Daryl L Deluca,William S Sparks. Владелец: Biotics Research Corp. Дата публикации: 2000-01-05.

Oregano for the treatment of internal parasites and protozoa

Номер патента: AU741087B2. Автор: Denis R. DeLuca,Robert A. Ronzio,Daryl L Deluca,William S Sparks. Владелец: Biotics Research Corp. Дата публикации: 2001-11-22.

Oregano for the treatment of internal parasites and protozoa

Номер патента: WO1999065505A1. Автор: Daryl L. DeLuca,William S. Sparks,Denis R. DeLuca,Robert A. Ronzio. Владелец: Biotics Research Corporation. Дата публикации: 1999-12-23.

Oregano for the treatment of internal parasites and protozoa

Номер патента: EP1089745A1. Автор: Daryl L. DeLuca,William S. Sparks,Denis R. DeLuca,Robert A. Ronzio. Владелец: Biotics Research Corp. Дата публикации: 2001-04-11.

New use of ethoxylated phytosterols and phytostanols

Номер патента: EP1448167A1. Автор: Erik Soderlind. Владелец: AstraZeneca AB. Дата публикации: 2004-08-25.

Use of dehydroeburicoic acid from antrodia camphorata in the treatment or prevention of diabetes and hyperlipidemia

Номер патента: US20170216384A1. Автор: Yueh-Hsiung Kuo,Chun-Ching Shih,Cheng-Hsiu Lin. Владелец: Individual. Дата публикации: 2017-08-03.

Compositions that modulate the activity of estrogen receptors and estrogen-related receptors and methods for use

Номер патента: US20060241094A1. Автор: Shiuan Chen. Владелец: Individual. Дата публикации: 2006-10-26.

Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof for preparing a medical composition for the treatment of parkinson's disease

Номер патента: IL181283A. Автор: . Владелец: Boehringer Ingelheim Int. Дата публикации: 2013-12-31.

Mixed orl1/mu-agonists for the treatment of pain

Номер патента: CA2664702C. Автор: Thomas Christoph,Elmar Friderichs,Klaus Linz,Jean De Vry,Babette-Yvonne Koegel,Wolfgang Schroeder. Владелец: GRUENENTHAL GmbH. Дата публикации: 2016-08-09.

Ornithine aminotransferase inhibition with gaba analogues for treatment of hepatocellular carcinoma

Номер патента: CA2966642C. Автор: Yaron Ilan,Richard B. Silverman. Владелец: Hadasit Medical Research Services and Development Co. Дата публикации: 2023-03-28.

THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF HYPERCHOLESTEREMIA CAUSED BY ANTIRETROVIRAL TREATMENT IN HIV-INFECTED PATIENTS

Номер патента: RU2007123368A. Автор: Жан ГАРДЕТТ,Жан ГАРДЕТТ (FR). Владелец: Пьер Фабр Медикаман (Fr). Дата публикации: 2009-01-10.

AUTISM SCREENING TEST, PATIENT SELECTION METHOD FOR TESTING AND USE OF BKCA CHANNEL ACTIVATING MEDICINES FOR THE TREATMENT OF SAID DISEASE

Номер патента: FR2857452B1. Автор: Sebastien Roger,Sylvain Briault,Frederic Laumonnier,Guennec Jean Yves Le. Владелец: UNIVERSITE FRANCOIS RABELAIS DE TOURS. Дата публикации: 2005-09-30.

USE OF BETA-CAROTIN AND LYCOPINE FOR THE TREATMENT OF SKIN AGING BY INHIBITING THE IMPACT OF THE METAL OPROTEINASE OF TYPE 1 OF THE EXTRACELLULAR MATRIX

Номер патента: DE60135364D1. Автор: Lionel Breton,Markus Baur. Владелец: LOreal SA. Дата публикации: 2008-09-25.

Prostate specific membrane antigen (psma) ligands and uses thereof

Номер патента: AU2024200850A1. Автор: Sangeeta Ray,Martin Gilbert Pomper,Lorenza Fugazza,Daniela Chicco,Maurizio F. MARIANI. Владелец: Advanced Accelerator Applications Italy SRL. Дата публикации: 2024-02-29.

Aspacytarabine pharmaceutical compositions and uses thereof

Номер патента: WO2021156869A1. Автор: Margarita Shumilov,Shoshi Tessler. Владелец: Biosight Ltd.. Дата публикации: 2021-08-12.

Aspacytarabine pharmaceutical compositions and uses thereof

Номер патента: CA3170114A1. Автор: Margarita Shumilov,Shoshi Tessler. Владелец: Biosight Ltd. Дата публикации: 2021-08-12.

Use of a metal ion chelating agent for the treatment of animal and human parasites

Номер патента: EP1879576A1. Автор: Russell Taylor. Владелец: AQand PLC. Дата публикации: 2008-01-23.

Use of a metal ion chelating agent for the treatment of animal and human parasites

Номер патента: CA2606908A1. Автор: Russell Taylor. Владелец: Aq+Plc. Дата публикации: 2006-10-19.

Sarm1 enzyme activity inhibitor and use thereof in neurodegenerative diseases

Номер патента: US20230414581A1. Автор: Deqiang Niu,Zhendong Zhu,Yongjuan ZHAO,Wanhua Li. Владелец: Artivila Biopharma. Дата публикации: 2023-12-28.

Aspacytarabine pharmaceutical compositions and uses thereof

Номер патента: EP4100020A1. Автор: Margarita Shumilov,Shoshi Tessler. Владелец: Biosight Ltd. Дата публикации: 2022-12-14.

Use of N-(indolecarbonyl)piperazine derivatives for treating obesity

Номер патента: NZ533667A. Автор: Amsterdam Christoph Van,Gerd Bartoszyk,Ewen Sedman,Jürgen Hellmann,Landenberg Friedrich Von. Владелец: Merck Patent GmBH. Дата публикации: 2006-11-30.

Methods for the treatment or prophylaxis of endometriosis

Номер патента: WO2024047229A1. Автор: Gunilla EKSTRÖM,Patric Stenberg,Göran Tornling,Charlotte EDENIUS,Eva BJÖRKSTRAND. Владелец: Gesynta Pharma AB. Дата публикации: 2024-03-07.

Use of 3,11 b-cis - dihydrotetrabenazine in the treatment of multiple sclerosis and autoimmune myelitis

Номер патента: IL204990A0. Автор: . Владелец: Biovail Lab Int Srl. Дата публикации: 2010-11-30.

Obizidine Fumarate Enteric-coated Pellets, and preparation and use thereof

Номер патента: US20240342102A1. Автор: Liren Cheng. Владелец: Shenzhen Zhenxing Medical Technology Co ltd. Дата публикации: 2024-10-17.

THE USE OF A H3R INVERSE AGONIST FOR THE TREATMENT OF SHIFT WORK DISORDER

Номер патента: US20200121679A1. Автор: Johns Donald,KUCHER Klaus,SOVAGO Judit. Владелец: . Дата публикации: 2020-04-23.

Preparation and Use of Ketamine Derivatives and Ketamine Modifiers in the Treatment of Pain

Номер патента: US20170348252A1. Автор: Kent Robert. Владелец: . Дата публикации: 2017-12-07.

Compositions and Uses Containing Acidic Extracts of Mastic Gum for the Treatment of Optic Neuropathies

Номер патента: JP7074352B2. Автор: ハザン，ザディク,アダムスキー，コンスタンティン,シー．ビー． ルカセン，アンドレ. Владелец: レジネラ ファーマ リミテッド. Дата публикации: 2022-05-24.

Use of neuronal calcium channel blockers for the manufacture of a medicament for the treatment of psychoses, schizophrenia and cocaine or amphetamine addiction

Номер патента: WO1997004797A1. Автор: Thomas Gary Heffner,Michael Francis Rafferty,James Nicholson Wiley. Владелец: Warner-Lambert Company. Дата публикации: 1997-02-13.

Use of NK-1 receptor antagonists for the manufacture of a medicament for intravenous formulation for the treatment and / or prevention of brain, spinal cord or nerve damage

Номер патента: NO20040057L. Автор: Robert Vink,Alan John Nimmo,Torsten Hoffmann,Andrew Sleight,Pierre Vankan. Владелец: Hoffmann La Roche. Дата публикации: 2004-01-07.

Methods and systems for use of photolyzable nitric oxide donors

Номер патента: US8980332B2. Автор: Roderick A. Hyde,Muriel Y. Ishikawa,Lowell L. Wood, JR.. Владелец: Invention Science Fund I LLC. Дата публикации: 2015-03-17.

Use of paclitaxel and its derivatives for the manufacture of a medicament for the treatment of restenosis

Номер патента: DE69434598T3. Автор: James L. Kinsella,Steven J. Sollot. Владелец: US Department of Health and Human Services. Дата публикации: 2010-07-29.

Use of Efaroxan and its derivatives for the preparation of a medicament intended for the treatment of Parkinson's disease.

Номер патента: FR2706303A1. Автор: Imbert Thierry,Colpaert Francis,Briley Michael. Владелец: Pierre Fabre Medicament SA. Дата публикации: 1994-12-23.

Use of Efaroxan and its derivatives for the preparation of a medicament intended for the treatment of Parkinson's disease.

Номер патента: FR2706303B1. Автор: Imbert Thierry,Colpaert Francis,Briley Michael. Владелец: Pierre Fabre Medicament SA. Дата публикации: 1995-09-08.

Use of efaroxan and its derivatives for the manufacture of medicaments intended for the treatment of neurodegenerative diseases and their progression.

Номер патента: FR2707166B1. Автор: Imbert Thierry,Colpaert Francis,Briley Michael. Владелец: Pierre Fabre Medicament SA. Дата публикации: 1995-09-29.

COSMETIC USES OF A JASMONIC ACID DERIVATIVE FOR THE NATURAL ANTIOXIDANT PROTECTION OF THE SKIN, FOR THE TREATMENT OF HAIR AND SCALP

Номер патента: FR2947449A1. Автор: Maria Dalko,Christophe Boulle. Владелец: LOreal SA. Дата публикации: 2011-01-07.

USE OF KYNURENINE-3-HYDROXYLASE INHIBITORS FOR THE TREATMENT OF DIABETES BY INCREASING THE NUMBER OF CELLS OF THE LANGERHANS ISLANDS

Номер патента: FR2849598A1. Автор: Gérard Moinet,Micheline Kergoat,Dominique Marais,Valerie Autier,Catherine Kargar,De Vacqueur Annick Arbellot. Владелец: Merck Sante SAS. Дата публикации: 2004-07-09.

Use of idazoxan and its derivatives for the preparation of a medicament intended for the treatment of Parkinson's disease and its evolution.

Номер патента: FR2698789B1. Автор: Thierry Imbert,Francis Colpaert,Mike Briley. Владелец: Pierre Fabre Medicament SA. Дата публикации: 1995-03-03.

USE OF GUANABENZ AND ITS DERIVATIVES FOR THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT OF MUCOVISCIDOSIS AND DISEASES ASSOCIATED WITH A DEFECT OF ADDRESSING PROTEINS IN CELLS

Номер патента: FR2893844B1. Автор: Frederic Becq,Marc Blondel,Deborah Tribouillard. Владелец: Universite De Poitiers. Дата публикации: 2008-02-01.

USE OF AN ILEX AQUIFOLIUM EXTRACT FOR THE TREATMENT OF PIGMENTATION DISORDERS AND FOR BLEACHING OF THE SKIN

Номер патента: FR3078891B1. Автор: Jose Luis,Didier Gigmes,Kamel Mabrouk,Laila Mkimer,Abd Haq Bengeloune,Marion Verdoni. Владелец: Laboratoire Inoya. Дата публикации: 2020-12-25.

USE OF 1,2-DIAZADIBENZOES, HAZAZULES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF DISEASES AND DISORDERS OF THE CENTRAL NERVOUS SYSTEM

Номер патента: DE602004019133D1. Автор: Mladen Mercep,Milan Mesic,Dijana Pesic. Владелец: GlaxoSmithKline Istrazivacki Centar Zagreb doo. Дата публикации: 2009-03-05.

Use of eipriprodil and its enantiomers for the preparation of medicaments useful in the treatment of peripheral neuropathies and central neurodegenerative diseases.

Номер патента: FR2717080B1. Автор: Serge Braun,Badia Ferzaz,Philippe Poindron. Владелец: Synthelabo SA. Дата публикации: 1996-12-13.

COSMETIC USES OF A JASMONIC ACID DERIVATIVE FOR THE NATURAL ANTIOXIDANT PROTECTION OF THE SKIN, FOR THE TREATMENT OF HAIR AND SCALP

Номер патента: FR2947449B1. Автор: Maria Dalko,Christophe Boulle. Владелец: LOreal SA. Дата публикации: 2011-10-21.

Use of the telomerase inhibitor imetelstat for the treatment of myelodysplastic syndrome

Номер патента: PL3456333T3. Автор: Stephen Kelsey,Monic J. Stuart. Владелец: Geron Corporation. Дата публикации: 2020-09-21.

Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma

Номер патента: CA2241559A1. Автор: Michael Shalmi,Birgitte Hjort Guldhammer,Niels Dyhr Christensen,Niels Korsgaard. Владелец: Individual. Дата публикации: 1997-07-17.

Use of orally-available prostacyclin derivatives for the production of a medicament for the treatment of disease states associated with bone marrow oedema

Номер патента: CA2488861A1. Автор: Cornelia Norden,Nicolas Aigner. Владелец: Individual. Дата публикации: 2003-12-18.

Use of 3, 4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms

Номер патента: IL124882A0. Автор: . Владелец: Novo Nordisk AS. Дата публикации: 1999-01-26.

USE OF AN ANTI-ATEROTROMBOTIC COMPOUND FOR THE OBTAINING OF MEDICINES FOR THE TREATMENT OF VASCULAR DISORDERS

Номер патента: UY30263A1. Автор: Tony Verbeuren,Alain Rupin,Gilbert Lavielle,Laurence Lerond,Agnes De Cordoue,Marie-Dominique Fratacci. Владелец: Servier Lab. Дата публикации: 2007-05-31.

Use of pyridin-2-ylmethylamine derivatives for the production of a medicament for the treatment of chronic pain symptoms of neuropathological or psychogenic origin

Номер патента: CN1761467B. Автор: F·科尔帕特,B·瓦谢. Владелец: Pierre Fabre Medicament SA. Дата публикации: 2011-09-21.

1,3-oxathiolanes useful in the treatment of hepatitis

Номер патента: CA2068943C. Автор: Nghe Nguyen-Ba,Bernard Belleau (Deceased). Владелец: Biochem Pharma Inc. Дата публикации: 2000-11-28.

Use of aminoguanidine or aminoguanidine analogs for the treatment of diseases of the nervous system

Номер патента: US20030018082A1. Автор: Rima Kaddurah-Daouk. Владелец: Rima Kaddurah-Daouk. Дата публикации: 2003-01-23.

Use of the telomerase inhibitor imetelstat for the treatment of myelofibrosis

Номер патента: ES2744790T3. Автор: Stephen Kelsey,Monic Stuart. Владелец: Geron Corp. Дата публикации: 2020-02-26.

The use of mmp-13 selective inhibitors for the treatment of osteoarthritis and other mmp-mediated disorders

Номер патента: CA2251197A1. Автор: Lawrence Alan Reiter,Kim Francis Mcclure,Ralph Pelton Robinson,Lori Lynn Lopresti-Morrow,Peter Geoffrey Mitchell,Lisa Marie Reeves,Sue Ann Yocum. Владелец: Pfizer Products Inc. Дата публикации: 1999-04-24.

Use of 3-oxa-d-prostaglandins for the manufacture of a medicament for the treatment of glaucoma

Номер патента: AU7726796A. Автор: Verney L. Sallee,Thomas R. Dean,Mark Hellberg. Владелец: Alcon Laboratories Inc. Дата публикации: 1997-07-17.

THE USE OF BRADYKININ-B2 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF OSTEOARTHROSIS

Номер патента: DE502004001159D1. Автор: Martin Michaelis,Karl Rudolphi. Владелец: Sanofi Aventis Deutschland GmbH. Дата публикации: 2006-09-21.

Use of an anti-atherothrombotic compound for the manufacture of drugs for the treatment of cerebrovascular disorders

Номер патента: DK1842537T3. Автор: Tony Verbeuren,Alain Rupin,Gilbert Lavielle,Cordoue Agnes De,Laurence Lerond,Marie-Dominique Fratacci. Владелец: Servier Lab. Дата публикации: 2010-04-12.

USE OF KYNURENINE-3-HYDROXYLASE INHIBITORS FOR THE TREATMENT OF DIABETES BY INCREASING THE NUMBER OF CELLS OF THE LANGERHANS ISLANDS

Номер патента: FR2849598B1. Автор: Gérard Moinet,Micheline Kergoat,Dominique Marais,Valerie Autier,Catherine Kargar,De Vacqueur Annick Arbellot. Владелец: Merck Sante SAS. Дата публикации: 2006-09-22.

Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease

Номер патента: CA2264097A1. Автор: Panayotis Nikolas Gerolymatos. Владелец: PN Gerolymatos SA. Дата публикации: 1998-02-19.

Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment ofdelayed graft function

Номер патента: HK1060855A1. Автор: Volker Brinkmann,Marc Bigaud,Tomasz Sablinski. Владелец: NOVARTIS AG. Дата публикации: 2004-08-27.

Use of creatine or creatine analogs for the treatment of diseases of the nervous system

Номер патента: CA2235350A1. Автор: Rima Kaddurah-Daouk,Ghaleb Daouk,M. Flint Beal. Владелец: Library Pharma, Inc.. Дата публикации: 1996-05-17.

Use of ifenprodil and diastereoisomers thereof for the preparation of medicines useful in the treatment of pheripheral neuropathies and central neurodegenerative diseases

Номер патента: CA2154906A1. Автор: Badia Ferzaz,Jesus Benavides,Pascal George,Bernard Scatton. Владелец: Synthelabo SA. Дата публикации: 1996-01-30.

The use of MMP-13 selective inhibitors for the treatment of osteoarthristis and other MMP-mediated disorders

Номер патента: AU758147B2. Автор: Lawrence Alan Reiter,Kim Francis Mcclure,Ralph Pelton Robinson,Lori Lynn Lopresti-Morrow,Peter Geoffrey Mitchell,Lisa Marie Reeves,Sue Ann Yocum. Владелец: Pfizer Products Inc. Дата публикации: 2003-03-13.

Use of trovafloxacin or derivatives thereof for the manufacture of a medicament for the treatment of H. pylori infections

Номер патента: EP0676199A1. Автор: Arthur E. Girard,Thomas D. Gootz. Владелец: PFIZER INC. Дата публикации: 1995-10-11.

Use of eipriprodil and its enantiomers for the preparation of medicaments useful in the treatment of peripheral neuropathies and central neurodegenerative diseases.

Номер патента: FR2717080A1. Автор: Ferzaz Badia,Poindron Philippe,Braun Serge. Владелец: Synthelabo SA. Дата публикации: 1995-09-15.

Use of the telomerase inhibitor imetelstat for the treatment of myelodysplastic syndrome

Номер патента: ES2789176T3. Автор: Stephen Kelsey,Monic Stuart. Владелец: Geron Corp. Дата публикации: 2020-10-26.

Use of an anti-atherothrombotic compound for the production of medicaments for use in the treatment of vascular disorders.

Номер патента: MX2007004108A. Автор: Tony Verbeuren,Gilbert Lavielle,Laurence Lerond,Agnes De Cordoue,Marie-Dominique Fratacci. Владелец: Servier Lab. Дата публикации: 2009-02-16.

USE OF IFENPRODIL AND ITS ENANTIOMERS FOR THE PREPARATION OF MEDICINES USEFUL IN THE TREATMENT OF PERIPHERAL NEUROPATHIES AND CENTRAL NEURODEGENERATIVE DISEASES

Номер патента: FR2722989A1. Автор: Badia Ferzaz,Jesus Benavides,Pascal George,Bernard Scatton. Владелец: Synthelabo SA. Дата публикации: 1996-02-02.

USE OF BRADIQUININE ANTAGONISTS NOT PREPARED FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT AND PREVENTION OF CHRONIC DISEASES OF FIBROGENETIC SYMPTOMS OF ACUTE FIGURE DISEASES AND RELATED COMPLICATIONS

Номер патента: PT808628E. Автор: Holger Heitsch,Adalbert Wagner,Martin Bickel,Klaus Wirth,Max Hropot. Владелец: Hoechst AG. Дата публикации: 2000-05-31.

Use of a natural polysaccharide gel for the preparation of an injectable formulation for the treatment of joint degeneration

Номер патента: CA2691600C. Автор: Samuel Gavard Molliard,Olivier Benoit. Владелец: APTISSEN SA. Дата публикации: 2017-01-10.

Use of a phosphoric acid diester for the manufacture of a medicament for the treatment of acne

Номер патента: EP0821962B1. Автор: Kazumi Ogata,Takahiro Sakaue,Sachiko Matsuura,Masahito Iemura. Владелец: Senju Pharmaceutical Co Ltd. Дата публикации: 2001-10-17.

Use of idazoxan and its derivatives for the preparation of a medicament for the treatment of Parkinson's disease and its evolution.

Номер патента: FR2698789A1. Автор: Imbert Thierry,Colpaert Francis,Briley Mike. Владелец: Pierre Fabre Medicament SA. Дата публикации: 1994-06-10.

Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of benign prostatic hypertrophy

Номер патента: CA2241519A1. Автор: Michael Shalmi,Birgitte Hjort Guldhammer,Niels Dyhr Christensen,Niels Korsgaard. Владелец: Individual. Дата публикации: 1997-07-17.

The use of estrogen receptor alpha modulators for the treatment of multiple sclerosis

Номер патента: CA2512021A1. Автор: Steven J. Adelman,Robert Mitchell,M. Merle Elloso,Douglas C. Harnish. Владелец: Douglas C. Harnish. Дата публикации: 2004-07-29.

Use of pyrrolicloncarboxylic acid alkyl esters for the manufacture of a medicament for the treatment of ichthyosis.

Номер патента: DE68912195D1. Автор: Ian Richard Scott. Владелец: Unilever NV. Дата публикации: 1994-02-24.

Use of the hdac inhibitor panobinostat for the treatment of myeloma

Номер патента: EP1912640B1. Автор: Peter W. Atadja. Владелец: NOVARTIS AG. Дата публикации: 2015-06-17.

The use of selective noradrenaline reuptake inhibitors for the treatment of tension-type headache

Номер патента: AU2002213830A1. Автор: Jes Olesen,Lars Bendtsen,Rigmor Jensen. Владелец: Head Explorer ApS. Дата публикации: 2002-05-15.

Use of the telomerase inhibitor imetelstat for the treatment of myelofibrosis

Номер патента: RS59363B1. Автор: Stephen Kelsey,Monic J Stuart. Владелец: Geron Corp. Дата публикации: 2019-11-29.

"USES OF AT LEAST ONE COMPOUND FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DERMATOLOGICAL AFFECTIONS"

Номер патента: BRPI0719467A2. Автор: Irina Safonova,Cecile Cousin,Leila Zarif. Владелец: Galderma Res & Dev. Дата публикации: 2014-10-29.

Use of the telomerase inhibitor imetelstat for the treatment of myelodysplastic syndrome

Номер патента: HRP20200993T1. Автор: Stephen Kelsey,Monic J. Stuart. Владелец: Geron Corporation. Дата публикации: 2020-11-27.

Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of idiopathic or physiologic gynaecomastia

Номер патента: HU9800133A2. Автор: Michael Shalmi,Birgitte Hjort Guldhammer,Niels Korsgaard. Владелец: Novo Nordisk A/S. Дата публикации: 1998-12-28.

Use of pharmaceutical compositions and compounds for the preparation of a medicament for the treatment of diseases

Номер патента: CN116270589A. Автор: 堵银道. Владелец: Beijing Aomi Jiade Pharmaceutical Technology Co ltd. Дата публикации: 2023-06-23.

USE OF AN ANTI-ATEROTROMBOTIC COMPOUND FOR THE OBTAINING OF MEDICINES FOR THE TREATMENT OF VASCULAR DISORDERS

Номер патента: CO5820217A1. Автор: Tony Verbeuren,Alain Rupin,Gilbert Lavielle,Laurence Lerond,Agnes De Cordoue,Marie-Dominique Fratacci. Владелец: Servier Lab. Дата публикации: 2007-11-30.

Cosmetic composition comprising a branched sulphonic polyester and a surfactant and uses in hair styling

Номер патента: US20100158848A1. Автор: Cecile Bebot,Dorothée Pasquet. Владелец: LOreal SA. Дата публикации: 2010-06-24.

USES OF GROWTH HORMONE IN COMPOSITIONS FOR THE TREATMENT OF INSULIN RESISTANCE IN THE HEART

Номер патента: PT1007085E. Автор: Harriet Ronnholm,Stephen James,Thomas Olin,Christina Reuterdahl,Axel STÅHLBOM,Antek Wielburski. Владелец: Pharmacia AB. Дата публикации: 2002-05-31.

The use of carotenoids for producing drugs for the treatment of dermatoses

Номер патента: CA2210957A1. Автор: Karl Kolter,Wolfgang Schmutzler. Владелец: Individual. Дата публикации: 1996-08-08.

The use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic depressive, bipolar disorders

Номер патента: NO317641B1. Автор: Richard P Shank. Владелец: Ortho Mcneil Pharm Inc. Дата публикации: 2004-11-29.

THE USE OF INHALED HENLE HANDLE DIURETICS FOR THE TREATMENT OF ALLERGEN-INDUCED NASAL REACTIONS.

Номер патента: ES2052998T3. Автор: Sebastiano Bianco. Владелец: Hoechst AG. Дата публикации: 1994-07-16.

Use of 3,1IB-Cis-Dihydrotetrabenazine for the Treatment of Symptoms of Huntingtons Disease

Номер патента: US20080319000A1. Автор: Robert Tridgett,Thierry Filloux. Владелец: Cambridge Laboratories Ireland Ltd. Дата публикации: 2008-12-25.

Use of orally-available prostacyclin derivatives for the production of a medicament for the treatment of disease states associated with bone marrow edema

Номер патента: ZA200500097B. Автор: Cornelia Norden,Nicolas Aigner. Владелец: Schering AG. Дата публикации: 2006-06-28.

USE OF BIOACTIVE METABOLITES OF GEPIRONA FOR THE MANUFACTURE OF A DRUG FOR THE TREATMENT OF PSYCHOLOGICAL DISORDERS

Номер патента: PT1242061E. Автор: Joseph P Yevich,Stephen J Kramer,Louis F Fabre. Владелец: Fabre Kramer Pharmaceuticals I. Дата публикации: 2005-09-30.

The combined use of cruciferous indoles and chelators for the treatment of papillomavirus-related conditions

Номер патента: CA2515424A1. Автор: Michael A. Zeligs. Владелец: Individual. Дата публикации: 2004-08-26.

USE OF EFAROXAN AND ITS DERIVATIVES FOR THE MANUFACTURE OF MEDICINES INTENDED FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

Номер патента: PT707477E. Автор: Thierry Imbert,Francis Colpaert,Michael Briley. Владелец: Pf Medicament. Дата публикации: 2000-04-28.

Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of idiopathic or physiologic gynaecomastia

Номер патента: CA2208868A1. Автор: Michael Shalmi,Birgitte Hjort Guldhammer,Niels Korsgaard. Владелец: Individual. Дата публикации: 1996-07-18.

Use of compositions containing isoindolinone derivatives for the preparation of a medicament for the treatment of phosphodiesterase mediated diseases

Номер патента: CN111514135A. Автор: 向飞,周小刚. Владелец: Individual. Дата публикации: 2020-08-11.

Use of 1,3-oxathiolannucleoside analogues for the preparation of a preparation for the treatment of hepatitis B

Номер патента: DK0565549T3. Автор: Nghe Nguyen-Ba,Bernard Belleau. Владелец: Iaf Biochem Int. Дата публикации: 1995-07-03.

USE OF A DNA OR RNA FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF TUMOR CELLS.

Номер патента: ES2301602T3. Автор: Gary J. Nabel,Elizabeth G. Nabel. Владелец: University of Michigan. Дата публикации: 2008-07-01.

Polymerization initiator system containing an alpha-diketone and a specific coinitiator compound and use of said polymerization initiator system in dental compositions

Номер патента: CA2939206C. Автор: Joachim Klee,Jacques LALEVÉE,Fabrice Morlet-Savary,Maximilian Maier,Jean Pierre Fouassier. Владелец: DENTSPLY DETREY GMBH. Дата публикации: 2021-06-29.

Use of 2-imidazolyl-substituted carbinols for the manufacture of a medicament for the treatment or prophylaxis of diseases caused by ischemic conditions

Номер патента: NO20021909L. Автор: Andreas Weichert,Udo Albus,Hans-Willi Jansen. Владелец: Aventis Pharma Gmbh. Дата публикации: 2002-04-23.

Use of at least one fucane for the manufacture of a medicament for the treatment of periodontal pathologies

Номер патента: EP1039916B8. Автор: Patrick Durand,Jacqueline Jozefonvicz,Corinne Sinquin,Karim Senni,Didier Letourneur,Bruno Gogly,Sylvia Colliec-Jouault,Bernard Pellat,Catherine Blondin. Владелец: Institut Francais de Recherche pour lExploitation de la Mer (IFREMER). Дата публикации: 2004-04-21.

USE OF A SERENOA REPENS EXTRACT FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF PROSTATE CANCER

Номер патента: FR2791573B1. Автор: Henri Cousse,Pierre Fabre,Jean Pierre Raynaud. Владелец: Pierre Fabre Medicament SA. Дата публикации: 2003-04-11.

Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease

Номер патента: EP0959888A1. Автор: Panayotis Nikolas Gerolymatos. Владелец: PN Gerolymatos SA. Дата публикации: 1999-12-01.

Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic-depressive bipolar disorders

Номер патента: EP0932398A1. Автор: Richard P. Shank. Владелец: Ortho Pharmaceutical Corp. Дата публикации: 1999-08-04.

USE OF EFAROXAN AND ITS DERIVATIVES FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF PARKINSON'S DISEASE

Номер патента: ATE192650T1. Автор: Thierry Imbert,Francis Colpaert,Michael Briley. Владелец: Pf Medicament. Дата публикации: 2000-05-15.

USE OF SUBSTITUTED CYCLOPROPANE ACID DERIVATIVES FOR THE PRODUCTION OF MEDICAMENTS FOR USE IN THE TREATMENT OF METABOLIC SYNDROME

Номер патента: MA29131B1. Автор: Hubert Heuer,Siegfried Stengelin,Dieter Kadereit,Harm Brummerhop. Владелец: Sanofi Aventis Deutschland. Дата публикации: 2008-01-02.

Use of rapamycin to prepare medicaments for the treatment of adult t-cell leukemia/lymphoma

Номер патента: NZ243175A. Автор: Glenn Alvin Miller,Mark Barry Rabin,William Joseph Harrington. Владелец: American Home Prod. Дата публикации: 1997-06-24.

The use of a h3r inverse agonist for the treatment of shift work disorder

Номер патента: CA3059131A1. Автор: Donald Johns,Judit SOVAGO,Klaus KUCHER. Владелец: NOVARTIS AG. Дата публикации: 2018-10-25.

Method and device for organizing and coordinating the combined use of topical aerosols and oral medications for the treatment of disorders

Номер патента: US5830490A. Автор: Robert E. Weinstein,Alan M. Weinstein. Владелец: Weinstein; Alan M.. Дата публикации: 1998-11-03.

Use of a catamenial tampon which comprises a non-ionic surfactant for the treatment of vaginal malodour

Номер патента: GB2414394A. Автор: Keith Edgett,Rosemary F Knuth. Владелец: PLAYTEX PRODUCTS LLC. Дата публикации: 2005-11-30.

Use of an optimal control algorithm for the design of mri refocusing pulses with phase-free rotation axis

Номер патента: WO2015158814A1. Автор: Nicolas Boulant,Aurélien Massire. Владелец: Commissariat à l'énergie atomique et aux énergies alternatives. Дата публикации: 2015-10-22.

Use of a fluid drug formulation for the treatment of an ocular disorder

Номер патента: CA2797258C. Автор: Mark R. Prausnitz,Henry F. Edelhauser,Samirkumar Rajnikant Patel. Владелец: Georgia Tech Research Corp. Дата публикации: 2018-03-20.

Module of use of leading heat conductor fluid for the power supplying of combined utilities

Номер патента: EP1949003A1. Автор: Dino D'angelosante,Fabrizio Mincone,Cesare Scenna. Владелец: Individual. Дата публикации: 2008-07-30.

Module of use of leading heat conductor fluid for the power supplying of combined utilities

Номер патента: WO2007054999A1. Автор: Dino D'angelosante,Fabrizio Mincone,Cesare Scenna. Владелец: D Angelosante Dino. Дата публикации: 2007-05-18.

Method, system and use of the method or system for the application of lacquer

Номер патента: CA2327473C. Автор: Uffe Norskov Laursen. Владелец: Ulmadan AS. Дата публикации: 2008-10-28.

Investment compound for moulding technics in dental technology, use of investment compound and method for the production thereof

Номер патента: AU4009297A. Автор: Helmut Hero. Владелец: Individual. Дата публикации: 1998-03-26.

Use of radiation cross-linked polyethylene for the production of cartridges

Номер патента: CA1207185A. Автор: Axel Homburg,Hans Umbach,Kurt Ballreich,Horst Rammensee. Владелец: Dynamit Nobel AG. Дата публикации: 1986-07-08.

Charge detector semiconductor component, system comprising a charge detector semiconductor component and a reference semiconductor component, wafer, use of a wafer, and method for the qualitative and quantitative measurement of charging of a wafer

Номер патента: US6747303B2. Автор: Hans-Ulrich Schroeder. Владелец: KONINKLIJKE PHILIPS ELECTRONICS NV. Дата публикации: 2004-06-08.

Method of producing catalyst and use thereof

Номер патента: RU2739759C2. Автор: Каушик БАСАК,Ариан ВАН МАУРИК,Нишитх ВЕРМА. Владелец: Шелл Интернэшнл Рисерч Маатсхаппий Б.В.. Дата публикации: 2020-12-28.

Genetically engineered vibrio sp. and uses thereof

Номер патента: US20200010816A1. Автор: Christopher M. Wilson,Matthew T Weinstock,Eric D. Hesek. Владелец: SGI DNA Inc. Дата публикации: 2020-01-09.

Differentiated immortalised cell lines capable of producing albumin and blood coagulation factors, methods of preparing thereof from a leukaemia cell line and uses thereof

Номер патента: WO2008081388A8. Автор: Luisa Gennero,Antonio Ponzetto,Gianfranco Merizzi,Andrea Savarino,Giampiero Pescarmona. Владелец: Medestea Biotech S R L. Дата публикации: 2008-09-25.

Binder composition on an oligoester basis, production thereof, and use thereof for binding organic or mineral fibres

Номер патента: US12071569B2. Автор: Edouard Obert,Pierre Salomon. Владелец: Saint Gobain Isover SA France. Дата публикации: 2024-08-27.

Binder composition on an oligoester basis, production thereof, and use thereof for binding organic or mineral fibres

Номер патента: US20240287361A1. Автор: Edouard Obert,Pierre Salomon. Владелец: Saint Gobain Isover SA France. Дата публикации: 2024-08-29.

Surface treatment of particles and their application

Номер патента: RU2664876C1. Автор: Фрауке ХЕННИНГ,Катрин ЛЕМАН,Кристиан МУНД,Ангела НАВРАКАЛА. Владелец: Эвоник Дегусса Гмбх. Дата публикации: 2018-08-23.

Use of glass-resin composite fibres for the reinforcement of concrete

Номер патента: AU2021403916A9. Автор: Kevin Roos,Pierre PLOUZENNEC,Raphael Martinez. Владелец: Compagnie Generale des Etablissements Michelin SCA. Дата публикации: 2024-04-18.

Use of glass-resin composite fibres for the reinforcement of concrete

Номер патента: AU2021403916A1. Автор: Kevin Roos,Pierre PLOUZENNEC,Raphael Martinez. Владелец: Compagnie Generale des Etablissements Michelin SCA. Дата публикации: 2023-06-22.

Process for the hydrolysis of biomass

Номер патента: US09988658B2. Автор: Michael Zavrel,Markus Jakob,Marcus VERHUELSDONK,Danielle DENNEWALD,Sandra Schuetze. Владелец: CLARIANT INTERNATIONAL LTD. Дата публикации: 2018-06-05.

Paints and use of these paints as topcoats for the finishing of automobile bodies

Номер патента: US5430083A. Автор: Peter Betz,Konrad Klier. Владелец: BASF Lacke und Farben AG. Дата публикации: 1995-07-04.

Method and device for producing a hydrogen or synthesis gas and use thereof

Номер патента: AU7520400A. Автор: Thomas Weimer,Michael Specht,Frank Baumgart,Andreas Bandi. Владелец: ZENTRUM fur SONNENENERGIE und. Дата публикации: 2001-04-30.

Fibrous composite materials and the production and use thereof

Номер патента: CA1162357A. Автор: Peter J. Briggs,Kevin Mcaloon,Graham R. Rideal. Владелец: Imperial Chemical Industries Ltd. Дата публикации: 1984-02-21.

Methods for the production of committed cardiac progenitor cells

Номер патента: US20230078230A1. Автор: Steven Kattman,Chad KOONCE,Meghan BOYER,Kristin STACK,Ellen HEBRON. Владелец: Fujifilm Cellular Dynamics Inc. Дата публикации: 2023-03-16.

Methods for the production of committed cardiac progenitor cells

Номер патента: AU2022343749A1. Автор: Steven Kattman,Chad KOONCE,Meghan BOYER,Ellen HEBRON,Kristen STACK. Владелец: Fujifilm Holdings America Corp. Дата публикации: 2024-03-28.

Methods for the production of committed cardiac progenitor cells

Номер патента: CA3231501A1. Автор: Steven Kattman,Chad KOONCE,Meghan BOYER,Ellen HEBRON,Kristen STACK. Владелец: Fujifilm Holdings America Corp. Дата публикации: 2023-03-16.

Bacterial unspecific peroxygenases (bupo's) and methods and uses thereof

Номер патента: EP4217474A1. Автор: Nikola Loncar,Lur ALONSO COTCHICO. Владелец: Gecco Biotech BV. Дата публикации: 2023-08-02.

Novel esterase mutants and uses thereof as stereoselective catalyst

Номер патента: WO2024022580A1. Автор: Valerio Borzatta,Carla Marchioro,Roberto Verga,Silvia RAPACIOLI,Silvia Carloni,Leni Moroni,Simone Stasi. Владелец: ENDURA S.P.A.. Дата публикации: 2024-02-01.

Use of polyethylenoxide polymers for the preparation of lipids conjugated with poly(ethylene oxide) having c1 to c3-alkyloxymethyl side chains

Номер патента: EP4372027A1. Автор: Holger Frey,Philip Dreier,Rebecca MATTHES. Владелец: Johannes Gutenberg Universitaet Mainz. Дата публикации: 2024-05-22.

Differentiated immortalised cell lines capable of producing albumin and blood coagulation factors, methods of preparing thereof from a leukaemia cell line and uses thereof

Номер патента: EP2102329A1. Автор: Luisa Gennero,Antonio Ponzetto,Gianfranco Merizzi,Andrea Savarino,Giampiero Pescarmona. Владелец: Medestea Biotech SpA. Дата публикации: 2009-09-23.

Circulating micro-rnas as biomarkers for the diagnosis of celiac disease and for monitoring adherence to a gluten-free diet

Номер патента: WO2021124369A1. Автор: Andrea Masotti,Cristina FELLI. Владелец: Ospedale Pediatrico Bambino Gesu'. Дата публикации: 2021-06-24.

USE OF AN ORGANIC REDUCING AGENT FOR THE TREATMENT OF WATER THROUGH THE ELIMINATION OF CHLORINE, CHLORINE AND OTHER COMPOUNDS OF ACTIVE CHLORINE OF MAINTENANCE WATER FOR AQUATIC ORGANISMS.

Номер патента: ES2340424T3. Автор: Gunter Ritter. Владелец: Tetra Gmbh. Дата публикации: 2010-06-02.

Stain-resistant article and use thereof

Номер патента: CA2812370C. Автор: Heinz Hoff,Mark Pfleghar,Etienne Aepli,Botho Hoffman. Владелец: EMS PATENT AG. Дата публикации: 2015-12-08.

Conductive polymer material, use of same, and method for the production of same

Номер патента: CN103748152A. Автор: H·赖因哈特,K-P·安哈尔特. Владелец: OTTO BOCK HEALTHCARE GMBH. Дата публикации: 2014-04-23.

Food supplement for the treatment of neuropathies

Номер патента: WO2010023065A1. Автор: Carlo Terruzzi. Владелец: Giellepi Chemicals S.P.A.. Дата публикации: 2010-03-04.

1-monoglyceride of c12 fatty acid for the treatment or prevention of infectious plant diseases

Номер патента: WO2024165554A1. Автор: Maria BLASCO BIGATÁ. Владелец: Mbp 4 Life, S.L.. Дата публикации: 2024-08-15.

Method for fixed pattern noise reduction and use of such method

Номер патента: US20180205898A1. Автор: Thomas Winzell,Emanuel Johansson,Jesper Bengtsson. Владелец: AXIS AB. Дата публикации: 2018-07-19.

Common point authoring system for the complex sharing of hierarchically authored data objects in a distribution chain

Номер патента: US20170255602A1. Автор: Marvin L. Stone,Steven L. Holcombe. Владелец: Pardalis Inc. Дата публикации: 2017-09-07.

Common point authoring system for the complex sharing of hierarchically authored data objects in a distribution chain

Номер патента: US20190392030A1. Автор: Marvin L. Stone,Steven L. Holcombe. Владелец: Pardalis Inc. Дата публикации: 2019-12-26.

Use of resonant microcavity display crt for the illumination of a light valve projector

Номер патента: EP1466474A2. Автор: Eugene Murphy O'Donnell,Jr. Estill Thone Hall. Владелец: Thomson Licensing SAS. Дата публикации: 2004-10-13.

Use of resonant microcavity display crt for the illumination of a light valve projector

Номер патента: WO2003061268A3. Автор: Eugene Murphy O'Donnell,Jr Estill Thone Hall. Владелец: Jr Estill Thone Hall. Дата публикации: 2003-10-16.

Use of resonant microcavity display crt for the illumination of a light valve projector

Номер патента: EP1466474A4. Автор: Eugene Murphy O'Donnell,Jr Estill Thone Hall. Владелец: Thomson Licensing SAS. Дата публикации: 2005-09-28.

Use of resonant microcavity display fed for the illumination of a light valve projector

Номер патента: EP1451638A1. Автор: Eugene Murphy O'Donnell,Jr. Estill Thone Hall. Владелец: Thomson Licensing SAS. Дата публикации: 2004-09-01.

Use of resonant microcavity display fed for the illumination of a light valve projector

Номер патента: EP1451638A4. Автор: Eugene Murphy O'Donnell,Jr Estill Thone Hall. Владелец: Thomson Licensing SAS. Дата публикации: 2005-03-02.

System for the management of loading and unloading operations of uav

Номер патента: WO2022190154A1. Автор: Francesco Ricci. Владелец: Francesco Ricci. Дата публикации: 2022-09-15.

Computer-implemented multi-scale machine learning model for the enhancement of compressed video

Номер патента: US20240236345A1. Автор: Christopher Andrew Segall,Kiran Mukesh MISRA,Byeongdoo CHOI. Владелец: Amazon Technologies Inc. Дата публикации: 2024-07-11.

Phytosanitary agent and its particular use in the treatment of plants infected by xylella fastidiosa

Номер патента: EP4057816A1. Автор: Costantino TOMASI. Владелец: Vextachem Srl. Дата публикации: 2022-09-21.

Phytosanitary agent and its particular use in the treatment of plants infected by xylella fastidiosa

Номер патента: US20230000077A1. Автор: Costantino TOMASI. Владелец: Tomasi Costantino. Дата публикации: 2023-01-05.

USE OF ELECTRIC OR HYBRID VEHICLES FOR THE TREATMENT OF AMBIENT AIR IN URBAN AREAS AND CONTROL CENTER FOR THE MANAGEMENT OF SUCH USE

Номер патента: FR3109099A1. Автор: Bruno Pintat,Denis Dumur,Karine Pajot,Gregory Blokkeel. Владелец: PSA Automobiles SA. Дата публикации: 2021-10-15.

USE OF ELECTRIC OR HYBRID VEHICLES FOR THE TREATMENT OF AMBIENT AIR IN URBAN ENVIRONMENTS AND CONTROL CENTER FOR THE MANAGEMENT OF SAID USE

Номер патента: FR3109099B1. Автор: Bruno Pintat,Denis Dumur,Karine Pajot,Gregory Blokkeel. Владелец: PSA Automobiles SA. Дата публикации: 2023-02-24.

Self-flowing treatment of wood, bamboo, and other porous materials

Номер патента: WO2023239833A1. Автор: Xuan Wang,Sheldon Q. Shi. Владелец: University of North Texas. Дата публикации: 2023-12-14.

Dynamic use of a packet recovery mechanism to avoid congestion along a network path

Номер патента: US20230291679A1. Автор: Giovanna Carofiglio,Michele Papalini,Jacques Olivier Samain,Giulio Grassi. Владелец: Cisco Technology Inc. Дата публикации: 2023-09-14.

Method and apparatus for forming and using a bore hole

Номер патента: US4431069A. Автор: Ben W. O. Dickinson, III,Robert W. Dickinson. Владелец: Individual. Дата публикации: 1984-02-14.

USE OF A QUATERNARY POLYAMONY POLYMER FOR THE CONTROL OF THE DEPOSITION OF ANIONIC AND RESIN IMPURITIES AND FOR THE TREATMENT OF STUCKED PAPER MANUFACTURING WASTE.

Номер патента: ES2210821T3. Автор: Jiansheng Tang,Jeffrey R. Cramm,Michael R. St. John,Laura M. Sherman. Владелец: Ondeo Nalco Co. Дата публикации: 2004-07-01.

USE OF ANTI-90K MONOCLONAL ANTIBODIES FOR THE PREVENTION AND TREATMENT OF TUMORS AND METASTASES THEREOF

Номер патента: US20120003157A1. Автор: Iacobelli Stefano. Владелец: . Дата публикации: 2012-01-05.

Use of 2-carboxamide cycloamino urea derivatives in the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family members

Номер патента: AU2015203865A1. Автор: Christine Fritsch,Sauveur-Michel Maira,Christian Rene Schnell,Carlos Garcia-Echeverria,Saskia Maria Brachmann. Владелец: NOVARTIS AG. Дата публикации: 2015-07-30.

Use of monoterpenes, sesquiterpernes and diterpernes for the treatment of cancer

Номер патента: WO1994020080A9. Автор: . Владелец: . Дата публикации: 1994-10-27.

Use of a phosphodiesterase 10 inhibitor for the treatment of tourette syndrome.

Номер патента: OA21483A. Автор: George GARIBALDI. Владелец: Noema Pharma Ag. Дата публикации: 2024-07-31.

Acylated enamide compounds, pharmaceutical compositions containing these, use of these compounds and process for the preparation of these compounds

Номер патента: CA1249999A. Автор: Heinz Viehe,Marcel Roberfroid,Francoise Hervens. Владелец: Biotec AB. Дата публикации: 1989-02-14.

Use of polysaccharide polymers and cations for the preparation of wet wipes

Номер патента: WO2009125405A1. Автор: . Владелец: . Дата публикации: 2009-10-15.

SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) AND USES THEREOF

Номер патента: US20120004220A9. Автор: Zhi Lin. Владелец: . Дата публикации: 2012-01-05.

6-SUBSTITUTED ISOFLAVONOID COMPOUNDS AND USES THEREOF

Номер патента: US20120003270A1. Автор: James Michael,HUSBAND Alan James,KUMAR Naresh. Владелец: . Дата публикации: 2012-01-05.

DIAGNOSIS AND TREATMENT OF CANCER USING ANTI-TM4SF20 ANTIBODY

Номер патента: US20120004117A1. Автор: Aburatani Hiroyuki,Ishikawa Shunpei,Kawai Shigeto. Владелец: . Дата публикации: 2012-01-05.

METHOD FOR THE DIAGNOSIS OF AGE-ASSOCIATED VASCULAR DISORDERS

Номер патента: US20120004133A1. Автор: Lakatta Edward G.,Wang Mingyi,Fu Zongming,Van Eyk Jennifer. Владелец: . Дата публикации: 2012-01-05.

ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODIES AND USES THEREOF

Номер патента: US20120321643A1. Автор: Weaver David,Rynkiewicz Michael,Cao Cheng,Jin Yanwen. Владелец: Guangzhou Recomgen Biotech Co., Ltd.. Дата публикации: 2012-12-20.

ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODIES AND USES THEREOF

Номер патента: US20130022624A1. Автор: Weaver David,Rynkiewicz Michael,Cao Cheng,Jin Yanwen. Владелец: Guangzhou Recomgen Biotech Co., Ltd.. Дата публикации: 2013-01-24.

USE OF HELIUM-OXYGEN GAS MIXTURES FOR TREATING PULMONARY ARTERIAL HYPERTENSION

Номер патента: US20120003325A1. Автор: . Владелец: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT. Дата публикации: 2012-01-05.

USE OF VAGINALLY-ADMINISTERED INSULIN SENSITIZING AGENTS

Номер патента: US20120004271A1. Автор: MOSCOSO DEL PRADO Jaime,Bandi Tosi Beatriz. Владелец: . Дата публикации: 2012-01-05.

Anti-epidermal growth factor monoclonal antibody

Номер патента: JPS6229598A. Автор: Masamitsu Sasaki,Toyoji Hozumi,Kuniki Kato,穂積　豊治,加藤　邦樹,佐々木　真実. Владелец: Wakunaga Pharmaceutical Co Ltd. Дата публикации: 1987-02-07.

Novel use of dpp-4 inhibitor in manufacture of drug for treatment of lupus nephritis

Номер патента: AU2023219870B1. Автор: Weiwei Li,Bin Yu,Chun Yao,Yongjun WANG,Ran Zhu,Zhifeng Gu,Zhanyun DA. Владелец: Affiliated Hospital of Nantong University. Дата публикации: 2024-02-08.

Cationic purpurinimide having antibacterial activity and using same for photodynamic inactivation of bacterial biofilms

Номер патента: RU2565450C1. Автор: Юлия Михайловна Романова,Александр Леонидович Гинцбург,Геннадий Александрович Меерович,Михаил Александрович Грин,Андрей Федорович Миронов,Сергей Сергеевич Брусов,Татьяна Валентиновна Степанова,Ирина Глебовна Тиганова,Юлия Сергеевна Колоскова. Владелец: Федеральное государственное бюджетное учреждение"Научно-исследовательский институт эпидемиологии и микробиологии им. Почетного академика Н.Ф. Гамалеи" Министерства Здравоохранения Российской Федерации( ФГБУ "НИИЭМ им. Н.Ф. Гамалеи" Минздрава России). Дата публикации: 2015-10-20.

Use of selected non-steroidal antiinflammatory compounds for the prevention and the treatment of neurodegenerative diseases

Номер патента: WO1998020864A9. Автор: . Владелец: . Дата публикации: 1998-08-27.

Use of ccn domain-containing proteins for the treatment of disease

Номер патента: GB202400055D0. Автор: . Владелец: Tribune Therapeutics AB. Дата публикации: 2024-02-14.

Use of benzo-heteroaryl sulfamide derivatives for the treatment of depression

Номер патента: TW200808304A. Автор: Virginia L Smith-Swintosky. Владелец: Janssen Pharmaceutica NV. Дата публикации: 2008-02-16.

Use of 1-hydroxy-2-pyridones for the treatment of skin diseases

Номер патента: MXPA99002865A. Автор: Bohn Manfred,Markus Astrid,Theodor Kraemer Karl. Владелец: Hoechst Ag 65929 Frankfurt De. Дата публикации: 1999-09-01.

Combinations for opioid-based treatment of pain comprising 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives

Номер патента: EP1635833A1. Автор: Frans Eduard Janssen Pharmaceutica N.V. JANSSENS,François Maria Janssen Pharmaceutica N.V. SOMMEN,Joseph E. Janssen Pharmaceutica N.V. LEENAERTS,Y.E.M. Janssen Pharmaceutica N.V. VAN ROOSBROECK,Theo Frans Janssen Pharmaceutica N.V. MEERT. Владелец: Janssen Pharmaceutica NV. Дата публикации: 2006-03-22.

Topical use of cytokines and/or chemokines for the treatment of viral or mykotic skin diseases or tumoral diseases

Номер патента: AU2002362204A1. Автор: John Nieland,Christoph Rehfuess. Владелец: MEDIGENE AG. Дата публикации: 2003-05-19.

Treatment of diabetic polyneuropathy using sildenafil (and cGMP-PDE5 inhibitors)

Номер патента: NZ507690A. Автор: Eric Ben Grossman,Nandan Parmanand Koppiker,Steven B Leichter. Владелец: Pfizer. Дата публикации: 2002-10-25.

Device and use of a pressure-sound-source for the treatment of fungal diseases

Номер патента: US20120172765A1. Автор: Esenwein Cornelia. Владелец: . Дата публикации: 2012-07-05.

Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative treatment.

Номер патента: ZA96251B. Автор: Charles E Hart,Michael Shalmi,Birgitte Hjort Guldhammer,Niels Korsgaard,Jan Ulrik Weis,Steven Bain. Владелец: Novo Nordisk AS. Дата публикации: 1997-02-20.

Use of a 3-phenoxyazetidine carboxamide for the preparation of a pharmaceutical composition for the treatment of muscle tension and / or muscle plasticity

Номер патента: DK170270B1. Автор: Jr Chandler Roy Taylor,Jr Albert Duncal Cale,David Norseen Johnson,Jr Harold Fisher Stauffer. Владелец: Robins Co Inc A H. Дата публикации: 1995-07-24.

Use of creatine or creatine analogs for the treatment of diseases of the nervous system

Номер патента: CA2507753A1. Автор: Rima Kaddurah-Daouk,Ghaleb Daouk,M. Flint Beal. Владелец: M. Flint Beal. Дата публикации: 1996-05-17.

Бесплатный поиск патентной информации. Построение патентных ландшафтов и отчетов.

Главная
Проекты и услуги
Контакты

© 2021-2022 - All Rights Reserved - разработано Ecoruspace.me.